data_2mp0_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2mp0 _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.3 mmm . . . . . 0 N--CA 1.493 1.682 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 72.6 mt -107.97 129.91 61.32 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.051 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 179.647 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 63.9 m -129.96 141.73 50.73 Favored 'General case' 0 N--CA 1.502 2.16 0 O-C-N 121.196 -0.94 . . . . 0.0 110.429 -179.599 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -123.41 -159.58 10.55 Favored Glycine 0 N--CA 1.499 2.842 0 N-CA-C 108.37 -1.892 . . . . 0.0 108.37 179.04 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.459 ' O ' ' O ' ' A' ' 6' ' ' LEU . 81.7 mt -94.95 -12.02 8.68 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 O-C-N 120.801 -1.411 . . . . 0.0 111.083 -178.735 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.459 ' O ' ' O ' ' A' ' 5' ' ' ILE . 58.9 tp 53.34 103.91 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.164 -0.96 . . . . 0.0 109.577 -179.645 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.473 ' O ' ' NE ' ' A' ' 195' ' ' ARG . . . -95.56 -25.52 16.15 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.257 -0.902 . . . . 0.0 109.823 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.421 ' CB ' ' O ' ' A' ' 199' ' ' LEU . 2.6 m -141.79 126.36 10.32 Favored Pre-proline 0 N--CA 1.496 1.847 0 O-C-N 121.234 -0.916 . . . . 0.0 108.875 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -80.14 142.83 15.53 Favored 'Trans proline' 0 N--CA 1.491 1.328 0 C-N-CA 121.938 1.758 . . . . 0.0 111.797 179.636 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.476 ' O ' ' O ' ' A' ' 221' ' ' ASP . . . 163.36 -160.83 33.5 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 108.651 -1.78 . . . . 0.0 108.651 -179.852 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 86.5 mt -149.55 150.13 14.09 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 O-C-N 121.079 -1.248 . . . . 0.0 108.253 178.617 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -156.22 154.68 31.14 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.815 -1.178 . . . . 0.0 111.157 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.546 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 2.0 m-85 -133.77 126.84 31.48 Favored 'General case' 0 N--CA 1.497 1.923 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 178.808 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -179.85 178.67 48.67 Favored Glycine 0 N--CA 1.496 2.652 0 C-N-CA 118.702 -1.713 . . . . 0.0 110.919 179.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -79.74 159.95 26.41 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.712 -0.876 . . . . 0.0 109.225 -179.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -104.79 129.0 53.14 Favored 'General case' 0 N--CA 1.501 2.106 0 O-C-N 121.328 -0.857 . . . . 0.0 111.126 -178.172 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 62.0 tp -100.87 134.67 43.49 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 178.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 57.1 tp -116.91 122.47 44.42 Favored 'General case' 0 N--CA 1.504 2.274 0 O-C-N 121.213 -0.93 . . . . 0.0 110.53 -179.103 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 17.9 mt -87.77 103.44 15.63 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.621 -0.675 . . . . 0.0 110.239 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 59.0 mttt -98.43 134.96 40.68 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.405 -0.809 . . . . 0.0 109.214 179.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -130.8 130.54 43.8 Favored 'General case' 0 N--CA 1.502 2.133 0 O-C-N 121.148 -0.97 . . . . 0.0 109.379 178.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 93.8 m-20 -75.9 147.42 39.0 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.875 -1.14 . . . . 0.0 109.365 179.325 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 86.0 tt0 -67.29 140.17 57.31 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.122 -0.987 . . . . 0.0 109.362 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 55.3 mt -79.31 130.22 36.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.492 -0.755 . . . . 0.0 109.522 -179.338 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 30.6 t -97.06 126.46 49.82 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.281 -0.887 . . . . 0.0 109.736 -179.456 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 87.4 mt -105.8 136.86 38.36 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 179.698 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -92.05 121.21 33.4 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.087 -1.008 . . . . 0.0 109.965 -179.294 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 6.6 mmt180 -88.54 -3.26 58.84 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.298 -0.876 . . . . 0.0 108.931 179.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 89.9 mttt -63.27 139.59 58.79 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.349 -0.845 . . . . 0.0 109.198 -179.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 92.3 mttt -86.23 150.03 24.67 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.251 -0.906 . . . . 0.0 109.087 179.631 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 4.7 pt -95.2 165.05 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.285 -0.885 . . . . 0.0 110.325 -179.422 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 75.6 p -96.25 173.08 7.57 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 178.234 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.93 -49.26 78.39 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.118 -0.989 . . . . 0.0 109.566 -179.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -54.42 -30.05 51.17 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.78 -1.2 . . . . 0.0 109.183 179.727 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -82.75 -10.4 58.91 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.229 -0.919 . . . . 0.0 110.712 -179.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 31.1 t -63.85 -52.75 53.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 120.601 -1.312 . . . . 0.0 108.674 179.692 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -60.37 -40.06 89.44 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.341 -0.849 . . . . 0.0 110.092 -179.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 33.8 mt-30 -68.66 -40.03 80.37 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.993 -1.067 . . . . 0.0 110.825 -178.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 60.1 mm-40 -65.34 -40.07 93.18 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.744 -1.222 . . . . 0.0 110.032 -179.201 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 55.5 t -60.4 -46.76 94.66 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 O-C-N 120.755 -1.216 . . . . 0.0 108.552 178.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 53.8 tp10 -60.08 -41.33 92.22 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.265 -0.897 . . . . 0.0 109.443 179.576 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -60.11 -44.19 95.04 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.003 -1.061 . . . . 0.0 108.227 179.081 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 65.9 t80 -60.74 -49.79 76.1 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 178.542 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 14.7 tp -61.39 -44.46 97.12 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.345 -0.847 . . . . 0.0 108.795 179.167 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 47.2 t -64.48 -43.77 93.12 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.961 -1.087 . . . . 0.0 109.208 179.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -68.92 -40.21 84.67 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 108.76 -1.736 . . . . 0.0 108.76 179.077 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.45 HH21 ' HG2' ' A' ' 81' ' ' GLU . 37.1 ttt-85 -65.56 -31.92 73.23 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 108.264 -1.014 . . . . 0.0 108.264 178.726 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.81 -41.11 90.55 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 179.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.43 ' O ' ' C ' ' A' ' 50' ' ' ALA . 6.7 ttpt -63.86 -73.01 0.12 Allowed 'General case' 0 C--N 1.305 -1.34 0 O-C-N 120.867 -1.146 . . . . 0.0 108.154 179.214 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.43 ' C ' ' O ' ' A' ' 49' ' ' LYS . . . -38.43 -33.77 0.11 Allowed 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.331 -0.855 . . . . 0.0 111.161 -178.734 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 15.3 t -58.53 -56.08 26.82 Favored 'General case' 0 C--N 1.3 -1.581 0 C-N-CA 118.553 -1.259 . . . . 0.0 108.139 179.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -69.8 -40.0 76.24 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.533 -0.729 . . . . 0.0 111.392 -179.084 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 27.8 mt-30 -67.34 -40.14 85.83 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 120.718 -1.239 . . . . 0.0 110.234 -179.391 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 76.9 mt -62.17 -40.16 95.08 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.833 -1.167 . . . . 0.0 108.868 178.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 60.6 mm-40 -61.31 -37.99 85.23 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.516 -0.74 . . . . 0.0 109.814 179.381 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 83.2 m -63.01 -41.44 99.56 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.022 -1.049 . . . . 0.0 109.231 -179.777 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.519 ' CD1' HH22 ' A' ' 136' ' ' ARG . 96.6 mt -62.72 -38.75 82.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.237 -0.914 . . . . 0.0 109.512 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.546 ' NZ ' ' O ' ' A' ' 70' ' ' GLU . 63.9 tttp -56.88 -51.37 69.35 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.501 -0.75 . . . . 0.0 109.844 -179.729 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 66.8 p -58.41 -33.98 70.26 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.314 -0.866 . . . . 0.0 110.451 -178.054 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.57 ' O ' ' OG1' ' A' ' 64' ' ' THR . 68.4 mttm -69.64 -37.48 76.78 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.871 -1.143 . . . . 0.0 109.347 -179.897 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -65.16 -43.84 90.46 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.467 -0.771 . . . . 0.0 109.545 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -60.26 -51.87 56.18 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 110.469 -1.052 . . . . 0.0 110.469 -179.448 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 71.5 mm-40 -69.91 -44.38 69.79 Favored 'General case' 0 C--O 1.205 -1.268 0 O-C-N 120.257 -1.731 . . . . 0.0 111.007 179.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.671 ' HG1' ' H ' ' A' ' 65' ' ' PHE . 76.6 p -64.9 -63.15 1.18 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.95 -1.094 . . . . 0.0 112.04 -178.299 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.671 ' H ' ' HG1' ' A' ' 64' ' ' THR . 10.7 m-85 -96.54 -48.68 5.44 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 121.055 -1.028 . . . . 0.0 111.609 -177.793 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 142.1 -168.72 25.61 Favored Glycine 0 N--CA 1.503 3.163 0 C-N-CA 119.561 -1.304 . . . . 0.0 111.392 179.676 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 75.5 mm-40 -70.11 -24.65 63.24 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.856 -0.791 . . . . 0.0 109.946 -179.775 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -61.05 -36.39 79.45 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.285 -0.885 . . . . 0.0 109.675 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 24.9 tttp -97.78 -20.91 17.25 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.339 -0.85 . . . . 0.0 110.522 -179.569 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.546 ' O ' ' NZ ' ' A' ' 58' ' ' LYS . 80.5 tt0 -67.15 -43.55 82.03 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.019 -1.051 . . . . 0.0 110.896 -179.019 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.434 ' HB1' ' O ' ' B' ' 345' ' ' ILE . . . -68.19 -28.5 67.32 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.279 -0.888 . . . . 0.0 111.209 -177.782 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 96.0 mt -59.19 -39.48 78.79 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 C-N-CA 117.867 -1.533 . . . . 0.0 108.479 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 73.6 m-85 -65.54 -38.73 90.45 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.117 -0.99 . . . . 0.0 109.756 179.462 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.474 ' HB2' ' NZ ' ' A' ' 58' ' ' LYS . 85.6 tt0 -59.76 -40.24 87.51 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 120.82 -1.175 . . . . 0.0 109.224 179.91 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -62.72 -47.95 85.09 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 108.772 -1.731 . . . . 0.0 108.772 179.01 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . 0.449 ' CD2' HD11 ' A' ' 133' ' ' ILE . 56.2 m170 -60.85 -45.65 93.66 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.565 -0.962 . . . . 0.0 109.024 179.769 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 96.9 mt -66.45 -47.14 84.8 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 121.319 -0.863 . . . . 0.0 109.01 179.578 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 65.8 ttp -60.06 -40.07 88.21 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.075 -1.016 . . . . 0.0 109.818 -179.349 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 46.6 tp -65.54 -40.1 92.51 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.324 -0.86 . . . . 0.0 109.562 179.37 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 9.2 tt -63.11 -39.29 94.27 Favored 'General case' 0 C--N 1.297 -1.697 0 O-C-N 121.673 -0.642 . . . . 0.0 109.902 -179.021 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.45 ' HG2' HH21 ' A' ' 47' ' ' ARG . 97.7 mt-10 -82.95 5.74 20.97 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.27 -0.894 . . . . 0.0 110.056 -179.265 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 34.7 m-20 -50.83 130.1 24.42 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.914 -1.116 . . . . 0.0 109.598 -179.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -60.8 -19.13 58.9 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.376 -0.828 . . . . 0.0 110.696 -178.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 -71.23 -35.88 71.63 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.865 -1.147 . . . . 0.0 109.52 178.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 85.3 mt -70.19 -39.97 74.9 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.568 -0.708 . . . . 0.0 110.086 179.65 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -60.62 -48.34 82.21 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.368 -0.833 . . . . 0.0 109.414 -179.087 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -69.89 -41.05 75.27 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.303 -0.873 . . . . 0.0 110.819 -179.502 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 51.3 tp10 -70.02 -40.22 75.35 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.029 -1.044 . . . . 0.0 111.804 -178.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 89.7 mt -67.5 -45.75 84.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 120.828 -1.17 . . . . 0.0 109.159 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 66.5 mt -67.83 -39.32 81.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.615 -0.678 . . . . 0.0 110.811 -179.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.425 ' O ' ' N ' ' A' ' 95' ' ' ASP . . . -60.2 -47.87 84.15 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.103 -0.998 . . . . 0.0 111.139 -178.735 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.441 ' O ' ' N ' ' A' ' 96' ' ' LYS . 19.6 mt -60.76 -46.01 92.11 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 120.858 -1.151 . . . . 0.0 109.842 -179.428 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 47.0 mt -61.19 -49.15 85.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.088 -1.008 . . . . 0.0 108.437 179.19 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 22.2 mttt -69.31 -42.02 75.96 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.431 -0.793 . . . . 0.0 110.651 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.425 ' N ' ' O ' ' A' ' 91' ' ' ALA . 51.9 t0 -81.92 -50.93 8.6 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.87 -1.144 . . . . 0.0 112.115 -178.248 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.441 ' N ' ' O ' ' A' ' 92' ' ' LEU . 17.7 mttp -91.58 -0.98 57.64 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 120.967 -1.083 . . . . 0.0 112.204 -177.557 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER 51.56 41.07 28.35 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 120.874 -1.141 . . . . 0.0 110.879 -178.834 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 25.5 mtp -93.11 169.79 10.14 Favored 'General case' 0 N--CA 1.498 1.941 0 CA-C-N 114.416 -1.265 . . . . 0.0 109.584 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 77.3 p -80.99 159.88 24.74 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.193 -0.942 . . . . 0.0 109.807 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -68.09 -40.19 82.69 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.192 -0.943 . . . . 0.0 110.71 -179.522 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . 0.548 ' OD1' ' N ' ' A' ' 101' ' ' ASP . 3.2 p-10 -70.58 -34.3 72.02 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.811 -1.18 . . . . 0.0 109.607 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -80.55 -40.44 25.92 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 120.949 -1.095 . . . . 0.0 109.484 179.142 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -70.34 -46.2 64.64 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.282 -0.886 . . . . 0.0 110.035 -179.7 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -61.4 -38.95 88.92 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.243 -0.911 . . . . 0.0 109.76 -179.722 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . 0.52 ' NE2' ' OE1' ' A' ' 109' ' ' GLU . 81.0 t60 -59.72 -40.18 87.15 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.31 -0.869 . . . . 0.0 109.875 -178.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 86.2 tt0 -63.85 -40.16 95.93 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.301 -0.874 . . . . 0.0 110.312 -179.103 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 97.9 t -63.67 -54.48 31.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.265 -0.897 . . . . 0.0 111.077 -178.345 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 50.6 mm -68.63 -40.69 82.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 120.846 -1.159 . . . . 0.0 109.216 -179.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.52 ' OE1' ' NE2' ' A' ' 105' ' ' HIS . 86.4 tt0 -64.94 -39.52 93.63 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 178.873 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -57.73 -49.42 74.28 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 110.08 -1.208 . . . . 0.0 110.08 -179.405 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 86.7 mt-30 -66.98 -52.92 36.81 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.781 -1.423 . . . . 0.0 109.35 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -54.98 -40.4 70.03 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.187 -0.946 . . . . 0.0 108.875 179.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' SER . . . . . 0.459 ' OG ' ' O ' ' A' ' 109' ' ' GLU . 55.1 m -59.59 -40.3 86.99 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.251 -0.905 . . . . 0.0 108.915 -179.893 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -63.79 -39.89 95.35 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.183 -0.948 . . . . 0.0 109.081 179.236 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.475 HD11 ' N ' ' A' ' 115' ' ' LEU . 9.2 mp -63.55 -40.11 96.15 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.306 -0.871 . . . . 0.0 109.779 -179.254 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . 0.444 ' O ' ' NZ ' ' A' ' 124' ' ' LYS . 79.9 mm-40 -59.85 -36.06 76.07 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.525 -1.36 . . . . 0.0 109.628 -179.55 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 65.4 mm-40 -54.76 -19.87 7.25 Favored 'General case' 0 C--O 1.202 -1.396 0 C-N-CA 117.998 -1.481 . . . . 0.0 110.984 179.008 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 88.3 mt -62.24 147.35 48.21 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.171 -0.955 . . . . 0.0 109.562 -179.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . 0.404 ' OD1' ' O ' ' A' ' 119' ' ' ASP . 57.0 t0 -98.56 40.62 1.18 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.467 -0.771 . . . . 0.0 109.894 -179.772 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -131.57 133.87 45.47 Favored 'General case' 0 N--CA 1.504 2.231 0 O-C-N 121.332 -0.855 . . . . 0.0 110.203 -179.611 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.455 ' OE1' ' N ' ' A' ' 121' ' ' GLU . 59.5 mp0 -70.15 -29.96 66.99 Favored 'General case' 0 N--CA 1.498 1.931 0 CA-C-O 121.366 0.603 . . . . 0.0 110.46 179.352 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 0.757 ' CG ' ' OE1' ' B' ' 397' ' ' GLU . 1.9 m-30 -71.91 -40.07 69.06 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.422 -0.799 . . . . 0.0 110.599 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.465 ' CD2' ' N ' ' A' ' 123' ' ' LEU . 3.1 mm? -73.84 -34.71 64.65 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.098 -1.001 . . . . 0.0 108.591 179.828 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . 0.444 ' NZ ' ' O ' ' A' ' 116' ' ' GLU . 67.7 mttm -62.04 -42.06 98.77 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.62 -0.675 . . . . 0.0 110.496 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . 0.557 ' CG ' ' HG ' ' A' ' 188' ' ' SER . 40.4 tp10 -60.51 -44.52 95.91 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 120.62 -1.3 . . . . 0.0 109.848 179.841 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 60.7 ttp180 -59.96 -36.08 76.35 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.904 -1.122 . . . . 0.0 108.382 179.63 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -61.29 -25.98 67.47 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 108.072 -1.085 . . . . 0.0 108.072 178.277 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -70.19 -40.1 74.81 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 108.739 -0.838 . . . . 0.0 108.739 178.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -66.35 -40.07 89.57 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.559 -0.713 . . . . 0.0 109.385 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 79.8 t -68.37 -40.13 81.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 179.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 71.5 ttt180 -60.07 -40.32 89.09 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.377 -0.827 . . . . 0.0 109.384 178.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -60.01 -39.5 86.03 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.649 -0.657 . . . . 0.0 110.172 -178.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . 0.449 HD11 ' CD2' ' A' ' 76' ' ' HIS . 96.7 mt -59.7 -45.42 94.45 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 O-C-N 121.038 -1.039 . . . . 0.0 109.892 -179.026 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -71.54 -34.54 63.25 Favored Glycine 0 N--CA 1.494 2.506 0 C-N-CA 119.955 -1.116 . . . . 0.0 110.333 -179.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 39.9 tttt -59.51 -47.77 84.24 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.371 -1.076 . . . . 0.0 109.612 -179.224 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.519 HH22 ' CD1' ' A' ' 57' ' ' ILE . 65.8 mtp180 -69.92 -31.06 68.65 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.991 -1.068 . . . . 0.0 109.952 -179.78 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 64.4 tp -58.04 -42.1 84.66 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.239 -0.913 . . . . 0.0 108.748 -179.454 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 51.6 mt -60.99 -40.06 92.03 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.15 -0.969 . . . . 0.0 109.245 178.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 27.2 mtt180 -67.44 -39.87 85.43 Favored 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 118.862 -1.135 . . . . 0.0 108.669 179.259 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 56.9 m-80 -62.2 -37.98 87.37 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.536 -0.728 . . . . 0.0 111.297 -179.45 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 83.5 mt -71.07 -43.5 75.87 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 120.391 -1.443 . . . . 0.0 108.037 179.515 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 95.5 mt -71.12 -32.82 69.47 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.416 -0.802 . . . . 0.0 109.103 179.663 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 84.07 42.34 7.63 Favored Glycine 0 N--CA 1.494 2.566 0 N-CA-C 109.035 -1.626 . . . . 0.0 109.035 -179.221 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 8.4 tp -74.54 148.62 40.74 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.551 -0.97 . . . . 0.0 110.652 -178.719 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 56.1 tptt -61.1 138.71 58.2 Favored 'General case' 0 N--CA 1.49 1.57 0 CA-C-O 121.31 0.576 . . . . 0.0 110.613 -179.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 84.3 mt -117.12 127.5 74.69 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 CA-C-O 122.354 1.073 . . . . 0.0 108.177 178.04 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 10.2 mt -66.28 -39.84 85.28 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.869 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.585 -178.362 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 36.7 t0 61.56 113.62 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.291 -0.881 . . . . 0.0 109.232 -179.384 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 79.2 mt -77.44 -0.79 27.27 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.249 -0.907 . . . . 0.0 110.309 -179.018 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -85.41 -14.94 44.68 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.618 -1.301 . . . . 0.0 109.989 -179.761 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -82.16 28.4 0.45 Allowed 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.035 -1.041 . . . . 0.0 111.313 -178.174 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 46.6 mm -89.17 119.75 36.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 120.284 -1.51 . . . . 0.0 110.053 -179.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 87.0 mt-30 -100.9 -13.11 18.47 Favored 'General case' 0 N--CA 1.502 2.134 0 O-C-N 121.317 -0.864 . . . . 0.0 110.505 179.449 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 94.8 m-20 -127.47 151.45 48.83 Favored 'General case' 0 N--CA 1.506 2.332 0 O-C-N 121.046 -1.034 . . . . 0.0 110.724 -178.61 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -64.02 134.01 54.19 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 179.537 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 28.6 m -151.84 165.2 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.44 -0.788 . . . . 0.0 110.088 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 74.4 mt -93.97 146.89 6.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 N-CA-C 105.424 -2.065 . . . . 0.0 105.424 176.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 62.6 tp -99.29 117.8 34.54 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.066 -1.021 . . . . 0.0 110.393 -178.029 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 59.0 t -121.07 129.83 75.29 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 179.7 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -157.27 160.94 39.12 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.015 -1.053 . . . . 0.0 109.232 -179.481 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -68.48 -37.26 79.96 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 120.246 -1.533 . . . . 0.0 107.945 178.262 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -170.31 146.63 2.93 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 178.539 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 25.9 mt -112.81 138.21 49.99 Favored 'General case' 0 N--CA 1.503 2.201 0 O-C-N 121.386 -0.821 . . . . 0.0 110.008 -179.199 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 45.3 p -93.99 146.31 31.42 Favored Pre-proline 0 N--CA 1.495 1.805 0 O-C-N 121.265 -0.897 . . . . 0.0 108.75 179.21 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 99.6 Cg_exo -39.75 -36.55 1.25 Allowed 'Trans proline' 0 N--CA 1.495 1.583 0 C-N-CA 122.151 1.901 . . . . 0.0 112.53 179.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 75.4 m -59.73 -40.33 87.69 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.213 -0.929 . . . . 0.0 110.325 -179.089 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 84.9 mt-10 -69.02 -40.67 78.53 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 120.999 -1.063 . . . . 0.0 110.003 -178.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 40.0 p -55.45 -30.99 61.55 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.309 -0.869 . . . . 0.0 111.626 -178.121 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -73.65 -52.81 12.08 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 120.8 -1.188 . . . . 0.0 110.298 -179.503 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 14.4 pt20 -84.54 36.98 0.61 Allowed 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.414 -0.804 . . . . 0.0 108.945 -179.323 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 22.3 tp -105.7 138.86 41.19 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.706 -0.622 . . . . 0.0 109.472 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 24.6 m120 -84.89 102.26 12.97 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.169 -0.957 . . . . 0.0 109.591 179.6 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 58.7 mt -65.03 -40.69 95.19 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.17 -0.956 . . . . 0.0 110.628 -179.482 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 65.1 mttt -69.43 -29.75 67.53 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.814 -1.179 . . . . 0.0 112.03 -177.634 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 77.9 mttt -93.17 -7.55 44.98 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 120.695 -1.253 . . . . 0.0 110.281 -177.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 78.7 t -102.05 113.73 39.34 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 177.477 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 90.5 mt -84.74 6.8 22.86 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.109 -0.994 . . . . 0.0 110.834 -177.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 168.89 174.71 37.73 Favored Glycine 0 N--CA 1.484 1.89 0 N-CA-C 109.349 -1.5 . . . . 0.0 109.349 179.141 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 9.9 m-85 -134.41 129.39 35.26 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.516 -0.991 . . . . 0.0 108.42 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 92.5 mt -132.0 126.28 56.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.429 -0.794 . . . . 0.0 109.101 179.098 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 72.8 p -149.97 162.13 40.96 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.847 -1.158 . . . . 0.0 110.941 -179.484 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . 0.588 ' N ' ' OD1' ' A' ' 182' ' ' ASP . 0.0 OUTLIER -104.43 24.86 10.95 Favored 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 -179.809 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' ALA . . . . . 0.428 ' O ' ' O ' ' A' ' 182' ' ' ASP . . . -55.28 -163.7 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.656 -1.277 . . . . 0.0 111.243 -178.87 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -74.61 -53.28 6.66 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 110.601 -1.0 . . . . 0.0 110.601 -179.382 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 169.76 -81.01 0.09 OUTLIER Glycine 0 N--CA 1.492 2.373 0 N-CA-C 107.218 -2.353 . . . . 0.0 107.218 -179.644 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 186' ' ' ARG . . . . . 0.55 ' O ' ' O ' ' A' ' 187' ' ' THR . 70.8 ttp85 -69.52 -40.62 76.82 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.499 -1.0 . . . . 0.0 109.617 179.08 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 187' ' ' THR . . . . . 0.585 ' O ' ' O ' ' A' ' 188' ' ' SER . 19.9 p 51.81 168.97 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.063 -1.023 . . . . 0.0 109.186 -179.341 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 188' ' ' SER . . . . . 0.585 ' O ' ' O ' ' A' ' 187' ' ' THR . 45.8 m -52.82 -125.65 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.47 -0.769 . . . . 0.0 110.261 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 5.7 m80 -86.27 -1.61 57.64 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.383 -0.823 . . . . 0.0 110.878 -179.616 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 190' ' ' THR . . . . . 0.692 ' O ' ' N ' ' A' ' 193' ' ' MET . 3.8 m -65.65 -85.47 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.271 -0.893 . . . . 0.0 110.89 -179.08 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 191' ' ' SER . . . . . 0.562 ' C ' ' O ' ' A' ' 190' ' ' THR . 10.1 t -36.62 -38.04 0.15 Allowed 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 106.01 -1.848 . . . . 0.0 106.01 178.462 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . 0.461 ' N ' ' O ' ' A' ' 190' ' ' THR . 86.8 mt -62.69 -38.14 80.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.101 -0.999 . . . . 0.0 109.162 179.853 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 193' ' ' MET . . . . . 0.692 ' N ' ' O ' ' A' ' 190' ' ' THR . 5.1 tpp -60.27 -40.71 91.32 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.262 -0.899 . . . . 0.0 110.731 -179.324 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -58.47 -42.38 87.32 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.705 -1.247 . . . . 0.0 108.463 179.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 195' ' ' ARG . . . . . 0.473 ' NE ' ' O ' ' A' ' 7' ' ' ALA . 26.5 mmt85 -60.63 -58.26 9.24 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.423 -0.798 . . . . 0.0 109.448 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 196' ' ' SER . . . . . 0.424 ' CB ' ' HB2' ' B' ' 372' ' ' GLU . 77.6 p -63.14 -39.81 95.74 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.368 -0.833 . . . . 0.0 111.41 -178.931 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 93.5 mt -70.95 -23.31 62.21 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.825 -1.172 . . . . 0.0 109.468 -179.221 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 64.64 49.4 2.33 Favored 'General case' 0 N--CA 1.494 1.742 0 CA-C-O 121.383 0.611 . . . . 0.0 110.127 -179.011 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . 0.421 ' O ' ' CB ' ' A' ' 8' ' ' SER . 85.3 mt -125.92 143.92 46.92 Favored Pre-proline 0 N--CA 1.5 2.051 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 178.518 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -59.23 137.5 79.21 Favored 'Trans proline' 0 N--CA 1.5 1.867 0 C-N-CA 121.866 1.711 . . . . 0.0 112.135 -179.462 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -171.36 150.71 2.93 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.009 -1.057 . . . . 0.0 111.431 -179.535 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 73.4 mt -122.42 148.63 26.0 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.063 0 N-CA-C 107.802 -1.184 . . . . 0.0 107.802 178.136 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 16.8 m -129.22 -9.98 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.196 0 O-C-N 121.021 -1.05 . . . . 0.0 110.244 -179.725 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . 0.404 ' O ' ' C ' ' A' ' 205' ' ' THR . . . -111.98 23.55 16.5 Favored Glycine 0 N--CA 1.501 2.981 0 N-CA-C 110.896 -0.881 . . . . 0.0 110.896 -178.848 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 205' ' ' THR . . . . . 0.404 ' C ' ' O ' ' A' ' 204' ' ' GLY . 3.7 p -44.53 -43.83 8.25 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.021 -1.282 . . . . 0.0 109.951 -179.391 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 94.61 -50.88 2.05 Favored Glycine 0 N--CA 1.496 2.691 0 C-N-CA 120.392 -0.909 . . . . 0.0 111.057 179.197 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 28.1 t -160.76 40.61 0.16 Allowed 'General case' 0 N--CA 1.497 1.887 0 O-C-N 120.65 -1.5 . . . . 0.0 111.212 -178.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 25.1 t -77.15 -41.07 30.61 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 O-C-N 120.877 -1.139 . . . . 0.0 109.568 179.201 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 2.6 p -56.92 -30.6 64.12 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.152 -0.967 . . . . 0.0 110.659 -178.539 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 14.5 t -77.42 -13.2 59.98 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.859 -1.151 . . . . 0.0 109.301 -179.425 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 2.3 mm-40 -102.47 -12.79 17.57 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.648 -0.657 . . . . 0.0 109.692 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 86.2 t -109.64 141.68 24.27 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.263 0 O-C-N 121.384 -0.822 . . . . 0.0 111.311 -178.292 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -110.94 156.31 21.39 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 105.746 -1.946 . . . . 0.0 105.746 176.608 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 214' ' ' ASN . . . . . 0.413 ' O ' ' HB2' ' A' ' 215' ' ' ASP . 51.3 p-10 -60.99 152.4 27.95 Favored 'General case' 0 C--N 1.295 -1.788 0 O-C-N 120.154 -1.592 . . . . 0.0 108.853 179.616 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 215' ' ' ASP . . . . . 0.413 ' HB2' ' O ' ' A' ' 214' ' ' ASN . 0.5 OUTLIER 75.16 9.94 3.77 Favored 'General case' 0 N--CA 1.505 2.297 0 CA-C-O 120.782 0.325 . . . . 0.0 110.766 179.266 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -79.95 143.39 34.23 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.878 -1.139 . . . . 0.0 107.962 178.502 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 46.1 t80 -91.72 122.06 33.93 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 178.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 77.4 mt -129.91 147.83 51.72 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.309 -0.87 . . . . 0.0 110.476 -178.496 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 76.8 mt -116.84 126.1 74.11 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 N-CA-C 106.255 -1.758 . . . . 0.0 106.255 177.072 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 25.4 tp -98.66 118.07 34.56 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.07 -1.019 . . . . 0.0 109.405 -178.331 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 221' ' ' ASP . . . . . 0.491 ' C ' ' H ' ' A' ' 223' ' ' VAL . 29.7 m-20 -75.79 -45.12 37.85 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.294 -0.879 . . . . 0.0 108.764 179.187 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . 49.82 14.39 0.12 Allowed 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.658 -0.868 . . . . 0.0 108.658 -179.533 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . 0.491 ' H ' ' C ' ' A' ' 221' ' ' ASP . 73.8 t -129.57 -46.9 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 N-CA-C 107.2 -1.407 . . . . 0.0 107.2 178.681 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 79.7 m-20 -97.39 0.9 48.61 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 106.499 -1.667 . . . . 0.0 106.499 176.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 11.4 t-20 60.01 46.57 10.74 Favored 'General case' 0 N--CA 1.487 1.389 0 CA-C-N 115.802 -0.635 . . . . 0.0 109.609 179.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -135.01 155.55 50.58 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 121.421 -0.799 . . . . 0.0 109.747 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 93.7 t -124.21 130.03 73.85 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 178.678 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 81.3 m-85 -102.75 122.76 45.12 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.464 -0.772 . . . . 0.0 109.542 179.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 56.5 t -100.99 113.88 38.41 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.001 0 O-C-N 121.657 -0.652 . . . . 0.0 110.587 -178.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 62.9 t-20 54.16 67.12 3.68 Favored Pre-proline 0 N--CA 1.495 1.825 0 O-C-N 121.134 -0.979 . . . . 0.0 110.777 179.317 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -89.22 144.37 4.92 Favored 'Trans proline' 0 C--N 1.307 -1.637 0 C-N-CA 122.876 2.384 . . . . 0.0 112.388 179.501 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -67.96 165.55 17.57 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.323 -0.861 . . . . 0.0 109.427 -179.575 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -60.06 -39.7 86.89 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.397 -0.814 . . . . 0.0 109.831 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -59.9 -36.86 77.85 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.283 -0.886 . . . . 0.0 109.616 -179.253 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 54.9 t -67.45 -40.42 84.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.076 -1.015 . . . . 0.0 109.317 179.222 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 86.2 mt -66.75 -45.71 87.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.173 -0.954 . . . . 0.0 109.052 179.616 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -55.04 -45.11 75.22 Favored 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 179.584 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 20.0 tttt -62.62 -40.35 96.71 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.432 -0.793 . . . . 0.0 108.985 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 79.0 mtp -69.83 -31.64 69.62 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.35 -0.844 . . . . 0.0 109.965 179.455 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 5.3 mmt180 -68.41 -40.0 81.42 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.159 -0.963 . . . . 0.0 109.993 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -60.04 -40.47 89.47 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.192 -0.943 . . . . 0.0 108.688 179.623 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 53.8 t -65.64 -40.06 86.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.386 -0.821 . . . . 0.0 109.35 179.716 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 63.1 tt0 -60.35 -39.89 88.75 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.145 -0.972 . . . . 0.0 108.71 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 64.0 mt-10 -60.64 -39.9 90.01 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.283 -0.885 . . . . 0.0 108.966 179.463 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 31.1 mt-30 -61.09 -43.15 99.32 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.131 -0.981 . . . . 0.0 108.537 178.744 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 93.9 t -61.05 -43.48 96.28 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 O-C-N 121.45 -0.781 . . . . 0.0 109.641 -179.656 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -60.23 -43.66 95.86 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.308 -0.87 . . . . 0.0 109.016 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 10.7 t -63.44 -40.02 96.03 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 179.422 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 . . . . . 0 N--CA 1.489 1.485 0 O-C-N 121.508 -0.745 . . . . 0.0 109.577 -179.547 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 319' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.217 -0.605 0 CA-C-O 122.558 1.171 . . . . 0.0 112.806 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 320' ' ' ILE . . . . . 0.817 ' HB ' ' CG1' ' B' ' 466' ' ' ILE . 2.3 mp -105.87 130.87 56.68 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.909 0 CA-C-O 122.69 1.233 . . . . 0.0 110.615 177.619 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 321' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -100.65 124.91 46.91 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-N 114.099 -1.409 . . . . 0.0 110.331 176.432 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 322' ' ' ILE . . . . . . . . . . . . . 10.2 mm -94.74 123.34 46.82 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 N-CA-C 105.987 -1.856 . . . . 0.0 105.987 176.449 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 323' ' ' ILE . . . . . . . . . . . . . 21.7 mm -92.04 146.68 6.01 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.574 0 CA-C-O 122.447 1.118 . . . . 0.0 111.822 -178.371 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 324' ' ' ALA . . . . . . . . . . . . . . . -58.53 121.07 50.3 Favored Pre-proline 0 N--CA 1.43 -1.437 0 N-CA-C 115.362 1.616 . . . . 0.0 115.362 -178.176 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 325' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_endo -76.07 -20.07 15.14 Favored 'Trans proline' 0 CA--C 1.559 1.753 0 C-N-CA 121.606 1.537 . . . . 0.0 111.484 -177.577 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 326' ' ' LEU . . . . . . . . . . . . 0.322 0.0 OUTLIER -147.45 161.31 41.32 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.849 0.86 . . . . 0.0 110.207 175.246 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 327' ' ' SER . . . . . . . . . . . . . 50.0 m -82.65 148.15 28.12 Favored 'General case' 0 CA--C 1.498 -1.034 0 CA-C-O 121.612 0.72 . . . . 0.0 111.047 177.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 328' ' ' GLY . . . . . . . . . . . . . . . 156.65 -155.44 26.35 Favored Glycine 0 N--CA 1.432 -1.607 0 C-N-CA 119.252 -1.451 . . . . 0.0 111.059 178.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 329' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -117.01 134.89 54.17 Favored 'General case' 0 C--N 1.293 -1.858 0 CA-C-N 114.058 -1.071 . . . . 0.0 110.165 -177.049 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 330' ' ' ILE . . . . . 0.445 HD13 HG21 ' B' ' 330' ' ' ILE . 71.4 mt -74.37 141.51 15.98 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.614 0 C-N-CA 117.645 -1.622 . . . . 0.0 110.366 -179.184 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 331' ' ' VAL . . . . . . . . . . . . . 14.6 t -132.59 155.88 41.79 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.17 0 CA-C-N 114.511 -1.222 . . . . 0.0 108.728 -178.463 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 332' ' ' ASN . . . . . 0.502 ' HB3' ' OE2' ' B' ' 334' ' ' GLU . 13.5 m120 -71.5 138.45 48.95 Favored 'General case' 0 CA--C 1.497 -1.084 0 CA-C-O 121.405 0.621 . . . . 0.0 111.055 178.804 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 333' ' ' ILE . . . . . 0.476 ' CD1' ' CG1' ' B' ' 439' ' ' VAL . 8.2 tt -67.84 -23.68 29.64 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.884 0 C-N-CA 118.642 -1.223 . . . . 0.0 108.768 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 334' ' ' GLU . . . . . 0.502 ' OE2' ' HB3' ' B' ' 332' ' ' ASN . 0.8 OUTLIER -73.9 -14.13 61.01 Favored 'General case' 0 C--N 1.292 -1.915 0 C-N-CA 118.742 -1.183 . . . . 0.0 110.555 180.0 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 335' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -94.99 12.52 28.12 Favored 'General case' 0 C--N 1.307 -1.275 0 N-CA-C 113.776 1.028 . . . . 0.0 113.776 -179.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 336' ' ' VAL . . . . . . . . . . . . . 3.0 t -86.52 130.95 47.31 Favored Pre-proline 0 C--N 1.288 -2.09 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 179.204 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 337' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_exo -70.5 48.16 0.74 Allowed 'Trans proline' 0 C--N 1.313 -1.317 0 C-N-CA 122.688 2.259 . . . . 0.0 111.702 -173.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 338' ' ' ASP . . . . . . . . . . . . . 65.3 t0 -150.74 115.81 5.32 Favored 'General case' 0 C--N 1.29 -1.987 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 179.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 339' ' ' VAL . . . . . . . . . . . . . 19.8 m -60.32 -37.96 75.89 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.256 0 C-N-CA 119.04 -1.064 . . . . 0.0 111.669 -178.482 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 340' ' ' VAL . . . . . . . . . . . . 0.406 17.6 m -62.36 -34.81 66.28 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 C-N-CA 116.983 -1.887 . . . . 0.0 112.136 -179.851 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 341' ' ' PHE . . . . . . . . . . . . . 69.5 m-85 -84.26 -44.38 13.92 Favored 'General case' 0 C--N 1.261 -3.248 0 O-C-N 120.185 -1.572 . . . . 0.0 109.777 179.625 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 342' ' ' ALA . . . . . . . . . . . . . . . -60.35 -37.9 82.14 Favored 'General case' 0 CA--C 1.487 -1.454 0 N-CA-C 108.793 -0.818 . . . . 0.0 108.793 -177.513 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 343' ' ' GLU . . . . . 0.457 ' O ' ' HG2' ' B' ' 344' ' ' LYS . 60.2 mt-10 -86.12 5.44 33.79 Favored 'General case' 0 C--O 1.209 -1.027 0 CA-C-O 123.061 1.41 . . . . 0.0 111.005 178.919 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 344' ' ' LYS . . . . . 0.552 ' HB2' ' O ' ' B' ' 347' ' ' GLY . 0.0 OUTLIER 51.1 40.06 24.85 Favored 'General case' 0 CA--C 1.502 -0.874 0 O-C-N 120.414 -1.429 . . . . 0.0 113.94 179.215 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 345' ' ' ILE . . . . . 0.434 ' O ' ' HB1' ' A' ' 71' ' ' ALA . 25.8 mt -67.25 -30.4 49.1 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.956 0 CA-C-O 123.58 1.657 . . . . 0.0 110.63 178.556 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 346' ' ' VAL . . . . . . . . . . . . 0.29 11.1 p -89.49 -7.77 10.82 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.953 0 CA-C-N 112.422 -2.172 . . . . 0.0 111.842 -175.495 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 347' ' ' GLY . . . . . 0.552 ' O ' ' HB2' ' B' ' 344' ' ' LYS . . . 133.44 -175.56 20.13 Favored Glycine 0 C--O 1.207 -1.576 0 N-CA-C 108.775 -1.73 . . . . 0.0 108.775 176.541 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 348' ' ' ASP . . . . . 0.602 ' OD2' ' SD ' ' B' ' 443' ' ' MET . 70.4 m-20 -119.48 155.38 32.19 Favored 'General case' 0 C--N 1.31 -1.15 0 C-N-CA 118.021 -1.471 . . . . 0.0 112.847 179.667 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 349' ' ' GLY . . . . . . . . . . . . . . . 172.17 -137.63 4.37 Favored Glycine 0 CA--C 1.536 1.405 0 C-N-CA 117.787 -2.149 . . . . 0.0 111.33 177.329 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 350' ' ' ILE . . . . . . . . . . . . . 2.8 pp -135.2 175.13 11.64 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.665 0 O-C-N 121.561 -0.964 . . . . 0.0 108.629 178.624 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 351' ' ' ALA . . . . . . . . . . . . . . . -121.52 158.49 28.36 Favored 'General case' 0 C--N 1.306 -1.305 0 C-N-CA 124.701 1.2 . . . . 0.0 108.421 175.549 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 352' ' ' ILE . . . . . . . . . . . . . 58.5 mt -133.39 128.92 55.81 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.843 0 O-C-N 121.595 -0.69 . . . . 0.0 110.965 178.032 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 353' ' ' LYS . . . . . 0.464 ' HA ' ' HD3' ' B' ' 354' ' ' PRO . 5.1 tmtt? -86.23 108.85 19.09 Favored Pre-proline 0 C--N 1.307 -1.275 0 N-CA-C 101.447 -3.538 . . . . 0.0 101.447 174.767 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 354' ' ' PRO . . . . . 0.464 ' HD3' ' HA ' ' B' ' 353' ' ' LYS . 2.0 Cg_endo -71.38 150.13 57.84 Favored 'Trans proline' 0 C--N 1.309 -1.534 0 C-N-CA 123.601 2.868 . . . . 0.0 113.08 -170.894 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 355' ' ' THR . . . . . . . . . . . . . 73.5 p -138.57 1.65 2.16 Favored 'General case' 0 C--N 1.315 -0.914 0 O-C-N 121.856 -0.527 . . . . 0.0 110.19 177.654 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 356' ' ' GLY . . . . . . . . . . . . . . . -108.76 -144.62 10.94 Favored Glycine 0 CA--C 1.533 1.196 0 O-C-N 121.444 -0.785 . . . . 0.0 114.592 -177.705 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 357' ' ' ASN . . . . . . . . . . . . . 22.1 p30 -142.85 14.32 1.91 Allowed 'General case' 0 CA--C 1.493 -1.237 0 O-C-N 122.317 -0.519 . . . . 0.0 112.11 -179.308 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 358' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -157.23 155.12 30.3 Favored 'General case' 0 N--CA 1.415 -2.219 0 C-N-CA 115.488 -2.485 . . . . 0.0 113.382 178.567 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 359' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -114.86 121.47 43.35 Favored 'General case' 0 N--CA 1.438 -1.051 0 CA-C-N 114.931 -1.031 . . . . 0.0 109.097 178.864 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 360' ' ' VAL . . . . . . . . . . . . . 3.1 m -114.36 174.55 2.75 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.797 0 CA-C-O 122.739 1.257 . . . . 0.0 110.921 -178.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 361' ' ' ALA . . . . . . . . . . . . . . . -68.03 126.76 93.03 Favored Pre-proline 0 C--N 1.289 -2.025 0 CA-C-N 113.797 -1.547 . . . . 0.0 109.762 179.199 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 362' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -86.05 -1.4 8.66 Favored 'Trans proline' 0 C--N 1.323 -0.81 0 CA-C-N 120.083 1.065 . . . . 0.0 110.344 -179.543 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 363' ' ' VAL . . . . . . . . . . . . . 17.1 m -158.52 165.03 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 CA-C-O 121.477 0.656 . . . . 0.0 111.202 -178.167 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 364' ' ' ASP . . . . . 0.473 ' OD1' ' N ' ' B' ' 415' ' ' VAL . 48.1 m-20 -81.58 127.27 32.68 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 103.484 -2.784 . . . . 0.0 103.484 174.683 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 365' ' ' GLY . . . . . 0.471 ' HA3' ' O ' ' B' ' 380' ' ' GLU . . . 173.99 -157.96 26.42 Favored Glycine 0 C--N 1.302 -1.346 0 N-CA-C 110.738 -0.945 . . . . 0.0 110.738 -175.487 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 366' ' ' THR . . . . . . . . . . . . . 33.3 p -123.72 134.84 53.63 Favored 'General case' 0 C--N 1.314 -0.976 0 C-N-CA 119.805 -0.758 . . . . 0.0 111.448 -177.384 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 367' ' ' ILE . . . . . 0.596 HG21 ' N ' ' B' ' 410' ' ' GLY . 1.6 tp -68.69 140.45 18.93 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.01 0 C-N-CA 117.629 -1.628 . . . . 0.0 107.357 178.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 368' ' ' GLY . . . . . . . . . . . . . . . -101.89 -64.09 0.75 Allowed Glycine 0 C--N 1.282 -2.447 0 CA-C-O 122.064 0.813 . . . . 0.0 114.278 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 369' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -141.5 136.38 31.15 Favored 'General case' 0 C--N 1.281 -2.407 0 CA-C-O 123.1 1.428 . . . . 0.0 111.833 -177.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 370' ' ' ILE . . . . . . . . . . . . . 97.5 mt -116.06 125.54 73.19 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.056 0 N-CA-C 105.583 -2.006 . . . . 0.0 105.583 179.629 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 371' ' ' PHE . . . . . 0.416 ' CE2' ' O3 ' ' B' ' 500' ' ' PO3 . 5.6 m-85 -62.69 145.36 54.89 Favored 'General case' 0 C--N 1.303 -1.413 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 -179.31 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 372' ' ' GLU . . . . . 0.424 ' HB2' ' CB ' ' A' ' 196' ' ' SER . 47.1 tp10 -61.71 -15.15 38.0 Favored 'General case' 0 C--N 1.296 -1.722 0 C-N-CA 123.717 0.807 . . . . 0.0 110.405 -178.338 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 373' ' ' THR . . . . . 0.667 ' OG1' ' CD2' ' B' ' 375' ' ' HIS . 41.6 p -97.63 5.2 49.73 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-O 123.591 1.663 . . . . 0.0 109.142 178.363 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 374' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 50.39 44.32 26.74 Favored 'General case' 0 C--N 1.263 -3.185 0 CA-C-N 113.207 -1.815 . . . . 0.0 112.66 175.416 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 375' ' ' HIS . . . . . 0.667 ' CD2' ' OG1' ' B' ' 373' ' ' THR . 0.3 OUTLIER -126.35 -1.54 6.93 Favored 'General case' 0 N--CA 1.429 -1.502 0 N-CA-C 113.557 0.947 . . . . 0.0 113.557 -177.499 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 376' ' ' ALA . . . . . . . . . . . . . . . -153.16 152.65 31.5 Favored 'General case' 0 N--CA 1.411 -2.406 0 O-C-N 120.616 -1.302 . . . . 0.0 111.108 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 377' ' ' PHE . . . . . . . . . . . . . 54.1 p90 -152.47 166.48 31.83 Favored 'General case' 0 C--N 1.308 -1.239 0 CA-C-O 123.021 1.391 . . . . 0.0 113.325 178.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 378' ' ' SER . . . . . . . . . . . . 0.256 4.9 p -118.36 139.67 51.01 Favored 'General case' 0 N--CA 1.438 -1.065 0 CA-C-N 113.268 -1.787 . . . . 0.0 109.832 -178.776 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 379' ' ' ILE . . . . . . . . . . . . . 19.9 tt -143.32 150.08 17.83 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 175.735 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 380' ' ' GLU . . . . . 0.471 ' O ' ' HA3' ' B' ' 365' ' ' GLY . 0.7 OUTLIER -118.5 129.69 55.51 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 105.65 -1.982 . . . . 0.0 105.65 178.127 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 381' ' ' SER . . . . . . . . . . . . . 13.7 p -80.84 167.21 20.17 Favored 'General case' 0 C--N 1.297 -1.699 0 C-N-CA 118.433 -1.307 . . . . 0.0 108.183 -176.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 382' ' ' ASP . . . . . 0.401 ' C ' ' H ' ' B' ' 384' ' ' GLY . 99.8 m-20 -68.04 -31.03 70.41 Favored 'General case' 0 C--N 1.278 -2.505 0 C-N-CA 118.466 -1.294 . . . . 0.0 108.296 177.813 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 383' ' ' SER . . . . . . . . . . . . . 4.6 m -70.22 4.42 2.22 Favored 'General case' 0 C--N 1.315 -0.903 0 C-N-CA 125.326 1.45 . . . . 0.0 112.023 -179.69 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 384' ' ' GLY . . . . . 0.401 ' H ' ' C ' ' B' ' 382' ' ' ASP . . . 78.9 14.45 81.99 Favored Glycine 0 C--N 1.279 -2.613 0 N-CA-C 117.198 1.639 . . . . 0.0 117.198 -178.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 385' ' ' VAL . . . . . 0.519 ' HA ' HD21 ' B' ' 442' ' ' ASN . 64.8 t -92.34 132.97 35.22 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.374 0 CA-C-N 121.237 2.518 . . . . 0.0 110.9 177.797 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 386' ' ' GLU . . . . . 0.803 ' H ' ' ND2' ' B' ' 442' ' ' ASN . 97.1 mt-10 -96.82 121.97 39.26 Favored 'General case' 0 N--CA 1.476 0.846 0 O-C-N 121.617 -0.677 . . . . 0.0 110.264 176.812 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 387' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -116.42 158.85 22.87 Favored 'General case' 0 C--O 1.216 -0.675 0 CA-C-O 122.002 0.906 . . . . 0.0 110.778 -178.848 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 388' ' ' PHE . . . . . 0.535 ' CE2' ' HB2' ' B' ' 390' ' ' HIS . 80.5 t80 -144.48 108.97 4.86 Favored 'General case' 0 C--N 1.297 -1.703 0 CA-C-O 121.703 0.763 . . . . 0.0 110.692 177.476 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 389' ' ' VAL . . . . . . . . . . . . . 95.2 t -100.3 116.54 43.9 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.015 0 C-N-CA 124.404 1.081 . . . . 0.0 111.477 179.434 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 390' ' ' HIS . . . . . 0.535 ' HB2' ' CE2' ' B' ' 388' ' ' PHE . 3.2 t-80 -122.14 106.45 11.17 Favored 'General case' 0 C--O 1.202 -1.444 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.126 -179.277 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 391' ' ' PHE . . . . . . . . . . . . . 30.6 t80 -63.7 124.16 20.72 Favored 'General case' 0 CA--C 1.559 1.294 0 N-CA-C 116.573 2.064 . . . . 0.0 116.573 178.675 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 392' ' ' GLY . . . . . . . . . . . . . . . 69.38 -175.86 32.24 Favored Glycine 0 C--O 1.215 -1.082 0 CA-C-O 122.815 1.231 . . . . 0.0 114.467 175.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 393' ' ' ILE . . . . . 0.478 HD11 HG21 ' B' ' 393' ' ' ILE . 0.2 OUTLIER -118.15 132.64 67.39 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.155 0 CA-C-O 123.109 1.433 . . . . 0.0 109.224 179.4 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 394' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 54.63 25.93 6.88 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-N 114.064 -1.425 . . . . 0.0 111.29 -177.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 395' ' ' THR . . . . . . . . . . . . . 48.8 p -64.44 -20.0 65.89 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 115.38 1.622 . . . . 0.0 115.38 -179.617 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 396' ' ' VAL . . . . . . . . . . . . . 15.0 p -57.04 -32.85 41.1 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.86 0 O-C-N 120.016 -1.678 . . . . 0.0 109.324 177.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 397' ' ' GLU . . . . . 0.757 ' OE1' ' CG ' ' A' ' 122' ' ' TYR . 98.5 mt-10 -58.47 -20.09 42.41 Favored 'General case' 0 CA--C 1.566 1.567 0 C-N-CA 119.806 -0.758 . . . . 0.0 112.216 -179.329 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 398' ' ' LEU . . . . . . . . . . . . . 10.8 mp -78.26 -3.22 41.75 Favored 'General case' 0 CA--C 1.564 1.511 0 O-C-N 119.536 -1.978 . . . . 0.0 113.861 178.046 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 399' ' ' LYS . . . . . 0.456 ' NZ ' ' HD3' ' A' ' 186' ' ' ARG . 63.7 mttp 49.04 46.05 22.65 Favored 'General case' 0 C--N 1.279 -2.466 0 N-CA-C 116.081 1.882 . . . . 0.0 116.081 -179.264 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 400' ' ' GLY . . . . . . . . . . . . . . . 90.84 -13.42 65.99 Favored Glycine 0 CA--C 1.541 1.671 0 N-CA-C 115.465 0.946 . . . . 0.0 115.465 176.229 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 401' ' ' GLU . . . . . . . . . . . . . 92.9 mt-10 -61.87 121.19 12.31 Favored 'General case' 0 C--N 1.284 -2.252 0 O-C-N 121.28 -1.129 . . . . 0.0 112.053 -179.576 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 402' ' ' GLY . . . . . 0.515 ' O ' ' HA ' ' B' ' 422' ' ' PHE . . . 97.77 -7.11 62.92 Favored Glycine 0 C--O 1.202 -1.9 0 N-CA-C 114.903 0.721 . . . . 0.0 114.903 178.292 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 403' ' ' PHE . . . . . . . . . . . . . 73.9 m-85 -115.78 152.37 33.42 Favored 'General case' 0 C--N 1.283 -2.302 0 C-N-CA 124.023 0.929 . . . . 0.0 110.945 177.724 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 404' ' ' LYS . . . . . 0.471 ' HD2' ' O ' ' B' ' 421' ' ' GLU . 0.0 OUTLIER -141.97 113.45 7.73 Favored 'General case' 0 C--N 1.317 -0.83 0 C-N-CA 124.726 1.21 . . . . 0.0 109.214 176.865 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 405' ' ' ARG . . . . . 0.712 ' NH1' ' OE2' ' B' ' 409' ' ' GLU . 4.9 ttm180 -67.28 123.45 20.37 Favored 'General case' 0 CA--C 1.463 -2.371 0 C-N-CA 120.401 -0.52 . . . . 0.0 109.956 178.845 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 406' ' ' ILE . . . . . . . . . . . . . 23.8 mm -106.15 -35.17 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.314 0 C-N-CA 115.008 -2.677 . . . . 0.0 108.169 -179.323 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 407' ' ' ALA . . . . . . . . . . . . . . . -95.06 178.27 5.61 Favored 'General case' 0 N--CA 1.435 -1.21 0 C-N-CA 118.763 -1.175 . . . . 0.0 112.165 -179.263 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 408' ' ' GLU . . . . . 0.429 ' O ' HG23 ' B' ' 367' ' ' ILE . 39.4 mt-10 -118.37 151.37 37.87 Favored 'General case' 0 C--O 1.212 -0.886 0 N-CA-C 112.547 0.573 . . . . 0.0 112.547 179.017 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 409' ' ' GLU . . . . . 0.712 ' OE2' ' NH1' ' B' ' 405' ' ' ARG . 0.0 OUTLIER -60.74 137.06 58.23 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 118.595 -1.242 . . . . 0.0 108.022 175.345 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 410' ' ' GLY . . . . . 0.596 ' N ' HG21 ' B' ' 367' ' ' ILE . . . 89.36 -5.02 84.33 Favored Glycine 0 N--CA 1.475 1.239 0 O-C-N 121.709 -0.619 . . . . 0.0 111.617 -179.548 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 411' ' ' GLN . . . . . 0.564 ' N ' ' CG2' ' B' ' 367' ' ' ILE . 30.0 tt0 -66.05 138.09 57.53 Favored 'General case' 0 C--N 1.287 -2.132 0 CA-C-O 123.032 1.396 . . . . 0.0 112.818 179.521 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 412' ' ' ARG . . . . . 0.48 ' NH1' ' CG ' ' B' ' 412' ' ' ARG . 0.0 OUTLIER -86.19 132.76 33.94 Favored 'General case' 0 N--CA 1.42 -1.937 0 CA-C-N 114.066 -1.425 . . . . 0.0 107.247 175.71 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 413' ' ' VAL . . . . . . . . . . . . . 34.5 m -140.14 160.29 25.96 Favored 'Isoleucine or valine' 0 CA--C 1.472 -2.056 0 C-N-CA 117.367 -1.733 . . . . 0.0 112.97 -176.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 414' ' ' LYS . . . . . 0.462 ' HE3' ' OD2' ' B' ' 417' ' ' ASP . 0.5 OUTLIER -110.79 156.7 20.71 Favored 'General case' 0 C--N 1.286 -2.179 0 CA-C-N 111.739 -2.482 . . . . 0.0 108.371 174.784 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 415' ' ' VAL . . . . . 0.473 ' N ' ' OD1' ' B' ' 364' ' ' ASP . 44.1 t -45.71 135.73 2.11 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.085 0 CA-C-O 121.653 0.74 . . . . 0.0 111.673 176.474 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 416' ' ' GLY . . . . . . . . . . . . . . . 89.14 -13.01 64.5 Favored Glycine 0 C--O 1.212 -1.235 0 O-C-N 121.552 -0.718 . . . . 0.0 114.552 178.066 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 417' ' ' ASP . . . . . 0.462 ' OD2' ' HE3' ' B' ' 414' ' ' LYS . 91.9 m-20 -63.04 136.32 57.75 Favored 'General case' 0 C--N 1.294 -1.817 0 O-C-N 120.813 -1.404 . . . . 0.0 109.861 179.144 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 418' ' ' THR . . . . . . . . . . . . . 23.3 m -76.7 132.39 39.31 Favored 'General case' 0 CA--C 1.497 -1.061 0 CA-C-O 123.008 1.385 . . . . 0.0 111.068 -177.744 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 419' ' ' VAL . . . . . 0.462 ' O ' HG13 ' B' ' 420' ' ' ILE . 44.8 t -105.88 -48.57 8.92 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.551 0 CA-C-N 113.427 -1.715 . . . . 0.0 109.164 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 420' ' ' ILE . . . . . 0.462 HG13 ' O ' ' B' ' 419' ' ' VAL . 11.0 mt -148.35 143.47 19.05 Favored 'Isoleucine or valine' 0 CA--C 1.48 -1.741 0 N-CA-C 114.037 1.125 . . . . 0.0 114.037 -177.198 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 421' ' ' GLU . . . . . 0.471 ' O ' ' HD2' ' B' ' 404' ' ' LYS . 48.7 mt-10 -112.16 147.4 36.22 Favored 'General case' 0 CA--C 1.482 -1.647 0 C-N-CA 116.701 -2.0 . . . . 0.0 107.399 175.847 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 422' ' ' PHE . . . . . 0.515 ' HA ' ' O ' ' B' ' 402' ' ' GLY . 36.0 p90 -132.81 163.69 28.51 Favored 'General case' 0 C--N 1.298 -1.667 0 CA-C-O 122.096 0.951 . . . . 0.0 111.53 -179.239 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 423' ' ' ASP . . . . . 0.445 ' OD1' ' HD2' ' B' ' 425' ' ' PRO . 10.3 t0 -100.7 98.04 8.63 Favored 'General case' 0 C--O 1.214 -0.775 0 CA-C-N 114.505 -1.225 . . . . 0.0 109.695 176.88 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 424' ' ' LEU . . . . . 0.628 ' HB3' ' HD3' ' B' ' 425' ' ' PRO . 3.1 tp -59.47 -54.71 53.3 Favored Pre-proline 0 C--N 1.292 -1.932 0 N-CA-C 115.97 1.841 . . . . 0.0 115.97 -176.035 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 425' ' ' PRO . . . . . 0.628 ' HD3' ' HB3' ' B' ' 424' ' ' LEU . 20.6 Cg_exo -56.73 -44.93 40.45 Favored 'Trans proline' 1 C--N 1.246 -4.853 0 C-N-CA 121.641 1.56 . . . . 0.0 109.665 -175.722 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 426' ' ' LEU . . . . . 0.442 HD11 ' O ' ' B' ' 426' ' ' LEU . 0.5 OUTLIER -57.03 -51.06 70.76 Favored 'General case' 0 C--N 1.314 -0.965 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 177.863 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 427' ' ' LEU . . . . . . . . . . . . . 49.5 mt -68.41 -31.46 70.81 Favored 'General case' 0 C--N 1.281 -2.371 0 O-C-N 121.088 -1.008 . . . . 0.0 111.955 -178.441 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 428' ' ' GLU . . . . . . . . . . . . . 20.6 mt-10 -65.04 -37.67 88.35 Favored 'General case' 0 C--N 1.278 -2.534 0 N-CA-C 106.768 -1.567 . . . . 0.0 106.768 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 429' ' ' GLU . . . . . . . . . . . . . 10.1 tt0 -75.28 -42.45 54.81 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-N 115.04 -0.982 . . . . 0.0 113.197 177.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 430' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -94.67 -29.3 14.9 Favored 'General case' 0 C--N 1.307 -1.262 0 N-CA-C 116.34 1.978 . . . . 0.0 116.34 -175.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 431' ' ' ALA . . . . . . . . . . . . . . . -78.61 142.93 36.87 Favored 'General case' 0 C--N 1.263 -3.162 0 N-CA-C 115.421 1.637 . . . . 0.0 115.421 -176.63 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 432' ' ' LYS . . . . . . . . . . . . . 66.8 mmtt -55.73 -37.75 68.87 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 179.136 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 433' ' ' SER . . . . . . . . . . . . . 3.8 t -163.82 143.93 8.38 Favored 'General case' 0 C--N 1.296 -1.733 0 C-N-CA 125.078 1.351 . . . . 0.0 110.601 178.352 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 434' ' ' THR . . . . . . . . . . . . . 75.9 p -96.05 -0.64 50.17 Favored 'General case' 0 C--O 1.222 -0.349 0 CA-C-N 114.773 -1.103 . . . . 0.0 110.535 179.409 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 435' ' ' LEU . . . . . . . . . . . . . 17.0 mt -56.16 130.56 44.74 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 177.086 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 436' ' ' THR . . . . . . . . . . . . . 92.9 m -119.01 97.01 50.62 Favored Pre-proline 0 N--CA 1.431 -1.381 0 N-CA-C 118.058 2.614 . . . . 0.0 118.058 -173.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 437' ' ' PRO . . . . . 0.449 ' HD2' ' O ' ' B' ' 390' ' ' HIS . 8.3 Cg_exo -67.11 142.98 63.39 Favored 'Trans proline' 0 N--CA 1.446 -1.27 0 C-N-CA 117.107 -1.462 . . . . 0.0 114.421 -179.208 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 438' ' ' VAL . . . . . . . . . . . . 0.314 1.6 m -125.82 104.62 13.44 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 N-CA-C 105.142 -2.169 . . . . 0.0 105.142 173.48 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 439' ' ' VAL . . . . . 0.476 ' CG1' ' CD1' ' B' ' 333' ' ' ILE . 34.5 m -123.44 158.74 28.62 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.583 0 N-CA-C 116.338 1.977 . . . . 0.0 116.338 -176.692 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 440' ' ' ILE . . . . . . . . . . . . . 3.3 mp -97.45 125.31 50.6 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.225 0 N-CA-C 104.618 -2.364 . . . . 0.0 104.618 178.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 441' ' ' SER . . . . . . . . . . . . . 69.6 m -98.23 -4.45 35.29 Favored 'General case' 0 C--N 1.295 -1.78 0 CA-C-O 123.209 1.481 . . . . 0.0 112.946 -175.64 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 442' ' ' ASN . . . . . 0.803 ' ND2' ' H ' ' B' ' 386' ' ' GLU 0.482 9.2 m-20 -97.76 15.19 24.42 Favored 'General case' 0 C--N 1.259 -3.368 0 C-N-CA 130.041 3.337 . . . . 0.0 114.592 -179.794 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 443' ' ' MET . . . . . 0.602 ' SD ' ' OD2' ' B' ' 348' ' ' ASP . 65.3 ttp -33.88 -44.05 0.15 Allowed 'General case' 0 C--N 1.284 -2.274 0 N-CA-C 115.586 1.698 . . . . 0.0 115.586 -174.135 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 444' ' ' ASP . . . . . . . . . . . . . 72.2 m-20 -65.67 -11.37 44.33 Favored 'General case' 0 C--N 1.282 -2.35 0 CA-C-O 115.88 -2.009 . . . . 0.0 110.995 -179.543 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 445' ' ' GLU . . . . . . . . . . . . . 74.9 mm-40 -105.59 12.72 30.9 Favored 'General case' 0 C--N 1.296 -1.731 0 CA-C-N 123.049 2.659 . . . . 0.0 111.539 -179.716 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 446' ' ' ILE . . . . . . . . . . . . . 96.7 mt -120.44 140.92 43.0 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.053 0 C-N-CA 115.898 -2.321 . . . . 0.0 113.898 -177.12 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 447' ' ' LYS . . . . . . . . . . . . 0.255 98.7 mttt -74.51 -54.61 7.19 Favored 'General case' 0 C--O 1.222 -0.377 0 CA-C-N 114.376 -1.283 . . . . 0.0 109.751 -179.802 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 448' ' ' GLU . . . . . 0.513 ' O ' ' HA ' ' B' ' 466' ' ' ILE . 0.0 OUTLIER -147.4 145.48 29.26 Favored 'General case' 0 C--N 1.288 -2.071 0 CA-C-O 123.831 1.777 . . . . 0.0 113.879 177.19 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 449' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -115.58 112.22 21.86 Favored 'General case' 0 N--CA 1.414 -2.228 0 CA-C-N 110.961 -2.836 . . . . 0.0 109.958 177.284 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 450' ' ' ILE . . . . . . . . . . . . . 62.1 mt -109.0 112.33 40.02 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.231 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 177.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 451' ' ' LYS . . . . . . . . . . . . . 34.7 mttt -85.07 129.77 34.74 Favored 'General case' 0 C--N 1.305 -1.343 0 C-N-CA 124.635 1.174 . . . . 0.0 113.2 -178.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 452' ' ' LEU . . . . . . . . . . . . 0.301 31.5 mt -94.29 175.63 6.62 Favored 'General case' 0 N--CA 1.415 -2.194 0 CA-C-O 122.67 1.224 . . . . 0.0 112.314 -179.341 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 453' ' ' SER . . . . . . . . . . . . 0.277 0.5 OUTLIER -131.05 160.38 34.8 Favored 'General case' 0 C--N 1.296 -1.749 0 CA-C-N 113.455 -1.702 . . . . 0.0 114.729 -174.371 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 454' ' ' GLY . . . . . . . . . . . . . . . 100.31 -158.87 19.4 Favored Glycine 0 CA--C 1.529 0.944 0 N-CA-C 118.743 2.257 . . . . 0.0 118.743 174.327 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 455' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -94.75 142.34 27.57 Favored 'General case' 0 C--O 1.215 -0.739 0 CA-C-N 111.987 -2.107 . . . . 0.0 109.939 -178.897 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 456' ' ' VAL . . . . . . . . . . . . . 16.5 m -132.02 159.65 42.97 Favored 'Isoleucine or valine' 0 CA--C 1.46 -2.515 0 CA-C-O 122.795 1.283 . . . . 0.0 110.042 -177.549 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 457' ' ' THR . . . . . . . . . . . . . 20.5 m -122.73 123.64 41.55 Favored 'General case' 0 C--N 1.272 -2.773 0 CA-C-N 112.693 -2.049 . . . . 0.0 108.319 -179.63 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 458' ' ' VAL . . . . . . . . . . . . . 11.9 p -37.22 123.71 0.16 Allowed 'Isoleucine or valine' 0 C--O 1.217 -0.638 0 CA-C-O 123.808 1.765 . . . . 0.0 113.974 179.24 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 459' ' ' GLY . . . . . . . . . . . . . . . 61.1 25.97 65.15 Favored Glycine 0 CA--C 1.487 -1.683 0 CA-C-N 112.792 -2.003 . . . . 0.0 114.155 175.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 460' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -136.5 -53.24 0.72 Allowed 'General case' 0 C--N 1.287 -2.117 0 CA-C-O 121.979 0.895 . . . . 0.0 111.9 178.86 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 461' ' ' THR . . . . . . . . . . . . . 8.9 m -85.41 122.99 73.51 Favored Pre-proline 0 C--N 1.284 -2.27 0 N-CA-C 114.097 1.147 . . . . 0.0 114.097 -175.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 462' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -62.48 141.42 86.53 Favored 'Trans proline' 0 CA--C 1.54 0.792 0 C-N-CA 123.104 2.536 . . . . 0.0 109.723 177.642 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 463' ' ' VAL . . . . . . . . . . . . . 29.3 m -116.68 -27.97 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 O-C-N 121.692 -0.63 . . . . 0.0 112.173 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 464' ' ' ILE . . . . . . . . . . . . . 30.5 mt -141.08 151.09 19.94 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.063 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 179.343 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 465' ' ' ARG . . . . . . . . . . . . . 5.9 mtt180 -125.89 130.72 51.89 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 105.78 -1.933 . . . . 0.0 105.78 176.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 466' ' ' ILE . . . . . 0.817 ' CG1' ' HB ' ' B' ' 320' ' ' ILE . 40.1 pt -128.38 155.61 40.19 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.632 0 C-N-CA 118.971 -1.091 . . . . 0.0 109.825 -178.064 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 467' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.295 -1.787 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 176.64 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 500' ' ' PO3 . . . . . 0.416 ' O3 ' ' CE2' ' B' ' 371' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.3 mmm . . . . . 0 N--CA 1.493 1.682 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 72.6 mt -107.97 129.91 61.32 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.051 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 179.647 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 63.9 m -129.96 141.73 50.73 Favored 'General case' 0 N--CA 1.502 2.16 0 O-C-N 121.196 -0.94 . . . . 0.0 110.429 -179.599 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -123.41 -159.58 10.55 Favored Glycine 0 N--CA 1.499 2.842 0 N-CA-C 108.37 -1.892 . . . . 0.0 108.37 179.04 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.477 HG22 ' O ' ' A' ' 5' ' ' ILE . 81.7 mt -94.95 -12.02 8.68 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 O-C-N 120.801 -1.411 . . . . 0.0 111.083 -178.735 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.459 ' O ' ' O ' ' A' ' 5' ' ' ILE . 58.9 tp 53.34 103.91 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.164 -0.96 . . . . 0.0 109.577 -179.645 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.473 ' O ' ' NE ' ' A' ' 195' ' ' ARG . . . -95.56 -25.52 16.15 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.257 -0.902 . . . . 0.0 109.823 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.421 ' CB ' ' O ' ' A' ' 199' ' ' LEU . 2.6 m -141.79 126.36 10.32 Favored Pre-proline 0 N--CA 1.496 1.847 0 O-C-N 121.234 -0.916 . . . . 0.0 108.875 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -80.14 142.83 15.53 Favored 'Trans proline' 0 N--CA 1.491 1.328 0 C-N-CA 121.938 1.758 . . . . 0.0 111.797 179.636 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.753 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 163.36 -160.83 33.5 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 108.651 -1.78 . . . . 0.0 108.651 -179.852 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 86.5 mt -149.55 150.13 14.09 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 O-C-N 121.079 -1.248 . . . . 0.0 108.253 178.617 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -156.22 154.68 31.14 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.815 -1.178 . . . . 0.0 111.157 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.546 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 2.0 m-85 -133.77 126.84 31.48 Favored 'General case' 0 N--CA 1.497 1.923 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 178.808 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -179.85 178.67 48.67 Favored Glycine 0 N--CA 1.496 2.652 0 C-N-CA 118.702 -1.713 . . . . 0.0 110.919 179.701 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -79.74 159.95 26.41 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.712 -0.876 . . . . 0.0 109.225 -179.73 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.481 ' HB2' HD12 ' A' ' 218' ' ' LEU . . . -104.79 129.0 53.14 Favored 'General case' 0 N--CA 1.501 2.106 0 O-C-N 121.328 -0.857 . . . . 0.0 111.126 -178.172 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 62.0 tp -100.87 134.67 43.49 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 178.911 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 57.1 tp -116.91 122.47 44.42 Favored 'General case' 0 N--CA 1.504 2.274 0 O-C-N 121.213 -0.93 . . . . 0.0 110.53 -179.103 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 17.9 mt -87.77 103.44 15.63 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.621 -0.675 . . . . 0.0 110.239 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 59.0 mttt -98.43 134.96 40.68 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.405 -0.809 . . . . 0.0 109.214 179.757 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -130.8 130.54 43.8 Favored 'General case' 0 N--CA 1.502 2.133 0 O-C-N 121.148 -0.97 . . . . 0.0 109.379 178.854 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 93.8 m-20 -75.9 147.42 39.0 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.875 -1.14 . . . . 0.0 109.365 179.325 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 86.0 tt0 -67.29 140.17 57.31 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.122 -0.987 . . . . 0.0 109.362 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 55.3 mt -79.31 130.22 36.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.492 -0.755 . . . . 0.0 109.522 -179.338 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 30.6 t -97.06 126.46 49.82 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.281 -0.887 . . . . 0.0 109.736 -179.456 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 87.4 mt -105.8 136.86 38.36 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 179.698 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -92.05 121.21 33.4 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.087 -1.008 . . . . 0.0 109.965 -179.294 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 6.6 mmt180 -88.54 -3.26 58.84 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.298 -0.876 . . . . 0.0 108.931 179.833 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 89.9 mttt -63.27 139.59 58.79 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.349 -0.845 . . . . 0.0 109.198 -179.764 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 92.3 mttt -86.23 150.03 24.67 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.251 -0.906 . . . . 0.0 109.087 179.631 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.465 HG21 ' HG3' ' A' ' 39' ' ' GLU . 4.7 pt -95.2 165.05 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.285 -0.885 . . . . 0.0 110.325 -179.422 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 75.6 p -96.25 173.08 7.57 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 178.234 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.93 -49.26 78.39 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.118 -0.989 . . . . 0.0 109.566 -179.812 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -54.42 -30.05 51.17 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.78 -1.2 . . . . 0.0 109.183 179.727 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -82.75 -10.4 58.91 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.229 -0.919 . . . . 0.0 110.712 -179.731 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 31.1 t -63.85 -52.75 53.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 120.601 -1.312 . . . . 0.0 108.674 179.692 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -60.37 -40.06 89.44 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.341 -0.849 . . . . 0.0 110.092 -179.821 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 33.8 mt-30 -68.66 -40.03 80.37 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.993 -1.067 . . . . 0.0 110.825 -178.681 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.465 ' HG3' HG21 ' A' ' 31' ' ' ILE . 60.1 mm-40 -65.34 -40.07 93.18 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.744 -1.222 . . . . 0.0 110.032 -179.201 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 55.5 t -60.4 -46.76 94.66 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 O-C-N 120.755 -1.216 . . . . 0.0 108.552 178.793 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 53.8 tp10 -60.08 -41.33 92.22 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.265 -0.897 . . . . 0.0 109.443 179.576 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -60.11 -44.19 95.04 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.003 -1.061 . . . . 0.0 108.227 179.081 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.422 ' CZ ' HD13 ' A' ' 89' ' ' ILE . 65.9 t80 -60.74 -49.79 76.1 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 178.542 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 14.7 tp -61.39 -44.46 97.12 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.345 -0.847 . . . . 0.0 108.795 179.167 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 47.2 t -64.48 -43.77 93.12 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.961 -1.087 . . . . 0.0 109.208 179.794 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -68.92 -40.21 84.67 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 108.76 -1.736 . . . . 0.0 108.76 179.077 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.467 HH21 ' HG2' ' A' ' 81' ' ' GLU . 37.1 ttt-85 -65.56 -31.92 73.23 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 108.264 -1.014 . . . . 0.0 108.264 178.726 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.81 -41.11 90.55 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 179.795 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.43 ' O ' ' C ' ' A' ' 50' ' ' ALA . 6.7 ttpt -63.86 -73.01 0.12 Allowed 'General case' 0 C--N 1.305 -1.34 0 O-C-N 120.867 -1.146 . . . . 0.0 108.154 179.214 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.43 ' C ' ' O ' ' A' ' 49' ' ' LYS . . . -38.43 -33.77 0.11 Allowed 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.331 -0.855 . . . . 0.0 111.161 -178.734 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 15.3 t -58.53 -56.08 26.82 Favored 'General case' 0 C--N 1.3 -1.581 0 C-N-CA 118.553 -1.259 . . . . 0.0 108.139 179.759 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -69.8 -40.0 76.24 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.533 -0.729 . . . . 0.0 111.392 -179.084 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 27.8 mt-30 -67.34 -40.14 85.83 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 120.718 -1.239 . . . . 0.0 110.234 -179.391 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 76.9 mt -62.17 -40.16 95.08 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.833 -1.167 . . . . 0.0 108.868 178.94 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 60.6 mm-40 -61.31 -37.99 85.23 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.516 -0.74 . . . . 0.0 109.814 179.381 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 83.2 m -63.01 -41.44 99.56 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.022 -1.049 . . . . 0.0 109.231 -179.777 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.524 ' CD1' HH22 ' A' ' 136' ' ' ARG . 96.6 mt -62.72 -38.75 82.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.237 -0.914 . . . . 0.0 109.512 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.54 ' NZ ' ' O ' ' A' ' 70' ' ' GLU . 63.9 tttp -56.88 -51.37 69.35 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.501 -0.75 . . . . 0.0 109.844 -179.729 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 66.8 p -58.41 -33.98 70.26 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.314 -0.866 . . . . 0.0 110.451 -178.054 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.666 ' O ' HG23 ' A' ' 64' ' ' THR . 68.4 mttm -69.64 -37.48 76.78 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.871 -1.143 . . . . 0.0 109.347 -179.897 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -65.16 -43.84 90.46 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.467 -0.771 . . . . 0.0 109.545 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -60.26 -51.87 56.18 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 110.469 -1.052 . . . . 0.0 110.469 -179.448 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 71.5 mm-40 -69.91 -44.38 69.79 Favored 'General case' 0 C--O 1.205 -1.268 0 O-C-N 120.257 -1.731 . . . . 0.0 111.007 179.806 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.666 HG23 ' O ' ' A' ' 60' ' ' LYS . 76.6 p -64.9 -63.15 1.18 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.95 -1.094 . . . . 0.0 112.04 -178.299 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 10.7 m-85 -96.54 -48.68 5.44 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 121.055 -1.028 . . . . 0.0 111.609 -177.793 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 142.1 -168.72 25.61 Favored Glycine 0 N--CA 1.503 3.163 0 C-N-CA 119.561 -1.304 . . . . 0.0 111.392 179.676 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 75.5 mm-40 -70.11 -24.65 63.24 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.856 -0.791 . . . . 0.0 109.946 -179.775 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -61.05 -36.39 79.45 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.285 -0.885 . . . . 0.0 109.675 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 24.9 tttp -97.78 -20.91 17.25 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.339 -0.85 . . . . 0.0 110.522 -179.569 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.54 ' O ' ' NZ ' ' A' ' 58' ' ' LYS . 80.5 tt0 -67.15 -43.55 82.03 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.019 -1.051 . . . . 0.0 110.896 -179.019 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.921 ' HB1' HG22 ' B' ' 345' ' ' ILE . . . -68.19 -28.5 67.32 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.279 -0.888 . . . . 0.0 111.209 -177.782 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 96.0 mt -59.19 -39.48 78.79 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 C-N-CA 117.867 -1.533 . . . . 0.0 108.479 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 73.6 m-85 -65.54 -38.73 90.45 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.117 -0.99 . . . . 0.0 109.756 179.462 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.488 ' HB2' ' NZ ' ' A' ' 58' ' ' LYS . 85.6 tt0 -59.76 -40.24 87.51 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 120.82 -1.175 . . . . 0.0 109.224 179.91 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -62.72 -47.95 85.09 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 108.772 -1.731 . . . . 0.0 108.772 179.01 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' HIS . . . . . 0.521 ' CG ' HD11 ' A' ' 133' ' ' ILE . 56.2 m170 -60.85 -45.65 93.66 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.565 -0.962 . . . . 0.0 109.024 179.769 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 96.9 mt -66.45 -47.14 84.8 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 121.319 -0.863 . . . . 0.0 109.01 179.578 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 65.8 ttp -60.06 -40.07 88.21 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.075 -1.016 . . . . 0.0 109.818 -179.349 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.714 HD12 ' OD2' ' A' ' 82' ' ' ASP . 46.6 tp -65.54 -40.1 92.51 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.324 -0.86 . . . . 0.0 109.562 179.37 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 9.2 tt -63.11 -39.29 94.27 Favored 'General case' 0 C--N 1.297 -1.697 0 O-C-N 121.673 -0.642 . . . . 0.0 109.902 -179.021 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.467 ' HG2' HH21 ' A' ' 47' ' ' ARG . 97.7 mt-10 -82.95 5.74 20.97 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.27 -0.894 . . . . 0.0 110.056 -179.265 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.714 ' OD2' HD12 ' A' ' 79' ' ' LEU . 34.7 m-20 -50.83 130.1 24.42 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.914 -1.116 . . . . 0.0 109.598 -179.795 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -60.8 -19.13 58.9 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.376 -0.828 . . . . 0.0 110.696 -178.891 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 -71.23 -35.88 71.63 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.865 -1.147 . . . . 0.0 109.52 178.918 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 85.3 mt -70.19 -39.97 74.9 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.568 -0.708 . . . . 0.0 110.086 179.65 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -60.62 -48.34 82.21 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.368 -0.833 . . . . 0.0 109.414 -179.087 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -69.89 -41.05 75.27 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.303 -0.873 . . . . 0.0 110.819 -179.502 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 51.3 tp10 -70.02 -40.22 75.35 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.029 -1.044 . . . . 0.0 111.804 -178.877 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.422 HD13 ' CZ ' ' A' ' 43' ' ' PHE . 89.7 mt -67.5 -45.75 84.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 120.828 -1.17 . . . . 0.0 109.159 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 66.5 mt -67.83 -39.32 81.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.615 -0.678 . . . . 0.0 110.811 -179.788 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -60.2 -47.87 84.15 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.103 -0.998 . . . . 0.0 111.139 -178.735 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.441 ' O ' ' N ' ' A' ' 96' ' ' LYS . 19.6 mt -60.76 -46.01 92.11 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 120.858 -1.151 . . . . 0.0 109.842 -179.428 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 47.0 mt -61.19 -49.15 85.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.088 -1.008 . . . . 0.0 108.437 179.19 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 22.2 mttt -69.31 -42.02 75.96 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.431 -0.793 . . . . 0.0 110.651 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 51.9 t0 -81.92 -50.93 8.6 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.87 -1.144 . . . . 0.0 112.115 -178.248 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.441 ' N ' ' O ' ' A' ' 92' ' ' LEU . 17.7 mttp -91.58 -0.98 57.64 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 120.967 -1.083 . . . . 0.0 112.204 -177.557 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER 51.56 41.07 28.35 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 120.874 -1.141 . . . . 0.0 110.879 -178.834 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 25.5 mtp -93.11 169.79 10.14 Favored 'General case' 0 N--CA 1.498 1.941 0 CA-C-N 114.416 -1.265 . . . . 0.0 109.584 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 77.3 p -80.99 159.88 24.74 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.193 -0.942 . . . . 0.0 109.807 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -68.09 -40.19 82.69 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.192 -0.943 . . . . 0.0 110.71 -179.522 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' ASP . . . . . 0.548 ' OD1' ' N ' ' A' ' 101' ' ' ASP . 3.2 p-10 -70.58 -34.3 72.02 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.811 -1.18 . . . . 0.0 109.607 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -80.55 -40.44 25.92 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 120.949 -1.095 . . . . 0.0 109.484 179.142 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -70.34 -46.2 64.64 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.282 -0.886 . . . . 0.0 110.035 -179.7 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -61.4 -38.95 88.92 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.243 -0.911 . . . . 0.0 109.76 -179.722 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' HIS . . . . . 0.52 ' NE2' ' OE1' ' A' ' 109' ' ' GLU . 81.0 t60 -59.72 -40.18 87.15 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.31 -0.869 . . . . 0.0 109.875 -178.979 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 86.2 tt0 -63.85 -40.16 95.93 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.301 -0.874 . . . . 0.0 110.312 -179.103 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 97.9 t -63.67 -54.48 31.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.265 -0.897 . . . . 0.0 111.077 -178.345 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 50.6 mm -68.63 -40.69 82.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 120.846 -1.159 . . . . 0.0 109.216 -179.879 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.52 ' OE1' ' NE2' ' A' ' 105' ' ' HIS . 86.4 tt0 -64.94 -39.52 93.63 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 178.873 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -57.73 -49.42 74.28 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 110.08 -1.208 . . . . 0.0 110.08 -179.405 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 86.7 mt-30 -66.98 -52.92 36.81 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.781 -1.423 . . . . 0.0 109.35 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -54.98 -40.4 70.03 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.187 -0.946 . . . . 0.0 108.875 179.757 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 55.1 m -59.59 -40.3 86.99 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.251 -0.905 . . . . 0.0 108.915 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -63.79 -39.89 95.35 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.183 -0.948 . . . . 0.0 109.081 179.236 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.448 ' HB3' ' HB2' ' A' ' 127' ' ' ALA . 9.2 mp -63.55 -40.11 96.15 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.306 -0.871 . . . . 0.0 109.779 -179.254 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.434 ' O ' ' NZ ' ' A' ' 124' ' ' LYS . 79.9 mm-40 -59.85 -36.06 76.07 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.525 -1.36 . . . . 0.0 109.628 -179.55 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 65.4 mm-40 -54.76 -19.87 7.25 Favored 'General case' 0 C--O 1.202 -1.396 0 C-N-CA 117.998 -1.481 . . . . 0.0 110.984 179.008 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 88.3 mt -62.24 147.35 48.21 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.171 -0.955 . . . . 0.0 109.562 -179.732 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' ASP . . . . . 0.404 ' OD1' ' O ' ' A' ' 119' ' ' ASP . 57.0 t0 -98.56 40.62 1.18 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.467 -0.771 . . . . 0.0 109.894 -179.772 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -131.57 133.87 45.47 Favored 'General case' 0 N--CA 1.504 2.231 0 O-C-N 121.332 -0.855 . . . . 0.0 110.203 -179.611 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.455 ' OE1' ' N ' ' A' ' 121' ' ' GLU . 59.5 mp0 -70.15 -29.96 66.99 Favored 'General case' 0 N--CA 1.498 1.931 0 CA-C-O 121.366 0.603 . . . . 0.0 110.46 179.352 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.757 ' CG ' ' OE1' ' B' ' 397' ' ' GLU . 1.9 m-30 -71.91 -40.07 69.06 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.422 -0.799 . . . . 0.0 110.599 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.465 ' CD2' ' N ' ' A' ' 123' ' ' LEU . 3.1 mm? -73.84 -34.71 64.65 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.098 -1.001 . . . . 0.0 108.591 179.828 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.434 ' NZ ' ' O ' ' A' ' 116' ' ' GLU . 67.7 mttm -62.04 -42.06 98.77 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.62 -0.675 . . . . 0.0 110.496 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' GLU . . . . . 0.449 ' O ' ' HB3' ' A' ' 128' ' ' ALA . 40.4 tp10 -60.51 -44.52 95.91 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 120.62 -1.3 . . . . 0.0 109.848 179.841 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 60.7 ttp180 -59.96 -36.08 76.35 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.904 -1.122 . . . . 0.0 108.382 179.63 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' ALA . . . . . 0.448 ' HB2' ' HB3' ' A' ' 115' ' ' LEU . . . -61.29 -25.98 67.47 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 108.072 -1.085 . . . . 0.0 108.072 178.277 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.449 ' HB3' ' O ' ' A' ' 125' ' ' GLU . . . -70.19 -40.1 74.81 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 108.739 -0.838 . . . . 0.0 108.739 178.857 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -66.35 -40.07 89.57 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.559 -0.713 . . . . 0.0 109.385 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 79.8 t -68.37 -40.13 81.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 179.82 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 71.5 ttt180 -60.07 -40.32 89.09 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.377 -0.827 . . . . 0.0 109.384 178.871 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -60.01 -39.5 86.03 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.649 -0.657 . . . . 0.0 110.172 -178.833 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' ILE . . . . . 0.521 HD11 ' CG ' ' A' ' 76' ' ' HIS . 96.7 mt -59.7 -45.42 94.45 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 O-C-N 121.038 -1.039 . . . . 0.0 109.892 -179.026 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -71.54 -34.54 63.25 Favored Glycine 0 N--CA 1.494 2.506 0 C-N-CA 119.955 -1.116 . . . . 0.0 110.333 -179.755 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 39.9 tttt -59.51 -47.77 84.24 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.371 -1.076 . . . . 0.0 109.612 -179.224 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.524 HH22 ' CD1' ' A' ' 57' ' ' ILE . 65.8 mtp180 -69.92 -31.06 68.65 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.991 -1.068 . . . . 0.0 109.952 -179.78 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 64.4 tp -58.04 -42.1 84.66 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.239 -0.913 . . . . 0.0 108.748 -179.454 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 51.6 mt -60.99 -40.06 92.03 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.15 -0.969 . . . . 0.0 109.245 178.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 27.2 mtt180 -67.44 -39.87 85.43 Favored 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 118.862 -1.135 . . . . 0.0 108.669 179.259 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 56.9 m-80 -62.2 -37.98 87.37 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.536 -0.728 . . . . 0.0 111.297 -179.45 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 83.5 mt -71.07 -43.5 75.87 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 120.391 -1.443 . . . . 0.0 108.037 179.515 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 95.5 mt -71.12 -32.82 69.47 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.416 -0.802 . . . . 0.0 109.103 179.663 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 84.07 42.34 7.63 Favored Glycine 0 N--CA 1.494 2.566 0 N-CA-C 109.035 -1.626 . . . . 0.0 109.035 -179.221 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 8.4 tp -74.54 148.62 40.74 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.551 -0.97 . . . . 0.0 110.652 -178.719 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 56.1 tptt -61.1 138.71 58.2 Favored 'General case' 0 N--CA 1.49 1.57 0 CA-C-O 121.31 0.576 . . . . 0.0 110.613 -179.856 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 84.3 mt -117.12 127.5 74.69 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 CA-C-O 122.354 1.073 . . . . 0.0 108.177 178.04 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 10.2 mt -66.28 -39.84 85.28 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.869 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.585 -178.362 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 36.7 t0 61.56 113.62 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.291 -0.881 . . . . 0.0 109.232 -179.384 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 79.2 mt -77.44 -0.79 27.27 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.249 -0.907 . . . . 0.0 110.309 -179.018 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -85.41 -14.94 44.68 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.618 -1.301 . . . . 0.0 109.989 -179.761 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -82.16 28.4 0.45 Allowed 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.035 -1.041 . . . . 0.0 111.313 -178.174 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 46.6 mm -89.17 119.75 36.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 120.284 -1.51 . . . . 0.0 110.053 -179.773 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 87.0 mt-30 -100.9 -13.11 18.47 Favored 'General case' 0 N--CA 1.502 2.134 0 O-C-N 121.317 -0.864 . . . . 0.0 110.505 179.449 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 94.8 m-20 -127.47 151.45 48.83 Favored 'General case' 0 N--CA 1.506 2.332 0 O-C-N 121.046 -1.034 . . . . 0.0 110.724 -178.61 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -64.02 134.01 54.19 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 179.537 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 28.6 m -151.84 165.2 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.44 -0.788 . . . . 0.0 110.088 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 74.4 mt -93.97 146.89 6.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 N-CA-C 105.424 -2.065 . . . . 0.0 105.424 176.941 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 62.6 tp -99.29 117.8 34.54 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.066 -1.021 . . . . 0.0 110.393 -178.029 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.482 HG12 HG22 ' A' ' 209' ' ' THR . 59.0 t -121.07 129.83 75.29 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 179.7 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -157.27 160.94 39.12 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.015 -1.053 . . . . 0.0 109.232 -179.481 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -68.48 -37.26 79.96 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 120.246 -1.533 . . . . 0.0 107.945 178.262 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -170.31 146.63 2.93 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 178.539 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 25.9 mt -112.81 138.21 49.99 Favored 'General case' 0 N--CA 1.503 2.201 0 O-C-N 121.386 -0.821 . . . . 0.0 110.008 -179.199 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 45.3 p -93.99 146.31 31.42 Favored Pre-proline 0 N--CA 1.495 1.805 0 O-C-N 121.265 -0.897 . . . . 0.0 108.75 179.21 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 99.6 Cg_exo -39.75 -36.55 1.25 Allowed 'Trans proline' 0 N--CA 1.495 1.583 0 C-N-CA 122.151 1.901 . . . . 0.0 112.53 179.85 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 166' ' ' SER . . . . . 0.404 ' HB3' HH12 ' A' ' 136' ' ' ARG . 75.4 m -59.73 -40.33 87.69 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.213 -0.929 . . . . 0.0 110.325 -179.089 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 84.9 mt-10 -69.02 -40.67 78.53 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 120.999 -1.063 . . . . 0.0 110.003 -178.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 40.0 p -55.45 -30.99 61.55 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.309 -0.869 . . . . 0.0 111.626 -178.121 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -73.65 -52.81 12.08 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 120.8 -1.188 . . . . 0.0 110.298 -179.503 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 14.4 pt20 -84.54 36.98 0.61 Allowed 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.414 -0.804 . . . . 0.0 108.945 -179.323 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 22.3 tp -105.7 138.86 41.19 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.706 -0.622 . . . . 0.0 109.472 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 24.6 m120 -84.89 102.26 12.97 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.169 -0.957 . . . . 0.0 109.591 179.6 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 58.7 mt -65.03 -40.69 95.19 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.17 -0.956 . . . . 0.0 110.628 -179.482 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 65.1 mttt -69.43 -29.75 67.53 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.814 -1.179 . . . . 0.0 112.03 -177.634 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 77.9 mttt -93.17 -7.55 44.98 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 120.695 -1.253 . . . . 0.0 110.281 -177.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 176' ' ' VAL . . . . . 0.51 HG12 ' H ' ' A' ' 178' ' ' GLY . 78.7 t -102.05 113.73 39.34 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 177.477 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 90.5 mt -84.74 6.8 22.86 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.109 -0.994 . . . . 0.0 110.834 -177.868 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 178' ' ' GLY . . . . . 0.51 ' H ' HG12 ' A' ' 176' ' ' VAL . . . 168.89 174.71 37.73 Favored Glycine 0 N--CA 1.484 1.89 0 N-CA-C 109.349 -1.5 . . . . 0.0 109.349 179.141 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 179' ' ' PHE . . . . . 0.47 ' O ' ' HB1' ' A' ' 201' ' ' ALA . 9.9 m-85 -134.41 129.39 35.26 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.516 -0.991 . . . . 0.0 108.42 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 92.5 mt -132.0 126.28 56.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.429 -0.794 . . . . 0.0 109.101 179.098 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 72.8 p -149.97 162.13 40.96 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.847 -1.158 . . . . 0.0 110.941 -179.484 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 182' ' ' ASP . . . . . 0.588 ' N ' ' OD1' ' A' ' 182' ' ' ASP . 0.0 OUTLIER -104.43 24.86 10.95 Favored 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 -179.809 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 183' ' ' ALA . . . . . 0.428 ' O ' ' O ' ' A' ' 182' ' ' ASP . . . -55.28 -163.7 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.656 -1.277 . . . . 0.0 111.243 -178.87 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -74.61 -53.28 6.66 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 110.601 -1.0 . . . . 0.0 110.601 -179.382 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 169.76 -81.01 0.09 OUTLIER Glycine 0 N--CA 1.492 2.373 0 N-CA-C 107.218 -2.353 . . . . 0.0 107.218 -179.644 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 186' ' ' ARG . . . . . 0.55 ' O ' ' O ' ' A' ' 187' ' ' THR . 70.8 ttp85 -69.52 -40.62 76.82 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.499 -1.0 . . . . 0.0 109.617 179.08 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 187' ' ' THR . . . . . 0.585 ' O ' ' O ' ' A' ' 188' ' ' SER . 19.9 p 51.81 168.97 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.063 -1.023 . . . . 0.0 109.186 -179.341 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 188' ' ' SER . . . . . 0.585 ' O ' ' O ' ' A' ' 187' ' ' THR . 45.8 m -52.82 -125.65 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.47 -0.769 . . . . 0.0 110.261 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 189' ' ' HIS . . . . . 0.447 ' HA ' HD12 ' A' ' 192' ' ' ILE . 5.7 m80 -86.27 -1.61 57.64 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.383 -0.823 . . . . 0.0 110.878 -179.616 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 190' ' ' THR . . . . . 0.692 ' O ' ' N ' ' A' ' 193' ' ' MET . 3.8 m -65.65 -85.47 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.271 -0.893 . . . . 0.0 110.89 -179.08 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 191' ' ' SER . . . . . 0.562 ' C ' ' O ' ' A' ' 190' ' ' THR . 10.1 t -36.62 -38.04 0.15 Allowed 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 106.01 -1.848 . . . . 0.0 106.01 178.462 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 192' ' ' ILE . . . . . 0.461 ' N ' ' O ' ' A' ' 190' ' ' THR . 86.8 mt -62.69 -38.14 80.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.101 -0.999 . . . . 0.0 109.162 179.853 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 193' ' ' MET . . . . . 0.692 ' N ' ' O ' ' A' ' 190' ' ' THR . 5.1 tpp -60.27 -40.71 91.32 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.262 -0.899 . . . . 0.0 110.731 -179.324 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -58.47 -42.38 87.32 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.705 -1.247 . . . . 0.0 108.463 179.835 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 195' ' ' ARG . . . . . 0.473 ' NE ' ' O ' ' A' ' 7' ' ' ALA . 26.5 mmt85 -60.63 -58.26 9.24 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.423 -0.798 . . . . 0.0 109.448 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 196' ' ' SER . . . . . 0.443 ' CB ' ' HB2' ' B' ' 372' ' ' GLU . 77.6 p -63.14 -39.81 95.74 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.368 -0.833 . . . . 0.0 111.41 -178.931 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 93.5 mt -70.95 -23.31 62.21 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.825 -1.172 . . . . 0.0 109.468 -179.221 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 64.64 49.4 2.33 Favored 'General case' 0 N--CA 1.494 1.742 0 CA-C-O 121.383 0.611 . . . . 0.0 110.127 -179.011 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 199' ' ' LEU . . . . . 0.421 ' O ' ' CB ' ' A' ' 8' ' ' SER . 85.3 mt -125.92 143.92 46.92 Favored Pre-proline 0 N--CA 1.5 2.051 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 178.518 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -59.23 137.5 79.21 Favored 'Trans proline' 0 N--CA 1.5 1.867 0 C-N-CA 121.866 1.711 . . . . 0.0 112.135 -179.462 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 201' ' ' ALA . . . . . 0.47 ' HB1' ' O ' ' A' ' 179' ' ' PHE . . . -171.36 150.71 2.93 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.009 -1.057 . . . . 0.0 111.431 -179.535 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 73.4 mt -122.42 148.63 26.0 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.063 0 N-CA-C 107.802 -1.184 . . . . 0.0 107.802 178.136 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 16.8 m -129.22 -9.98 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.196 0 O-C-N 121.021 -1.05 . . . . 0.0 110.244 -179.725 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 204' ' ' GLY . . . . . 0.404 ' O ' ' C ' ' A' ' 205' ' ' THR . . . -111.98 23.55 16.5 Favored Glycine 0 N--CA 1.501 2.981 0 N-CA-C 110.896 -0.881 . . . . 0.0 110.896 -178.848 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 205' ' ' THR . . . . . 0.404 ' C ' ' O ' ' A' ' 204' ' ' GLY . 3.7 p -44.53 -43.83 8.25 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.021 -1.282 . . . . 0.0 109.951 -179.391 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 206' ' ' GLY . . . . . 0.463 ' H ' ' HB3' ' A' ' 182' ' ' ASP . . . 94.61 -50.88 2.05 Favored Glycine 0 N--CA 1.496 2.691 0 C-N-CA 120.392 -0.909 . . . . 0.0 111.057 179.197 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 28.1 t -160.76 40.61 0.16 Allowed 'General case' 0 N--CA 1.497 1.887 0 O-C-N 120.65 -1.5 . . . . 0.0 111.212 -178.941 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 25.1 t -77.15 -41.07 30.61 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 O-C-N 120.877 -1.139 . . . . 0.0 109.568 179.201 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 209' ' ' THR . . . . . 0.482 HG22 HG12 ' A' ' 159' ' ' VAL . 2.6 p -56.92 -30.6 64.12 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.152 -0.967 . . . . 0.0 110.659 -178.539 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 14.5 t -77.42 -13.2 59.98 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.859 -1.151 . . . . 0.0 109.301 -179.425 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 2.3 mm-40 -102.47 -12.79 17.57 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.648 -0.657 . . . . 0.0 109.692 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 86.2 t -109.64 141.68 24.27 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.263 0 O-C-N 121.384 -0.822 . . . . 0.0 111.311 -178.292 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -110.94 156.31 21.39 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 105.746 -1.946 . . . . 0.0 105.746 176.608 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 214' ' ' ASN . . . . . 0.421 ' O ' ' HB2' ' A' ' 215' ' ' ASP . 51.3 p-10 -60.99 152.4 27.95 Favored 'General case' 0 C--N 1.295 -1.788 0 O-C-N 120.154 -1.592 . . . . 0.0 108.853 179.616 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 215' ' ' ASP . . . . . 0.421 ' HB2' ' O ' ' A' ' 214' ' ' ASN . 0.5 OUTLIER 75.16 9.94 3.77 Favored 'General case' 0 N--CA 1.505 2.297 0 CA-C-O 120.782 0.325 . . . . 0.0 110.766 179.266 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -79.95 143.39 34.23 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.878 -1.139 . . . . 0.0 107.962 178.502 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 46.1 t80 -91.72 122.06 33.93 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 178.925 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 218' ' ' LEU . . . . . 0.481 HD12 ' HB2' ' A' ' 16' ' ' ALA . 77.4 mt -129.91 147.83 51.72 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.309 -0.87 . . . . 0.0 110.476 -178.496 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 76.8 mt -116.84 126.1 74.11 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 N-CA-C 106.255 -1.758 . . . . 0.0 106.255 177.072 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 25.4 tp -98.66 118.07 34.56 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.07 -1.019 . . . . 0.0 109.405 -178.331 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 221' ' ' ASP . . . . . 0.476 ' O ' ' O ' ' A' ' 10' ' ' GLY . 29.7 m-20 -75.79 -45.12 37.85 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.294 -0.879 . . . . 0.0 108.764 179.187 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 222' ' ' ALA . . . . . 0.753 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 49.82 14.39 0.12 Allowed 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.658 -0.868 . . . . 0.0 108.658 -179.533 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 223' ' ' VAL . . . . . 0.476 ' N ' ' C ' ' A' ' 221' ' ' ASP . 73.8 t -129.57 -46.9 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 N-CA-C 107.2 -1.407 . . . . 0.0 107.2 178.681 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 79.7 m-20 -97.39 0.9 48.61 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 106.499 -1.667 . . . . 0.0 106.499 176.721 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 11.4 t-20 60.01 46.57 10.74 Favored 'General case' 0 N--CA 1.487 1.389 0 CA-C-N 115.802 -0.635 . . . . 0.0 109.609 179.876 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -135.01 155.55 50.58 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 121.421 -0.799 . . . . 0.0 109.747 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 93.7 t -124.21 130.03 73.85 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 178.678 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 81.3 m-85 -102.75 122.76 45.12 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.464 -0.772 . . . . 0.0 109.542 179.658 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 56.5 t -100.99 113.88 38.41 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.001 0 O-C-N 121.657 -0.652 . . . . 0.0 110.587 -178.844 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 62.9 t-20 54.16 67.12 3.68 Favored Pre-proline 0 N--CA 1.495 1.825 0 O-C-N 121.134 -0.979 . . . . 0.0 110.777 179.317 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -89.22 144.37 4.92 Favored 'Trans proline' 0 C--N 1.307 -1.637 0 C-N-CA 122.876 2.384 . . . . 0.0 112.388 179.501 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -67.96 165.55 17.57 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.323 -0.861 . . . . 0.0 109.427 -179.575 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -60.06 -39.7 86.89 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.397 -0.814 . . . . 0.0 109.831 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -59.9 -36.86 77.85 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.283 -0.886 . . . . 0.0 109.616 -179.253 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 54.9 t -67.45 -40.42 84.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.076 -1.015 . . . . 0.0 109.317 179.222 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 86.2 mt -66.75 -45.71 87.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.173 -0.954 . . . . 0.0 109.052 179.616 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -55.04 -45.11 75.22 Favored 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 179.584 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 20.0 tttt -62.62 -40.35 96.71 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.432 -0.793 . . . . 0.0 108.985 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 79.0 mtp -69.83 -31.64 69.62 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.35 -0.844 . . . . 0.0 109.965 179.455 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 5.3 mmt180 -68.41 -40.0 81.42 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.159 -0.963 . . . . 0.0 109.993 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -60.04 -40.47 89.47 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.192 -0.943 . . . . 0.0 108.688 179.623 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 53.8 t -65.64 -40.06 86.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.386 -0.821 . . . . 0.0 109.35 179.716 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 63.1 tt0 -60.35 -39.89 88.75 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.145 -0.972 . . . . 0.0 108.71 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 64.0 mt-10 -60.64 -39.9 90.01 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.283 -0.885 . . . . 0.0 108.966 179.463 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 31.1 mt-30 -61.09 -43.15 99.32 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.131 -0.981 . . . . 0.0 108.537 178.744 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 93.9 t -61.05 -43.48 96.28 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 O-C-N 121.45 -0.781 . . . . 0.0 109.641 -179.656 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -60.23 -43.66 95.86 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.308 -0.87 . . . . 0.0 109.016 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 10.7 t -63.44 -40.02 96.03 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 179.422 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 . . . . . 0 N--CA 1.489 1.485 0 O-C-N 121.508 -0.745 . . . . 0.0 109.577 -179.547 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 319' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.217 -0.605 0 CA-C-O 122.558 1.171 . . . . 0.0 112.806 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 320' ' ' ILE . . . . . 0.823 ' HB ' ' CG1' ' B' ' 466' ' ' ILE . 2.3 mp -105.87 130.87 56.68 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.909 0 CA-C-O 122.69 1.233 . . . . 0.0 110.615 177.619 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 321' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -100.65 124.91 46.91 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-N 114.099 -1.409 . . . . 0.0 110.331 176.432 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 322' ' ' ILE . . . . . . . . . . . . . 10.2 mm -94.74 123.34 46.82 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 N-CA-C 105.987 -1.856 . . . . 0.0 105.987 176.449 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 323' ' ' ILE . . . . . . . . . . . . . 21.7 mm -92.04 146.68 6.01 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.574 0 CA-C-O 122.447 1.118 . . . . 0.0 111.822 -178.371 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 324' ' ' ALA . . . . . . . . . . . . . . . -58.53 121.07 50.3 Favored Pre-proline 0 N--CA 1.43 -1.437 0 N-CA-C 115.362 1.616 . . . . 0.0 115.362 -178.176 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 325' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_endo -76.07 -20.07 15.14 Favored 'Trans proline' 0 CA--C 1.559 1.753 0 C-N-CA 121.606 1.537 . . . . 0.0 111.484 -177.577 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 326' ' ' LEU . . . . . 0.461 ' N ' HD12 ' B' ' 326' ' ' LEU 0.322 0.0 OUTLIER -147.45 161.31 41.32 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.849 0.86 . . . . 0.0 110.207 175.246 . . . . . . . . 4 4 . 1 . 001 nuclear build full ' B' B ' 327' ' ' SER . . . . . . . . . . . . . 50.0 m -82.65 148.15 28.12 Favored 'General case' 0 CA--C 1.498 -1.034 0 CA-C-O 121.612 0.72 . . . . 0.0 111.047 177.755 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 328' ' ' GLY . . . . . . . . . . . . . . . 156.65 -155.44 26.35 Favored Glycine 0 N--CA 1.432 -1.607 0 C-N-CA 119.252 -1.451 . . . . 0.0 111.059 178.773 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 329' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -117.01 134.89 54.17 Favored 'General case' 0 C--N 1.293 -1.858 0 CA-C-N 114.058 -1.071 . . . . 0.0 110.165 -177.049 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 330' ' ' ILE . . . . . . . . . . . . . 71.4 mt -74.37 141.51 15.98 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.614 0 C-N-CA 117.645 -1.622 . . . . 0.0 110.366 -179.184 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 331' ' ' VAL . . . . . . . . . . . . . 14.6 t -132.59 155.88 41.79 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.17 0 CA-C-N 114.511 -1.222 . . . . 0.0 108.728 -178.463 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 332' ' ' ASN . . . . . 0.504 ' HB3' ' OE2' ' B' ' 334' ' ' GLU . 86.2 m-20 -71.5 138.45 48.95 Favored 'General case' 0 CA--C 1.497 -1.084 0 CA-C-O 121.405 0.621 . . . . 0.0 111.055 178.804 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 333' ' ' ILE . . . . . 0.476 ' CD1' ' CG1' ' B' ' 439' ' ' VAL . 8.2 tt -67.84 -23.68 29.64 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.884 0 C-N-CA 118.642 -1.223 . . . . 0.0 108.768 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 334' ' ' GLU . . . . . 0.504 ' OE2' ' HB3' ' B' ' 332' ' ' ASN . 0.8 OUTLIER -73.9 -14.13 61.01 Favored 'General case' 0 C--N 1.292 -1.915 0 C-N-CA 118.742 -1.183 . . . . 0.0 110.555 180.0 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 335' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -94.99 12.52 28.12 Favored 'General case' 0 C--N 1.307 -1.275 0 N-CA-C 113.776 1.028 . . . . 0.0 113.776 -179.796 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 336' ' ' VAL . . . . . . . . . . . . . 3.0 t -86.52 130.95 47.31 Favored Pre-proline 0 C--N 1.288 -2.09 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 179.204 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 337' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_exo -70.5 48.16 0.74 Allowed 'Trans proline' 0 C--N 1.313 -1.317 0 C-N-CA 122.688 2.259 . . . . 0.0 111.702 -173.906 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 338' ' ' ASP . . . . . . . . . . . . . 65.3 t0 -150.74 115.81 5.32 Favored 'General case' 0 C--N 1.29 -1.987 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 179.796 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 339' ' ' VAL . . . . . . . . . . . . . 19.8 m -60.32 -37.96 75.89 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.256 0 C-N-CA 119.04 -1.064 . . . . 0.0 111.669 -178.482 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 340' ' ' VAL . . . . . 0.82 ' HA ' HD12 ' B' ' 345' ' ' ILE 0.406 17.6 m -62.36 -34.81 66.28 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 C-N-CA 116.983 -1.887 . . . . 0.0 112.136 -179.851 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 341' ' ' PHE . . . . . . . . . . . . . 69.5 m-85 -84.26 -44.38 13.92 Favored 'General case' 0 C--N 1.261 -3.248 0 O-C-N 120.185 -1.572 . . . . 0.0 109.777 179.625 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 342' ' ' ALA . . . . . . . . . . . . . . . -60.35 -37.9 82.14 Favored 'General case' 0 CA--C 1.487 -1.454 0 N-CA-C 108.793 -0.818 . . . . 0.0 108.793 -177.513 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 343' ' ' GLU . . . . . 0.435 ' O ' ' HG2' ' B' ' 344' ' ' LYS . 60.2 mt-10 -86.12 5.44 33.79 Favored 'General case' 0 C--O 1.209 -1.027 0 CA-C-O 123.061 1.41 . . . . 0.0 111.005 178.919 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 344' ' ' LYS . . . . . 0.562 ' HB2' ' O ' ' B' ' 347' ' ' GLY . 0.0 OUTLIER 51.1 40.06 24.85 Favored 'General case' 0 CA--C 1.502 -0.874 0 O-C-N 120.414 -1.429 . . . . 0.0 113.94 179.215 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 345' ' ' ILE . . . . . 0.921 HG22 ' HB1' ' A' ' 71' ' ' ALA . 25.8 mt -67.25 -30.4 49.1 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.956 0 CA-C-O 123.58 1.657 . . . . 0.0 110.63 178.556 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 346' ' ' VAL . . . . . 0.439 HG12 ' H ' ' B' ' 346' ' ' VAL 0.29 11.1 p -89.49 -7.77 10.82 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.953 0 CA-C-N 112.422 -2.172 . . . . 0.0 111.842 -175.495 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 347' ' ' GLY . . . . . 0.562 ' O ' ' HB2' ' B' ' 344' ' ' LYS . . . 133.44 -175.56 20.13 Favored Glycine 0 C--O 1.207 -1.576 0 N-CA-C 108.775 -1.73 . . . . 0.0 108.775 176.541 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 348' ' ' ASP . . . . . 0.602 ' OD2' ' SD ' ' B' ' 443' ' ' MET . 70.4 m-20 -119.48 155.38 32.19 Favored 'General case' 0 C--N 1.31 -1.15 0 C-N-CA 118.021 -1.471 . . . . 0.0 112.847 179.667 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 349' ' ' GLY . . . . . . . . . . . . . . . 172.17 -137.63 4.37 Favored Glycine 0 CA--C 1.536 1.405 0 C-N-CA 117.787 -2.149 . . . . 0.0 111.33 177.329 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 350' ' ' ILE . . . . . 0.454 ' C ' HD12 ' B' ' 350' ' ' ILE . 2.8 pp -135.2 175.13 11.64 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.665 0 O-C-N 121.561 -0.964 . . . . 0.0 108.629 178.624 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 351' ' ' ALA . . . . . . . . . . . . . . . -121.52 158.49 28.36 Favored 'General case' 0 C--N 1.306 -1.305 0 C-N-CA 124.701 1.2 . . . . 0.0 108.421 175.549 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 352' ' ' ILE . . . . . . . . . . . . . 58.5 mt -133.39 128.92 55.81 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.843 0 O-C-N 121.595 -0.69 . . . . 0.0 110.965 178.032 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 353' ' ' LYS . . . . . . . . . . . . . 5.1 tmtt? -86.23 108.85 19.09 Favored Pre-proline 0 C--N 1.307 -1.275 0 N-CA-C 101.447 -3.538 . . . . 0.0 101.447 174.767 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 354' ' ' PRO . . . . . 0.454 ' HB3' HD22 ' B' ' 326' ' ' LEU . 2.0 Cg_endo -71.38 150.13 57.84 Favored 'Trans proline' 0 C--N 1.309 -1.534 0 C-N-CA 123.601 2.868 . . . . 0.0 113.08 -170.894 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 355' ' ' THR . . . . . . . . . . . . . 73.5 p -138.57 1.65 2.16 Favored 'General case' 0 C--N 1.315 -0.914 0 O-C-N 121.856 -0.527 . . . . 0.0 110.19 177.654 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 356' ' ' GLY . . . . . . . . . . . . . . . -108.76 -144.62 10.94 Favored Glycine 0 CA--C 1.533 1.196 0 O-C-N 121.444 -0.785 . . . . 0.0 114.592 -177.705 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 357' ' ' ASN . . . . . . . . . . . . . 22.1 p30 -142.85 14.32 1.91 Allowed 'General case' 0 CA--C 1.493 -1.237 0 O-C-N 122.317 -0.519 . . . . 0.0 112.11 -179.308 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 358' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -157.23 155.12 30.3 Favored 'General case' 0 N--CA 1.415 -2.219 0 C-N-CA 115.488 -2.485 . . . . 0.0 113.382 178.567 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 359' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -114.86 121.47 43.35 Favored 'General case' 0 N--CA 1.438 -1.051 0 CA-C-N 114.931 -1.031 . . . . 0.0 109.097 178.864 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 360' ' ' VAL . . . . . . . . . . . . . 3.1 m -114.36 174.55 2.75 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.797 0 CA-C-O 122.739 1.257 . . . . 0.0 110.921 -178.912 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 361' ' ' ALA . . . . . . . . . . . . . . . -68.03 126.76 93.03 Favored Pre-proline 0 C--N 1.289 -2.025 0 CA-C-N 113.797 -1.547 . . . . 0.0 109.762 179.199 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 362' ' ' PRO . . . . . 0.404 ' HG2' HD13 ' B' ' 387' ' ' LEU . 18.0 Cg_endo -86.05 -1.4 8.66 Favored 'Trans proline' 0 C--N 1.323 -0.81 0 CA-C-N 120.083 1.065 . . . . 0.0 110.344 -179.543 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 363' ' ' VAL . . . . . 0.434 ' HA ' HG22 ' B' ' 415' ' ' VAL . 17.1 m -158.52 165.03 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 CA-C-O 121.477 0.656 . . . . 0.0 111.202 -178.167 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 364' ' ' ASP . . . . . 0.823 ' OD1' HG23 ' B' ' 415' ' ' VAL . 48.1 m-20 -81.58 127.27 32.68 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 103.484 -2.784 . . . . 0.0 103.484 174.683 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 365' ' ' GLY . . . . . 0.484 ' HA3' ' O ' ' B' ' 380' ' ' GLU . . . 173.99 -157.96 26.42 Favored Glycine 0 C--N 1.302 -1.346 0 N-CA-C 110.738 -0.945 . . . . 0.0 110.738 -175.487 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 366' ' ' THR . . . . . 0.599 HG22 ' HG3' ' B' ' 412' ' ' ARG . 33.3 p -123.72 134.84 53.63 Favored 'General case' 0 C--N 1.314 -0.976 0 C-N-CA 119.805 -0.758 . . . . 0.0 111.448 -177.384 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 367' ' ' ILE . . . . . 0.799 HG21 ' O ' ' B' ' 408' ' ' GLU . 1.6 tp -68.69 140.45 18.93 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.01 0 C-N-CA 117.629 -1.628 . . . . 0.0 107.357 178.968 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 368' ' ' GLY . . . . . . . . . . . . . . . -101.89 -64.09 0.75 Allowed Glycine 0 C--N 1.282 -2.447 0 CA-C-O 122.064 0.813 . . . . 0.0 114.278 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 369' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -141.5 136.38 31.15 Favored 'General case' 0 C--N 1.281 -2.407 0 CA-C-O 123.1 1.428 . . . . 0.0 111.833 -177.867 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 370' ' ' ILE . . . . . 0.64 HD12 ' OE1' ' B' ' 409' ' ' GLU . 97.5 mt -116.06 125.54 73.19 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.056 0 N-CA-C 105.583 -2.006 . . . . 0.0 105.583 179.629 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 371' ' ' PHE . . . . . 0.416 ' CE2' ' O3 ' ' B' ' 500' ' ' PO3 . 5.6 m-85 -62.69 145.36 54.89 Favored 'General case' 0 C--N 1.303 -1.413 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 -179.31 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 372' ' ' GLU . . . . . 0.443 ' HB2' ' CB ' ' A' ' 196' ' ' SER . 47.1 tp10 -61.71 -15.15 38.0 Favored 'General case' 0 C--N 1.296 -1.722 0 C-N-CA 123.717 0.807 . . . . 0.0 110.405 -178.338 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 373' ' ' THR . . . . . 0.667 ' OG1' ' CD2' ' B' ' 375' ' ' HIS . 41.6 p -97.63 5.2 49.73 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-O 123.591 1.663 . . . . 0.0 109.142 178.363 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 374' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 50.39 44.32 26.74 Favored 'General case' 0 C--N 1.263 -3.185 0 CA-C-N 113.207 -1.815 . . . . 0.0 112.66 175.416 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 375' ' ' HIS . . . . . 0.667 ' CD2' ' OG1' ' B' ' 373' ' ' THR . 0.3 OUTLIER -126.35 -1.54 6.93 Favored 'General case' 0 N--CA 1.429 -1.502 0 N-CA-C 113.557 0.947 . . . . 0.0 113.557 -177.499 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 376' ' ' ALA . . . . . . . . . . . . . . . -153.16 152.65 31.5 Favored 'General case' 0 N--CA 1.411 -2.406 0 O-C-N 120.616 -1.302 . . . . 0.0 111.108 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 377' ' ' PHE . . . . . . . . . . . . . 54.1 p90 -152.47 166.48 31.83 Favored 'General case' 0 C--N 1.308 -1.239 0 CA-C-O 123.021 1.391 . . . . 0.0 113.325 178.822 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 378' ' ' SER . . . . . 0.766 ' O ' HD12 ' B' ' 367' ' ' ILE 0.256 4.9 p -118.36 139.67 51.01 Favored 'General case' 0 N--CA 1.438 -1.065 0 CA-C-N 113.268 -1.787 . . . . 0.0 109.832 -178.776 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 379' ' ' ILE . . . . . . . . . . . . . 19.9 tt -143.32 150.08 17.83 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 175.735 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 380' ' ' GLU . . . . . 0.484 ' O ' ' HA3' ' B' ' 365' ' ' GLY . 0.7 OUTLIER -118.5 129.69 55.51 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 105.65 -1.982 . . . . 0.0 105.65 178.127 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 381' ' ' SER . . . . . . . . . . . . . 13.7 p -80.84 167.21 20.17 Favored 'General case' 0 C--N 1.297 -1.699 0 C-N-CA 118.433 -1.307 . . . . 0.0 108.183 -176.835 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 382' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -68.04 -31.03 70.41 Favored 'General case' 0 C--N 1.278 -2.505 0 C-N-CA 118.466 -1.294 . . . . 0.0 108.296 177.813 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 383' ' ' SER . . . . . . . . . . . . . 4.6 m -70.22 4.42 2.22 Favored 'General case' 0 C--N 1.315 -0.903 0 C-N-CA 125.326 1.45 . . . . 0.0 112.023 -179.69 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 384' ' ' GLY . . . . . . . . . . . . . . . 78.9 14.45 81.99 Favored Glycine 0 C--N 1.279 -2.613 0 N-CA-C 117.198 1.639 . . . . 0.0 117.198 -178.928 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 385' ' ' VAL . . . . . 0.817 HG21 ' CD1' ' B' ' 466' ' ' ILE . 64.8 t -92.34 132.97 35.22 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.374 0 CA-C-N 121.237 2.518 . . . . 0.0 110.9 177.797 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 386' ' ' GLU . . . . . 0.538 ' HB2' ' ND2' ' B' ' 442' ' ' ASN . 97.1 mt-10 -96.82 121.97 39.26 Favored 'General case' 0 N--CA 1.476 0.846 0 O-C-N 121.617 -0.677 . . . . 0.0 110.264 176.812 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 387' ' ' LEU . . . . . 0.404 HD13 ' HG2' ' B' ' 362' ' ' PRO . 0.9 OUTLIER -116.42 158.85 22.87 Favored 'General case' 0 C--O 1.216 -0.675 0 CA-C-O 122.002 0.906 . . . . 0.0 110.778 -178.848 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 388' ' ' PHE . . . . . 0.542 ' CE2' ' HB2' ' B' ' 390' ' ' HIS . 80.5 t80 -144.48 108.97 4.86 Favored 'General case' 0 C--N 1.297 -1.703 0 CA-C-O 121.703 0.763 . . . . 0.0 110.692 177.476 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 389' ' ' VAL . . . . . . . . . . . . . 95.2 t -100.3 116.54 43.9 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.015 0 C-N-CA 124.404 1.081 . . . . 0.0 111.477 179.434 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 390' ' ' HIS . . . . . 0.542 ' HB2' ' CE2' ' B' ' 388' ' ' PHE . 3.4 t-160 -122.14 106.45 11.17 Favored 'General case' 0 C--O 1.202 -1.444 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.126 -179.277 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 391' ' ' PHE . . . . . . . . . . . . . 30.6 t80 -63.7 124.16 20.72 Favored 'General case' 0 CA--C 1.559 1.294 0 N-CA-C 116.573 2.064 . . . . 0.0 116.573 178.675 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 392' ' ' GLY . . . . . . . . . . . . . . . 69.38 -175.86 32.24 Favored Glycine 0 C--O 1.215 -1.082 0 CA-C-O 122.815 1.231 . . . . 0.0 114.467 175.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 393' ' ' ILE . . . . . 0.503 HD13 ' HB3' ' B' ' 433' ' ' SER . 0.2 OUTLIER -118.15 132.64 67.39 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.155 0 CA-C-O 123.109 1.433 . . . . 0.0 109.224 179.4 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 394' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 54.63 25.93 6.88 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-N 114.064 -1.425 . . . . 0.0 111.29 -177.0 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 395' ' ' THR . . . . . . . . . . . . . 48.8 p -64.44 -20.0 65.89 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 115.38 1.622 . . . . 0.0 115.38 -179.617 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 396' ' ' VAL . . . . . 0.525 HG23 HG21 ' B' ' 373' ' ' THR . 15.0 p -57.04 -32.85 41.1 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.86 0 O-C-N 120.016 -1.678 . . . . 0.0 109.324 177.955 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 397' ' ' GLU . . . . . 0.757 ' OE1' ' CG ' ' A' ' 122' ' ' TYR . 98.5 mt-10 -58.47 -20.09 42.41 Favored 'General case' 0 CA--C 1.566 1.567 0 C-N-CA 119.806 -0.758 . . . . 0.0 112.216 -179.329 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 398' ' ' LEU . . . . . 0.467 HD12 ' N ' ' B' ' 398' ' ' LEU . 10.8 mp -78.26 -3.22 41.75 Favored 'General case' 0 CA--C 1.564 1.511 0 O-C-N 119.536 -1.978 . . . . 0.0 113.861 178.046 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 399' ' ' LYS . . . . . 0.524 ' HZ1' ' HD3' ' A' ' 186' ' ' ARG . 63.7 mttp 49.04 46.05 22.65 Favored 'General case' 0 C--N 1.279 -2.466 0 N-CA-C 116.081 1.882 . . . . 0.0 116.081 -179.264 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 400' ' ' GLY . . . . . . . . . . . . . . . 90.84 -13.42 65.99 Favored Glycine 0 CA--C 1.541 1.671 0 N-CA-C 115.465 0.946 . . . . 0.0 115.465 176.229 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 401' ' ' GLU . . . . . . . . . . . . . 92.9 mt-10 -61.87 121.19 12.31 Favored 'General case' 0 C--N 1.284 -2.252 0 O-C-N 121.28 -1.129 . . . . 0.0 112.053 -179.576 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 402' ' ' GLY . . . . . 0.532 ' O ' ' NZ ' ' B' ' 404' ' ' LYS . . . 97.77 -7.11 62.92 Favored Glycine 0 C--O 1.202 -1.9 0 N-CA-C 114.903 0.721 . . . . 0.0 114.903 178.292 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 403' ' ' PHE . . . . . . . . . . . . . 73.9 m-85 -115.78 152.37 33.42 Favored 'General case' 0 C--N 1.283 -2.302 0 C-N-CA 124.023 0.929 . . . . 0.0 110.945 177.724 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 404' ' ' LYS . . . . . 0.532 ' NZ ' ' O ' ' B' ' 402' ' ' GLY . 0.0 OUTLIER -141.97 113.45 7.73 Favored 'General case' 0 C--N 1.317 -0.83 0 C-N-CA 124.726 1.21 . . . . 0.0 109.214 176.865 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 405' ' ' ARG . . . . . 0.712 ' NH1' ' OE2' ' B' ' 409' ' ' GLU . 4.9 ttm180 -67.28 123.45 20.37 Favored 'General case' 0 CA--C 1.463 -2.371 0 C-N-CA 120.401 -0.52 . . . . 0.0 109.956 178.845 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 406' ' ' ILE . . . . . 0.407 HG13 ' HG3' ' B' ' 421' ' ' GLU . 23.8 mm -106.15 -35.17 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.314 0 C-N-CA 115.008 -2.677 . . . . 0.0 108.169 -179.323 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 407' ' ' ALA . . . . . . . . . . . . . . . -95.06 178.27 5.61 Favored 'General case' 0 N--CA 1.435 -1.21 0 C-N-CA 118.763 -1.175 . . . . 0.0 112.165 -179.263 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 408' ' ' GLU . . . . . 0.799 ' O ' HG21 ' B' ' 367' ' ' ILE . 39.4 mt-10 -118.37 151.37 37.87 Favored 'General case' 0 C--O 1.212 -0.886 0 N-CA-C 112.547 0.573 . . . . 0.0 112.547 179.017 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 409' ' ' GLU . . . . . 0.712 ' OE2' ' NH1' ' B' ' 405' ' ' ARG . 0.0 OUTLIER -60.74 137.06 58.23 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 118.595 -1.242 . . . . 0.0 108.022 175.345 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 410' ' ' GLY . . . . . 0.655 ' N ' HG23 ' B' ' 367' ' ' ILE . . . 89.36 -5.02 84.33 Favored Glycine 0 N--CA 1.475 1.239 0 O-C-N 121.709 -0.619 . . . . 0.0 111.617 -179.548 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 411' ' ' GLN . . . . . 0.581 ' H ' ' CG2' ' B' ' 367' ' ' ILE . 30.0 tt0 -66.05 138.09 57.53 Favored 'General case' 0 C--N 1.287 -2.132 0 CA-C-O 123.032 1.396 . . . . 0.0 112.818 179.521 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 412' ' ' ARG . . . . . 0.599 ' HG3' HG22 ' B' ' 366' ' ' THR . 0.0 OUTLIER -86.19 132.76 33.94 Favored 'General case' 0 N--CA 1.42 -1.937 0 CA-C-N 114.066 -1.425 . . . . 0.0 107.247 175.71 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 413' ' ' VAL . . . . . . . . . . . . . 34.5 m -140.14 160.29 25.96 Favored 'Isoleucine or valine' 0 CA--C 1.472 -2.056 0 C-N-CA 117.367 -1.733 . . . . 0.0 112.97 -176.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 414' ' ' LYS . . . . . 0.481 ' HE3' ' OD2' ' B' ' 417' ' ' ASP . 0.5 OUTLIER -110.79 156.7 20.71 Favored 'General case' 0 C--N 1.286 -2.179 0 CA-C-N 111.739 -2.482 . . . . 0.0 108.371 174.784 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 415' ' ' VAL . . . . . 0.823 HG23 ' OD1' ' B' ' 364' ' ' ASP . 44.1 t -45.71 135.73 2.11 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.085 0 CA-C-O 121.653 0.74 . . . . 0.0 111.673 176.474 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 416' ' ' GLY . . . . . . . . . . . . . . . 89.14 -13.01 64.5 Favored Glycine 0 C--O 1.212 -1.235 0 O-C-N 121.552 -0.718 . . . . 0.0 114.552 178.066 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 417' ' ' ASP . . . . . 0.481 ' OD2' ' HE3' ' B' ' 414' ' ' LYS . 91.9 m-20 -63.04 136.32 57.75 Favored 'General case' 0 C--N 1.294 -1.817 0 O-C-N 120.813 -1.404 . . . . 0.0 109.861 179.144 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 418' ' ' THR . . . . . . . . . . . . . 23.3 m -76.7 132.39 39.31 Favored 'General case' 0 CA--C 1.497 -1.061 0 CA-C-O 123.008 1.385 . . . . 0.0 111.068 -177.744 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 419' ' ' VAL . . . . . 0.472 ' O ' HG13 ' B' ' 420' ' ' ILE . 44.8 t -105.88 -48.57 8.92 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.551 0 CA-C-N 113.427 -1.715 . . . . 0.0 109.164 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 420' ' ' ILE . . . . . 0.472 HG13 ' O ' ' B' ' 419' ' ' VAL . 11.0 mt -148.35 143.47 19.05 Favored 'Isoleucine or valine' 0 CA--C 1.48 -1.741 0 N-CA-C 114.037 1.125 . . . . 0.0 114.037 -177.198 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 421' ' ' GLU . . . . . 0.49 ' O ' ' HD2' ' B' ' 404' ' ' LYS . 48.7 mt-10 -112.16 147.4 36.22 Favored 'General case' 0 CA--C 1.482 -1.647 0 C-N-CA 116.701 -2.0 . . . . 0.0 107.399 175.847 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 422' ' ' PHE . . . . . 0.525 ' HA ' ' O ' ' B' ' 402' ' ' GLY . 36.0 p90 -132.81 163.69 28.51 Favored 'General case' 0 C--N 1.298 -1.667 0 CA-C-O 122.096 0.951 . . . . 0.0 111.53 -179.239 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 423' ' ' ASP . . . . . 0.436 ' OD1' ' HD2' ' B' ' 425' ' ' PRO . 10.3 t0 -100.7 98.04 8.63 Favored 'General case' 0 C--O 1.214 -0.775 0 CA-C-N 114.505 -1.225 . . . . 0.0 109.695 176.88 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 424' ' ' LEU . . . . . 0.614 ' HB3' ' HD3' ' B' ' 425' ' ' PRO . 3.1 tp -59.47 -54.71 53.3 Favored Pre-proline 0 C--N 1.292 -1.932 0 N-CA-C 115.97 1.841 . . . . 0.0 115.97 -176.035 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 425' ' ' PRO . . . . . 0.614 ' HD3' ' HB3' ' B' ' 424' ' ' LEU . 20.6 Cg_exo -56.73 -44.93 40.45 Favored 'Trans proline' 1 C--N 1.246 -4.853 0 C-N-CA 121.641 1.56 . . . . 0.0 109.665 -175.722 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 426' ' ' LEU . . . . . 0.7 ' O ' HD12 ' B' ' 426' ' ' LEU . 0.5 OUTLIER -57.03 -51.06 70.76 Favored 'General case' 0 C--N 1.314 -0.965 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 177.863 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 427' ' ' LEU . . . . . . . . . . . . . 49.5 mt -68.41 -31.46 70.81 Favored 'General case' 0 C--N 1.281 -2.371 0 O-C-N 121.088 -1.008 . . . . 0.0 111.955 -178.441 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 428' ' ' GLU . . . . . . . . . . . . . 20.6 mt-10 -65.04 -37.67 88.35 Favored 'General case' 0 C--N 1.278 -2.534 0 N-CA-C 106.768 -1.567 . . . . 0.0 106.768 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 429' ' ' GLU . . . . . . . . . . . . . 10.1 tt0 -75.28 -42.45 54.81 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-N 115.04 -0.982 . . . . 0.0 113.197 177.809 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 430' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -94.67 -29.3 14.9 Favored 'General case' 0 C--N 1.307 -1.262 0 N-CA-C 116.34 1.978 . . . . 0.0 116.34 -175.748 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 431' ' ' ALA . . . . . . . . . . . . . . . -78.61 142.93 36.87 Favored 'General case' 0 C--N 1.263 -3.162 0 N-CA-C 115.421 1.637 . . . . 0.0 115.421 -176.63 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 432' ' ' LYS . . . . . . . . . . . . . 66.8 mmtt -55.73 -37.75 68.87 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 179.136 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 433' ' ' SER . . . . . 0.503 ' HB3' HD13 ' B' ' 393' ' ' ILE . 3.8 t -163.82 143.93 8.38 Favored 'General case' 0 C--N 1.296 -1.733 0 C-N-CA 125.078 1.351 . . . . 0.0 110.601 178.352 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 434' ' ' THR . . . . . . . . . . . . . 75.9 p -96.05 -0.64 50.17 Favored 'General case' 0 C--O 1.222 -0.349 0 CA-C-N 114.773 -1.103 . . . . 0.0 110.535 179.409 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 435' ' ' LEU . . . . . 0.495 ' HA ' HD23 ' B' ' 435' ' ' LEU . 17.0 mt -56.16 130.56 44.74 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 177.086 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 436' ' ' THR . . . . . . . . . . . . . 92.9 m -119.01 97.01 50.62 Favored Pre-proline 0 N--CA 1.431 -1.381 0 N-CA-C 118.058 2.614 . . . . 0.0 118.058 -173.906 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 437' ' ' PRO . . . . . 0.451 ' HD2' ' O ' ' B' ' 390' ' ' HIS . 8.3 Cg_exo -67.11 142.98 63.39 Favored 'Trans proline' 0 N--CA 1.446 -1.27 0 C-N-CA 117.107 -1.462 . . . . 0.0 114.421 -179.208 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 438' ' ' VAL . . . . . . . . . . . . 0.314 1.6 m -125.82 104.62 13.44 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 N-CA-C 105.142 -2.169 . . . . 0.0 105.142 173.48 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 439' ' ' VAL . . . . . 0.476 ' CG1' ' CD1' ' B' ' 333' ' ' ILE . 34.5 m -123.44 158.74 28.62 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.583 0 N-CA-C 116.338 1.977 . . . . 0.0 116.338 -176.692 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 440' ' ' ILE . . . . . 0.832 HD13 HD11 ' B' ' 449' ' ' LEU . 3.3 mp -97.45 125.31 50.6 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.225 0 N-CA-C 104.618 -2.364 . . . . 0.0 104.618 178.815 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 441' ' ' SER . . . . . . . . . . . . . 69.6 m -98.23 -4.45 35.29 Favored 'General case' 0 C--N 1.295 -1.78 0 CA-C-O 123.209 1.481 . . . . 0.0 112.946 -175.64 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 442' ' ' ASN . . . . . 0.538 ' ND2' ' HB2' ' B' ' 386' ' ' GLU 0.482 1.0 OUTLIER -97.76 15.19 24.42 Favored 'General case' 0 C--N 1.259 -3.368 0 C-N-CA 130.041 3.337 . . . . 0.0 114.592 -179.794 . . . . . . . . 4 4 . 1 . 001 nuclear build full ' B' B ' 443' ' ' MET . . . . . 0.602 ' SD ' ' OD2' ' B' ' 348' ' ' ASP . 65.3 ttp -33.88 -44.05 0.15 Allowed 'General case' 0 C--N 1.284 -2.274 0 N-CA-C 115.586 1.698 . . . . 0.0 115.586 -174.135 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 444' ' ' ASP . . . . . . . . . . . . . 72.2 m-20 -65.67 -11.37 44.33 Favored 'General case' 0 C--N 1.282 -2.35 0 CA-C-O 115.88 -2.009 . . . . 0.0 110.995 -179.543 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 445' ' ' GLU . . . . . . . . . . . . . 74.9 mm-40 -105.59 12.72 30.9 Favored 'General case' 0 C--N 1.296 -1.731 0 CA-C-N 123.049 2.659 . . . . 0.0 111.539 -179.716 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 446' ' ' ILE . . . . . 0.554 HD12 HG21 ' B' ' 440' ' ' ILE . 96.7 mt -120.44 140.92 43.0 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.053 0 C-N-CA 115.898 -2.321 . . . . 0.0 113.898 -177.12 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 447' ' ' LYS . . . . . . . . . . . . 0.255 98.7 mttt -74.51 -54.61 7.19 Favored 'General case' 0 C--O 1.222 -0.377 0 CA-C-N 114.376 -1.283 . . . . 0.0 109.751 -179.802 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 448' ' ' GLU . . . . . 0.461 ' O ' ' HA ' ' B' ' 466' ' ' ILE . 0.0 OUTLIER -147.4 145.48 29.26 Favored 'General case' 0 C--N 1.288 -2.071 0 CA-C-O 123.831 1.777 . . . . 0.0 113.879 177.19 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 449' ' ' LEU . . . . . 0.832 HD11 HD13 ' B' ' 440' ' ' ILE . 0.5 OUTLIER -115.58 112.22 21.86 Favored 'General case' 0 N--CA 1.414 -2.228 0 CA-C-N 110.961 -2.836 . . . . 0.0 109.958 177.284 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 450' ' ' ILE . . . . . . . . . . . . . 62.1 mt -109.0 112.33 40.02 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.231 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 177.8 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 451' ' ' LYS . . . . . . . . . . . . . 34.7 mttt -85.07 129.77 34.74 Favored 'General case' 0 C--N 1.305 -1.343 0 C-N-CA 124.635 1.174 . . . . 0.0 113.2 -178.955 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 452' ' ' LEU . . . . . . . . . . . . 0.301 31.5 mt -94.29 175.63 6.62 Favored 'General case' 0 N--CA 1.415 -2.194 0 CA-C-O 122.67 1.224 . . . . 0.0 112.314 -179.341 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 453' ' ' SER . . . . . . . . . . . . 0.277 0.5 OUTLIER -131.05 160.38 34.8 Favored 'General case' 0 C--N 1.296 -1.749 0 CA-C-N 113.455 -1.702 . . . . 0.0 114.729 -174.371 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 454' ' ' GLY . . . . . . . . . . . . . . . 100.31 -158.87 19.4 Favored Glycine 0 CA--C 1.529 0.944 0 N-CA-C 118.743 2.257 . . . . 0.0 118.743 174.327 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 455' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -94.75 142.34 27.57 Favored 'General case' 0 C--O 1.215 -0.739 0 CA-C-N 111.987 -2.107 . . . . 0.0 109.939 -178.897 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 456' ' ' VAL . . . . . 0.537 HG11 HG12 ' B' ' 463' ' ' VAL . 16.5 m -132.02 159.65 42.97 Favored 'Isoleucine or valine' 0 CA--C 1.46 -2.515 0 CA-C-O 122.795 1.283 . . . . 0.0 110.042 -177.549 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 457' ' ' THR . . . . . . . . . . . . . 20.5 m -122.73 123.64 41.55 Favored 'General case' 0 C--N 1.272 -2.773 0 CA-C-N 112.693 -2.049 . . . . 0.0 108.319 -179.63 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 458' ' ' VAL . . . . . . . . . . . . . 11.9 p -37.22 123.71 0.16 Allowed 'Isoleucine or valine' 0 C--O 1.217 -0.638 0 CA-C-O 123.808 1.765 . . . . 0.0 113.974 179.24 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 459' ' ' GLY . . . . . . . . . . . . . . . 61.1 25.97 65.15 Favored Glycine 0 CA--C 1.487 -1.683 0 CA-C-N 112.792 -2.003 . . . . 0.0 114.155 175.91 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 460' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -136.5 -53.24 0.72 Allowed 'General case' 0 C--N 1.287 -2.117 0 CA-C-O 121.979 0.895 . . . . 0.0 111.9 178.86 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 461' ' ' THR . . . . . 0.453 ' CG2' HG12 ' B' ' 456' ' ' VAL . 8.9 m -85.41 122.99 73.51 Favored Pre-proline 0 C--N 1.284 -2.27 0 N-CA-C 114.097 1.147 . . . . 0.0 114.097 -175.691 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 462' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -62.48 141.42 86.53 Favored 'Trans proline' 0 CA--C 1.54 0.792 0 C-N-CA 123.104 2.536 . . . . 0.0 109.723 177.642 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 463' ' ' VAL . . . . . 0.537 HG12 HG11 ' B' ' 456' ' ' VAL . 29.3 m -116.68 -27.97 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 O-C-N 121.692 -0.63 . . . . 0.0 112.173 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 464' ' ' ILE . . . . . . . . . . . . . 30.5 mt -141.08 151.09 19.94 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.063 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 179.343 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 465' ' ' ARG . . . . . . . . . . . . . 5.9 mtt180 -125.89 130.72 51.89 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 105.78 -1.933 . . . . 0.0 105.78 176.871 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 466' ' ' ILE . . . . . 0.823 ' CG1' ' HB ' ' B' ' 320' ' ' ILE . 40.1 pt -128.38 155.61 40.19 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.632 0 C-N-CA 118.971 -1.091 . . . . 0.0 109.825 -178.064 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 467' ' ' LYS . . . . . 0.429 ' O ' HG23 ' B' ' 446' ' ' ILE . 1.0 OUTLIER . . . . . 0 C--N 1.295 -1.787 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 176.64 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 500' ' ' PO3 . . . . . 0.429 ' P ' ' HE1' ' B' ' 390' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.3 mmm . . . . . 0 N--CA 1.493 1.682 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 72.6 mt -107.97 129.91 61.32 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.051 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 179.647 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 63.9 m -129.96 141.73 50.73 Favored 'General case' 0 N--CA 1.502 2.16 0 O-C-N 121.196 -0.94 . . . . 0.0 110.429 -179.599 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -123.41 -159.58 10.55 Favored Glycine 0 N--CA 1.499 2.842 0 N-CA-C 108.37 -1.892 . . . . 0.0 108.37 179.04 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.477 HG22 ' O ' ' A' ' 5' ' ' ILE . 81.7 mt -94.95 -12.02 8.68 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 O-C-N 120.801 -1.411 . . . . 0.0 111.083 -178.735 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.459 ' O ' ' O ' ' A' ' 5' ' ' ILE . 58.9 tp 53.34 103.91 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.164 -0.96 . . . . 0.0 109.577 -179.645 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.473 ' O ' ' NE ' ' A' ' 195' ' ' ARG . . . -95.56 -25.52 16.15 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.257 -0.902 . . . . 0.0 109.823 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.421 ' CB ' ' O ' ' A' ' 199' ' ' LEU . 2.6 m -141.79 126.36 10.32 Favored Pre-proline 0 N--CA 1.496 1.847 0 O-C-N 121.234 -0.916 . . . . 0.0 108.875 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -80.14 142.83 15.53 Favored 'Trans proline' 0 N--CA 1.491 1.328 0 C-N-CA 121.938 1.758 . . . . 0.0 111.797 179.636 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.753 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 163.36 -160.83 33.5 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 108.651 -1.78 . . . . 0.0 108.651 -179.852 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 86.5 mt -149.55 150.13 14.09 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 O-C-N 121.079 -1.248 . . . . 0.0 108.253 178.617 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -156.22 154.68 31.14 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.815 -1.178 . . . . 0.0 111.157 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.546 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 2.0 m-85 -133.77 126.84 31.48 Favored 'General case' 0 N--CA 1.497 1.923 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 178.808 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -179.85 178.67 48.67 Favored Glycine 0 N--CA 1.496 2.652 0 C-N-CA 118.702 -1.713 . . . . 0.0 110.919 179.701 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -79.74 159.95 26.41 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.712 -0.876 . . . . 0.0 109.225 -179.73 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.481 ' HB2' HD12 ' A' ' 218' ' ' LEU . . . -104.79 129.0 53.14 Favored 'General case' 0 N--CA 1.501 2.106 0 O-C-N 121.328 -0.857 . . . . 0.0 111.126 -178.172 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 62.0 tp -100.87 134.67 43.49 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 178.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 57.1 tp -116.91 122.47 44.42 Favored 'General case' 0 N--CA 1.504 2.274 0 O-C-N 121.213 -0.93 . . . . 0.0 110.53 -179.103 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 17.9 mt -87.77 103.44 15.63 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.621 -0.675 . . . . 0.0 110.239 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 59.0 mttt -98.43 134.96 40.68 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.405 -0.809 . . . . 0.0 109.214 179.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -130.8 130.54 43.8 Favored 'General case' 0 N--CA 1.502 2.133 0 O-C-N 121.148 -0.97 . . . . 0.0 109.379 178.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 93.8 m-20 -75.9 147.42 39.0 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.875 -1.14 . . . . 0.0 109.365 179.325 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 86.0 tt0 -67.29 140.17 57.31 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.122 -0.987 . . . . 0.0 109.362 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 55.3 mt -79.31 130.22 36.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.492 -0.755 . . . . 0.0 109.522 -179.338 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 30.6 t -97.06 126.46 49.82 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.281 -0.887 . . . . 0.0 109.736 -179.456 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 87.4 mt -105.8 136.86 38.36 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 179.698 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -92.05 121.21 33.4 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.087 -1.008 . . . . 0.0 109.965 -179.294 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 6.6 mmt180 -88.54 -3.26 58.84 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.298 -0.876 . . . . 0.0 108.931 179.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 89.9 mttt -63.27 139.59 58.79 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.349 -0.845 . . . . 0.0 109.198 -179.764 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 92.3 mttt -86.23 150.03 24.67 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.251 -0.906 . . . . 0.0 109.087 179.631 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.465 HG21 ' HG3' ' A' ' 39' ' ' GLU . 4.7 pt -95.2 165.05 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.285 -0.885 . . . . 0.0 110.325 -179.422 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 75.6 p -96.25 173.08 7.57 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 178.234 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.93 -49.26 78.39 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.118 -0.989 . . . . 0.0 109.566 -179.812 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -54.42 -30.05 51.17 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.78 -1.2 . . . . 0.0 109.183 179.727 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -82.75 -10.4 58.91 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.229 -0.919 . . . . 0.0 110.712 -179.731 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 31.1 t -63.85 -52.75 53.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 120.601 -1.312 . . . . 0.0 108.674 179.692 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -60.37 -40.06 89.44 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.341 -0.849 . . . . 0.0 110.092 -179.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 33.8 mt-30 -68.66 -40.03 80.37 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.993 -1.067 . . . . 0.0 110.825 -178.681 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.465 ' HG3' HG21 ' A' ' 31' ' ' ILE . 60.1 mm-40 -65.34 -40.07 93.18 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.744 -1.222 . . . . 0.0 110.032 -179.201 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 55.5 t -60.4 -46.76 94.66 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 O-C-N 120.755 -1.216 . . . . 0.0 108.552 178.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 53.8 tp10 -60.08 -41.33 92.22 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.265 -0.897 . . . . 0.0 109.443 179.576 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -60.11 -44.19 95.04 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.003 -1.061 . . . . 0.0 108.227 179.081 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.422 ' CZ ' HD13 ' A' ' 89' ' ' ILE . 65.9 t80 -60.74 -49.79 76.1 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 178.542 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 14.7 tp -61.39 -44.46 97.12 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.345 -0.847 . . . . 0.0 108.795 179.167 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 47.2 t -64.48 -43.77 93.12 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.961 -1.087 . . . . 0.0 109.208 179.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -68.92 -40.21 84.67 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 108.76 -1.736 . . . . 0.0 108.76 179.077 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.467 HH21 ' HG2' ' A' ' 81' ' ' GLU . 37.1 ttt-85 -65.56 -31.92 73.23 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 108.264 -1.014 . . . . 0.0 108.264 178.726 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.81 -41.11 90.55 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 179.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.43 ' O ' ' C ' ' A' ' 50' ' ' ALA . 6.7 ttpt -63.86 -73.01 0.12 Allowed 'General case' 0 C--N 1.305 -1.34 0 O-C-N 120.867 -1.146 . . . . 0.0 108.154 179.214 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.43 ' C ' ' O ' ' A' ' 49' ' ' LYS . . . -38.43 -33.77 0.11 Allowed 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.331 -0.855 . . . . 0.0 111.161 -178.734 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 15.3 t -58.53 -56.08 26.82 Favored 'General case' 0 C--N 1.3 -1.581 0 C-N-CA 118.553 -1.259 . . . . 0.0 108.139 179.759 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -69.8 -40.0 76.24 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.533 -0.729 . . . . 0.0 111.392 -179.084 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 27.8 mt-30 -67.34 -40.14 85.83 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 120.718 -1.239 . . . . 0.0 110.234 -179.391 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 76.9 mt -62.17 -40.16 95.08 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.833 -1.167 . . . . 0.0 108.868 178.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 60.6 mm-40 -61.31 -37.99 85.23 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.516 -0.74 . . . . 0.0 109.814 179.381 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 83.2 m -63.01 -41.44 99.56 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.022 -1.049 . . . . 0.0 109.231 -179.777 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.524 ' CD1' HH22 ' A' ' 136' ' ' ARG . 96.6 mt -62.72 -38.75 82.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.237 -0.914 . . . . 0.0 109.512 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.54 ' NZ ' ' O ' ' A' ' 70' ' ' GLU . 63.9 tttp -56.88 -51.37 69.35 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.501 -0.75 . . . . 0.0 109.844 -179.729 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 66.8 p -58.41 -33.98 70.26 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.314 -0.866 . . . . 0.0 110.451 -178.054 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.666 ' O ' HG23 ' A' ' 64' ' ' THR . 68.4 mttm -69.64 -37.48 76.78 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.871 -1.143 . . . . 0.0 109.347 -179.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -65.16 -43.84 90.46 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.467 -0.771 . . . . 0.0 109.545 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -60.26 -51.87 56.18 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 110.469 -1.052 . . . . 0.0 110.469 -179.448 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 71.5 mm-40 -69.91 -44.38 69.79 Favored 'General case' 0 C--O 1.205 -1.268 0 O-C-N 120.257 -1.731 . . . . 0.0 111.007 179.806 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.666 HG23 ' O ' ' A' ' 60' ' ' LYS . 76.6 p -64.9 -63.15 1.18 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.95 -1.094 . . . . 0.0 112.04 -178.299 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 10.7 m-85 -96.54 -48.68 5.44 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 121.055 -1.028 . . . . 0.0 111.609 -177.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 142.1 -168.72 25.61 Favored Glycine 0 N--CA 1.503 3.163 0 C-N-CA 119.561 -1.304 . . . . 0.0 111.392 179.676 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 75.5 mm-40 -70.11 -24.65 63.24 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.856 -0.791 . . . . 0.0 109.946 -179.775 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -61.05 -36.39 79.45 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.285 -0.885 . . . . 0.0 109.675 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 24.9 tttp -97.78 -20.91 17.25 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.339 -0.85 . . . . 0.0 110.522 -179.569 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.54 ' O ' ' NZ ' ' A' ' 58' ' ' LYS . 80.5 tt0 -67.15 -43.55 82.03 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.019 -1.051 . . . . 0.0 110.896 -179.019 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.921 ' HB1' HG22 ' B' ' 345' ' ' ILE . . . -68.19 -28.5 67.32 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.279 -0.888 . . . . 0.0 111.209 -177.782 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 96.0 mt -59.19 -39.48 78.79 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 C-N-CA 117.867 -1.533 . . . . 0.0 108.479 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 73.6 m-85 -65.54 -38.73 90.45 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.117 -0.99 . . . . 0.0 109.756 179.462 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.488 ' HB2' ' NZ ' ' A' ' 58' ' ' LYS . 85.6 tt0 -59.76 -40.24 87.51 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 120.82 -1.175 . . . . 0.0 109.224 179.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -62.72 -47.95 85.09 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 108.772 -1.731 . . . . 0.0 108.772 179.01 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . 0.521 ' CG ' HD11 ' A' ' 133' ' ' ILE . 56.2 m170 -60.85 -45.65 93.66 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.565 -0.962 . . . . 0.0 109.024 179.769 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 96.9 mt -66.45 -47.14 84.8 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 121.319 -0.863 . . . . 0.0 109.01 179.578 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 65.8 ttp -60.06 -40.07 88.21 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.075 -1.016 . . . . 0.0 109.818 -179.349 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.714 HD12 ' OD2' ' A' ' 82' ' ' ASP . 46.6 tp -65.54 -40.1 92.51 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.324 -0.86 . . . . 0.0 109.562 179.37 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 9.2 tt -63.11 -39.29 94.27 Favored 'General case' 0 C--N 1.297 -1.697 0 O-C-N 121.673 -0.642 . . . . 0.0 109.902 -179.021 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.467 ' HG2' HH21 ' A' ' 47' ' ' ARG . 97.7 mt-10 -82.95 5.74 20.97 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.27 -0.894 . . . . 0.0 110.056 -179.265 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.714 ' OD2' HD12 ' A' ' 79' ' ' LEU . 34.7 m-20 -50.83 130.1 24.42 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.914 -1.116 . . . . 0.0 109.598 -179.795 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -60.8 -19.13 58.9 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.376 -0.828 . . . . 0.0 110.696 -178.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 -71.23 -35.88 71.63 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.865 -1.147 . . . . 0.0 109.52 178.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 85.3 mt -70.19 -39.97 74.9 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.568 -0.708 . . . . 0.0 110.086 179.65 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -60.62 -48.34 82.21 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.368 -0.833 . . . . 0.0 109.414 -179.087 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -69.89 -41.05 75.27 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.303 -0.873 . . . . 0.0 110.819 -179.502 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 51.3 tp10 -70.02 -40.22 75.35 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.029 -1.044 . . . . 0.0 111.804 -178.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.422 HD13 ' CZ ' ' A' ' 43' ' ' PHE . 89.7 mt -67.5 -45.75 84.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 120.828 -1.17 . . . . 0.0 109.159 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 66.5 mt -67.83 -39.32 81.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.615 -0.678 . . . . 0.0 110.811 -179.788 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -60.2 -47.87 84.15 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.103 -0.998 . . . . 0.0 111.139 -178.735 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.441 ' O ' ' N ' ' A' ' 96' ' ' LYS . 19.6 mt -60.76 -46.01 92.11 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 120.858 -1.151 . . . . 0.0 109.842 -179.428 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 47.0 mt -61.19 -49.15 85.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.088 -1.008 . . . . 0.0 108.437 179.19 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 22.2 mttt -69.31 -42.02 75.96 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.431 -0.793 . . . . 0.0 110.651 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 51.9 t0 -81.92 -50.93 8.6 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.87 -1.144 . . . . 0.0 112.115 -178.248 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.441 ' N ' ' O ' ' A' ' 92' ' ' LEU . 17.7 mttp -91.58 -0.98 57.64 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 120.967 -1.083 . . . . 0.0 112.204 -177.557 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER 51.56 41.07 28.35 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 120.874 -1.141 . . . . 0.0 110.879 -178.834 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 25.5 mtp -93.11 169.79 10.14 Favored 'General case' 0 N--CA 1.498 1.941 0 CA-C-N 114.416 -1.265 . . . . 0.0 109.584 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 77.3 p -80.99 159.88 24.74 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.193 -0.942 . . . . 0.0 109.807 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -68.09 -40.19 82.69 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.192 -0.943 . . . . 0.0 110.71 -179.522 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . 0.548 ' OD1' ' N ' ' A' ' 101' ' ' ASP . 3.2 p-10 -70.58 -34.3 72.02 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.811 -1.18 . . . . 0.0 109.607 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -80.55 -40.44 25.92 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 120.949 -1.095 . . . . 0.0 109.484 179.142 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -70.34 -46.2 64.64 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.282 -0.886 . . . . 0.0 110.035 -179.7 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -61.4 -38.95 88.92 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.243 -0.911 . . . . 0.0 109.76 -179.722 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . 0.52 ' NE2' ' OE1' ' A' ' 109' ' ' GLU . 81.0 t60 -59.72 -40.18 87.15 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.31 -0.869 . . . . 0.0 109.875 -178.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 86.2 tt0 -63.85 -40.16 95.93 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.301 -0.874 . . . . 0.0 110.312 -179.103 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 97.9 t -63.67 -54.48 31.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.265 -0.897 . . . . 0.0 111.077 -178.345 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 50.6 mm -68.63 -40.69 82.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 120.846 -1.159 . . . . 0.0 109.216 -179.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.52 ' OE1' ' NE2' ' A' ' 105' ' ' HIS . 86.4 tt0 -64.94 -39.52 93.63 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 178.873 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -57.73 -49.42 74.28 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 110.08 -1.208 . . . . 0.0 110.08 -179.405 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 86.7 mt-30 -66.98 -52.92 36.81 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.781 -1.423 . . . . 0.0 109.35 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -54.98 -40.4 70.03 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.187 -0.946 . . . . 0.0 108.875 179.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 55.1 m -59.59 -40.3 86.99 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.251 -0.905 . . . . 0.0 108.915 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -63.79 -39.89 95.35 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.183 -0.948 . . . . 0.0 109.081 179.236 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.448 ' HB3' ' HB2' ' A' ' 127' ' ' ALA . 9.2 mp -63.55 -40.11 96.15 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.306 -0.871 . . . . 0.0 109.779 -179.254 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.434 ' O ' ' NZ ' ' A' ' 124' ' ' LYS . 79.9 mm-40 -59.85 -36.06 76.07 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.525 -1.36 . . . . 0.0 109.628 -179.55 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 65.4 mm-40 -54.76 -19.87 7.25 Favored 'General case' 0 C--O 1.202 -1.396 0 C-N-CA 117.998 -1.481 . . . . 0.0 110.984 179.008 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 88.3 mt -62.24 147.35 48.21 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.171 -0.955 . . . . 0.0 109.562 -179.732 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . 0.404 ' OD1' ' O ' ' A' ' 119' ' ' ASP . 57.0 t0 -98.56 40.62 1.18 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.467 -0.771 . . . . 0.0 109.894 -179.772 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -131.57 133.87 45.47 Favored 'General case' 0 N--CA 1.504 2.231 0 O-C-N 121.332 -0.855 . . . . 0.0 110.203 -179.611 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.455 ' OE1' ' N ' ' A' ' 121' ' ' GLU . 59.5 mp0 -70.15 -29.96 66.99 Favored 'General case' 0 N--CA 1.498 1.931 0 CA-C-O 121.366 0.603 . . . . 0.0 110.46 179.352 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.757 ' CG ' ' OE1' ' B' ' 397' ' ' GLU . 1.9 m-30 -71.91 -40.07 69.06 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.422 -0.799 . . . . 0.0 110.599 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.465 ' CD2' ' N ' ' A' ' 123' ' ' LEU . 3.1 mm? -73.84 -34.71 64.65 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.098 -1.001 . . . . 0.0 108.591 179.828 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.434 ' NZ ' ' O ' ' A' ' 116' ' ' GLU . 67.7 mttm -62.04 -42.06 98.77 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.62 -0.675 . . . . 0.0 110.496 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . 0.449 ' O ' ' HB3' ' A' ' 128' ' ' ALA . 40.4 tp10 -60.51 -44.52 95.91 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 120.62 -1.3 . . . . 0.0 109.848 179.841 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 60.7 ttp180 -59.96 -36.08 76.35 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.904 -1.122 . . . . 0.0 108.382 179.63 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . 0.448 ' HB2' ' HB3' ' A' ' 115' ' ' LEU . . . -61.29 -25.98 67.47 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 108.072 -1.085 . . . . 0.0 108.072 178.277 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.449 ' HB3' ' O ' ' A' ' 125' ' ' GLU . . . -70.19 -40.1 74.81 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 108.739 -0.838 . . . . 0.0 108.739 178.857 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -66.35 -40.07 89.57 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.559 -0.713 . . . . 0.0 109.385 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 79.8 t -68.37 -40.13 81.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 179.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 71.5 ttt180 -60.07 -40.32 89.09 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.377 -0.827 . . . . 0.0 109.384 178.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -60.01 -39.5 86.03 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.649 -0.657 . . . . 0.0 110.172 -178.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . 0.521 HD11 ' CG ' ' A' ' 76' ' ' HIS . 96.7 mt -59.7 -45.42 94.45 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 O-C-N 121.038 -1.039 . . . . 0.0 109.892 -179.026 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -71.54 -34.54 63.25 Favored Glycine 0 N--CA 1.494 2.506 0 C-N-CA 119.955 -1.116 . . . . 0.0 110.333 -179.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 39.9 tttt -59.51 -47.77 84.24 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.371 -1.076 . . . . 0.0 109.612 -179.224 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.524 HH22 ' CD1' ' A' ' 57' ' ' ILE . 65.8 mtp180 -69.92 -31.06 68.65 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.991 -1.068 . . . . 0.0 109.952 -179.78 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 64.4 tp -58.04 -42.1 84.66 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.239 -0.913 . . . . 0.0 108.748 -179.454 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 51.6 mt -60.99 -40.06 92.03 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.15 -0.969 . . . . 0.0 109.245 178.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 27.2 mtt180 -67.44 -39.87 85.43 Favored 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 118.862 -1.135 . . . . 0.0 108.669 179.259 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 56.9 m-80 -62.2 -37.98 87.37 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.536 -0.728 . . . . 0.0 111.297 -179.45 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 83.5 mt -71.07 -43.5 75.87 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 120.391 -1.443 . . . . 0.0 108.037 179.515 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 95.5 mt -71.12 -32.82 69.47 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.416 -0.802 . . . . 0.0 109.103 179.663 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 84.07 42.34 7.63 Favored Glycine 0 N--CA 1.494 2.566 0 N-CA-C 109.035 -1.626 . . . . 0.0 109.035 -179.221 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 8.4 tp -74.54 148.62 40.74 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.551 -0.97 . . . . 0.0 110.652 -178.719 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 56.1 tptt -61.1 138.71 58.2 Favored 'General case' 0 N--CA 1.49 1.57 0 CA-C-O 121.31 0.576 . . . . 0.0 110.613 -179.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 84.3 mt -117.12 127.5 74.69 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 CA-C-O 122.354 1.073 . . . . 0.0 108.177 178.04 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 10.2 mt -66.28 -39.84 85.28 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.869 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.585 -178.362 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 36.7 t0 61.56 113.62 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.291 -0.881 . . . . 0.0 109.232 -179.384 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 79.2 mt -77.44 -0.79 27.27 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.249 -0.907 . . . . 0.0 110.309 -179.018 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -85.41 -14.94 44.68 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.618 -1.301 . . . . 0.0 109.989 -179.761 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -82.16 28.4 0.45 Allowed 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.035 -1.041 . . . . 0.0 111.313 -178.174 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 46.6 mm -89.17 119.75 36.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 120.284 -1.51 . . . . 0.0 110.053 -179.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 87.0 mt-30 -100.9 -13.11 18.47 Favored 'General case' 0 N--CA 1.502 2.134 0 O-C-N 121.317 -0.864 . . . . 0.0 110.505 179.449 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 94.8 m-20 -127.47 151.45 48.83 Favored 'General case' 0 N--CA 1.506 2.332 0 O-C-N 121.046 -1.034 . . . . 0.0 110.724 -178.61 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -64.02 134.01 54.19 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 179.537 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 28.6 m -151.84 165.2 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.44 -0.788 . . . . 0.0 110.088 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 74.4 mt -93.97 146.89 6.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 N-CA-C 105.424 -2.065 . . . . 0.0 105.424 176.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 62.6 tp -99.29 117.8 34.54 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.066 -1.021 . . . . 0.0 110.393 -178.029 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.482 HG12 HG22 ' A' ' 209' ' ' THR . 59.0 t -121.07 129.83 75.29 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 179.7 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -157.27 160.94 39.12 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.015 -1.053 . . . . 0.0 109.232 -179.481 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -68.48 -37.26 79.96 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 120.246 -1.533 . . . . 0.0 107.945 178.262 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -170.31 146.63 2.93 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 178.539 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 25.9 mt -112.81 138.21 49.99 Favored 'General case' 0 N--CA 1.503 2.201 0 O-C-N 121.386 -0.821 . . . . 0.0 110.008 -179.199 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 45.3 p -93.99 146.31 31.42 Favored Pre-proline 0 N--CA 1.495 1.805 0 O-C-N 121.265 -0.897 . . . . 0.0 108.75 179.21 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 99.6 Cg_exo -39.75 -36.55 1.25 Allowed 'Trans proline' 0 N--CA 1.495 1.583 0 C-N-CA 122.151 1.901 . . . . 0.0 112.53 179.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . 0.404 ' HB3' HH12 ' A' ' 136' ' ' ARG . 75.4 m -59.73 -40.33 87.69 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.213 -0.929 . . . . 0.0 110.325 -179.089 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 84.9 mt-10 -69.02 -40.67 78.53 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 120.999 -1.063 . . . . 0.0 110.003 -178.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 40.0 p -55.45 -30.99 61.55 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.309 -0.869 . . . . 0.0 111.626 -178.121 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -73.65 -52.81 12.08 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 120.8 -1.188 . . . . 0.0 110.298 -179.503 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 14.4 pt20 -84.54 36.98 0.61 Allowed 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.414 -0.804 . . . . 0.0 108.945 -179.323 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 22.3 tp -105.7 138.86 41.19 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.706 -0.622 . . . . 0.0 109.472 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 24.6 m120 -84.89 102.26 12.97 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.169 -0.957 . . . . 0.0 109.591 179.6 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 58.7 mt -65.03 -40.69 95.19 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.17 -0.956 . . . . 0.0 110.628 -179.482 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 65.1 mttt -69.43 -29.75 67.53 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.814 -1.179 . . . . 0.0 112.03 -177.634 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 77.9 mttt -93.17 -7.55 44.98 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 120.695 -1.253 . . . . 0.0 110.281 -177.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . 0.51 HG12 ' H ' ' A' ' 178' ' ' GLY . 78.7 t -102.05 113.73 39.34 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 177.477 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 90.5 mt -84.74 6.8 22.86 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.109 -0.994 . . . . 0.0 110.834 -177.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . 0.51 ' H ' HG12 ' A' ' 176' ' ' VAL . . . 168.89 174.71 37.73 Favored Glycine 0 N--CA 1.484 1.89 0 N-CA-C 109.349 -1.5 . . . . 0.0 109.349 179.141 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' PHE . . . . . 0.47 ' O ' ' HB1' ' A' ' 201' ' ' ALA . 9.9 m-85 -134.41 129.39 35.26 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.516 -0.991 . . . . 0.0 108.42 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 92.5 mt -132.0 126.28 56.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.429 -0.794 . . . . 0.0 109.101 179.098 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 72.8 p -149.97 162.13 40.96 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.847 -1.158 . . . . 0.0 110.941 -179.484 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . 0.588 ' N ' ' OD1' ' A' ' 182' ' ' ASP . 0.0 OUTLIER -104.43 24.86 10.95 Favored 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 -179.809 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' ALA . . . . . 0.428 ' O ' ' O ' ' A' ' 182' ' ' ASP . . . -55.28 -163.7 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.656 -1.277 . . . . 0.0 111.243 -178.87 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -74.61 -53.28 6.66 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 110.601 -1.0 . . . . 0.0 110.601 -179.382 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 169.76 -81.01 0.09 OUTLIER Glycine 0 N--CA 1.492 2.373 0 N-CA-C 107.218 -2.353 . . . . 0.0 107.218 -179.644 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 186' ' ' ARG . . . . . 0.55 ' O ' ' O ' ' A' ' 187' ' ' THR . 70.8 ttp85 -69.52 -40.62 76.82 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.499 -1.0 . . . . 0.0 109.617 179.08 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . 0.585 ' O ' ' O ' ' A' ' 188' ' ' SER . 19.9 p 51.81 168.97 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.063 -1.023 . . . . 0.0 109.186 -179.341 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . 0.585 ' O ' ' O ' ' A' ' 187' ' ' THR . 45.8 m -52.82 -125.65 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.47 -0.769 . . . . 0.0 110.261 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 189' ' ' HIS . . . . . 0.447 ' HA ' HD12 ' A' ' 192' ' ' ILE . 5.7 m80 -86.27 -1.61 57.64 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.383 -0.823 . . . . 0.0 110.878 -179.616 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 190' ' ' THR . . . . . 0.692 ' O ' ' N ' ' A' ' 193' ' ' MET . 3.8 m -65.65 -85.47 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.271 -0.893 . . . . 0.0 110.89 -179.08 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . 0.562 ' C ' ' O ' ' A' ' 190' ' ' THR . 10.1 t -36.62 -38.04 0.15 Allowed 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 106.01 -1.848 . . . . 0.0 106.01 178.462 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . 0.461 ' N ' ' O ' ' A' ' 190' ' ' THR . 86.8 mt -62.69 -38.14 80.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.101 -0.999 . . . . 0.0 109.162 179.853 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 193' ' ' MET . . . . . 0.692 ' N ' ' O ' ' A' ' 190' ' ' THR . 5.1 tpp -60.27 -40.71 91.32 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.262 -0.899 . . . . 0.0 110.731 -179.324 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -58.47 -42.38 87.32 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.705 -1.247 . . . . 0.0 108.463 179.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 195' ' ' ARG . . . . . 0.473 ' NE ' ' O ' ' A' ' 7' ' ' ALA . 26.5 mmt85 -60.63 -58.26 9.24 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.423 -0.798 . . . . 0.0 109.448 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 196' ' ' SER . . . . . 0.443 ' CB ' ' HB2' ' B' ' 372' ' ' GLU . 77.6 p -63.14 -39.81 95.74 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.368 -0.833 . . . . 0.0 111.41 -178.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 93.5 mt -70.95 -23.31 62.21 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.825 -1.172 . . . . 0.0 109.468 -179.221 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 64.64 49.4 2.33 Favored 'General case' 0 N--CA 1.494 1.742 0 CA-C-O 121.383 0.611 . . . . 0.0 110.127 -179.011 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . 0.421 ' O ' ' CB ' ' A' ' 8' ' ' SER . 85.3 mt -125.92 143.92 46.92 Favored Pre-proline 0 N--CA 1.5 2.051 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 178.518 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -59.23 137.5 79.21 Favored 'Trans proline' 0 N--CA 1.5 1.867 0 C-N-CA 121.866 1.711 . . . . 0.0 112.135 -179.462 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 201' ' ' ALA . . . . . 0.47 ' HB1' ' O ' ' A' ' 179' ' ' PHE . . . -171.36 150.71 2.93 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.009 -1.057 . . . . 0.0 111.431 -179.535 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 73.4 mt -122.42 148.63 26.0 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.063 0 N-CA-C 107.802 -1.184 . . . . 0.0 107.802 178.136 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 16.8 m -129.22 -9.98 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.196 0 O-C-N 121.021 -1.05 . . . . 0.0 110.244 -179.725 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . 0.404 ' O ' ' C ' ' A' ' 205' ' ' THR . . . -111.98 23.55 16.5 Favored Glycine 0 N--CA 1.501 2.981 0 N-CA-C 110.896 -0.881 . . . . 0.0 110.896 -178.848 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . 0.404 ' C ' ' O ' ' A' ' 204' ' ' GLY . 3.7 p -44.53 -43.83 8.25 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.021 -1.282 . . . . 0.0 109.951 -179.391 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 206' ' ' GLY . . . . . 0.463 ' H ' ' HB3' ' A' ' 182' ' ' ASP . . . 94.61 -50.88 2.05 Favored Glycine 0 N--CA 1.496 2.691 0 C-N-CA 120.392 -0.909 . . . . 0.0 111.057 179.197 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 28.1 t -160.76 40.61 0.16 Allowed 'General case' 0 N--CA 1.497 1.887 0 O-C-N 120.65 -1.5 . . . . 0.0 111.212 -178.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 25.1 t -77.15 -41.07 30.61 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 O-C-N 120.877 -1.139 . . . . 0.0 109.568 179.201 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 209' ' ' THR . . . . . 0.482 HG22 HG12 ' A' ' 159' ' ' VAL . 2.6 p -56.92 -30.6 64.12 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.152 -0.967 . . . . 0.0 110.659 -178.539 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 14.5 t -77.42 -13.2 59.98 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.859 -1.151 . . . . 0.0 109.301 -179.425 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 2.3 mm-40 -102.47 -12.79 17.57 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.648 -0.657 . . . . 0.0 109.692 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 86.2 t -109.64 141.68 24.27 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.263 0 O-C-N 121.384 -0.822 . . . . 0.0 111.311 -178.292 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -110.94 156.31 21.39 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 105.746 -1.946 . . . . 0.0 105.746 176.608 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 214' ' ' ASN . . . . . 0.421 ' O ' ' HB2' ' A' ' 215' ' ' ASP . 51.3 p-10 -60.99 152.4 27.95 Favored 'General case' 0 C--N 1.295 -1.788 0 O-C-N 120.154 -1.592 . . . . 0.0 108.853 179.616 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 215' ' ' ASP . . . . . 0.421 ' HB2' ' O ' ' A' ' 214' ' ' ASN . 0.5 OUTLIER 75.16 9.94 3.77 Favored 'General case' 0 N--CA 1.505 2.297 0 CA-C-O 120.782 0.325 . . . . 0.0 110.766 179.266 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -79.95 143.39 34.23 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.878 -1.139 . . . . 0.0 107.962 178.502 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 46.1 t80 -91.72 122.06 33.93 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 178.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . 0.481 HD12 ' HB2' ' A' ' 16' ' ' ALA . 77.4 mt -129.91 147.83 51.72 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.309 -0.87 . . . . 0.0 110.476 -178.496 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 76.8 mt -116.84 126.1 74.11 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 N-CA-C 106.255 -1.758 . . . . 0.0 106.255 177.072 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 25.4 tp -98.66 118.07 34.56 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.07 -1.019 . . . . 0.0 109.405 -178.331 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 221' ' ' ASP . . . . . 0.476 ' O ' ' O ' ' A' ' 10' ' ' GLY . 29.7 m-20 -75.79 -45.12 37.85 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.294 -0.879 . . . . 0.0 108.764 179.187 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . 0.753 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 49.82 14.39 0.12 Allowed 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.658 -0.868 . . . . 0.0 108.658 -179.533 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . 0.476 ' N ' ' C ' ' A' ' 221' ' ' ASP . 73.8 t -129.57 -46.9 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 N-CA-C 107.2 -1.407 . . . . 0.0 107.2 178.681 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 79.7 m-20 -97.39 0.9 48.61 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 106.499 -1.667 . . . . 0.0 106.499 176.721 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 11.4 t-20 60.01 46.57 10.74 Favored 'General case' 0 N--CA 1.487 1.389 0 CA-C-N 115.802 -0.635 . . . . 0.0 109.609 179.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -135.01 155.55 50.58 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 121.421 -0.799 . . . . 0.0 109.747 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 93.7 t -124.21 130.03 73.85 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 178.678 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 81.3 m-85 -102.75 122.76 45.12 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.464 -0.772 . . . . 0.0 109.542 179.658 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 56.5 t -100.99 113.88 38.41 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.001 0 O-C-N 121.657 -0.652 . . . . 0.0 110.587 -178.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 62.9 t-20 54.16 67.12 3.68 Favored Pre-proline 0 N--CA 1.495 1.825 0 O-C-N 121.134 -0.979 . . . . 0.0 110.777 179.317 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -89.22 144.37 4.92 Favored 'Trans proline' 0 C--N 1.307 -1.637 0 C-N-CA 122.876 2.384 . . . . 0.0 112.388 179.501 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -67.96 165.55 17.57 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.323 -0.861 . . . . 0.0 109.427 -179.575 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -60.06 -39.7 86.89 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.397 -0.814 . . . . 0.0 109.831 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -59.9 -36.86 77.85 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.283 -0.886 . . . . 0.0 109.616 -179.253 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 54.9 t -67.45 -40.42 84.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.076 -1.015 . . . . 0.0 109.317 179.222 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 86.2 mt -66.75 -45.71 87.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.173 -0.954 . . . . 0.0 109.052 179.616 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -55.04 -45.11 75.22 Favored 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 179.584 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 20.0 tttt -62.62 -40.35 96.71 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.432 -0.793 . . . . 0.0 108.985 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 79.0 mtp -69.83 -31.64 69.62 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.35 -0.844 . . . . 0.0 109.965 179.455 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 5.3 mmt180 -68.41 -40.0 81.42 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.159 -0.963 . . . . 0.0 109.993 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -60.04 -40.47 89.47 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.192 -0.943 . . . . 0.0 108.688 179.623 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 53.8 t -65.64 -40.06 86.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.386 -0.821 . . . . 0.0 109.35 179.716 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 63.1 tt0 -60.35 -39.89 88.75 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.145 -0.972 . . . . 0.0 108.71 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 64.0 mt-10 -60.64 -39.9 90.01 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.283 -0.885 . . . . 0.0 108.966 179.463 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 31.1 mt-30 -61.09 -43.15 99.32 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.131 -0.981 . . . . 0.0 108.537 178.744 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 93.9 t -61.05 -43.48 96.28 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 O-C-N 121.45 -0.781 . . . . 0.0 109.641 -179.656 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -60.23 -43.66 95.86 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.308 -0.87 . . . . 0.0 109.016 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 10.7 t -63.44 -40.02 96.03 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 179.422 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 . . . . . 0 N--CA 1.489 1.485 0 O-C-N 121.508 -0.745 . . . . 0.0 109.577 -179.547 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 319' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.217 -0.605 0 CA-C-O 122.558 1.171 . . . . 0.0 112.806 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 320' ' ' ILE . . . . . 0.823 ' HB ' ' CG1' ' B' ' 466' ' ' ILE . 2.3 mp -105.87 130.87 56.68 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.909 0 CA-C-O 122.69 1.233 . . . . 0.0 110.615 177.619 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 321' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -100.65 124.91 46.91 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-N 114.099 -1.409 . . . . 0.0 110.331 176.432 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 322' ' ' ILE . . . . . . . . . . . . . 10.2 mm -94.74 123.34 46.82 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 N-CA-C 105.987 -1.856 . . . . 0.0 105.987 176.449 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 323' ' ' ILE . . . . . . . . . . . . . 21.7 mm -92.04 146.68 6.01 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.574 0 CA-C-O 122.447 1.118 . . . . 0.0 111.822 -178.371 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 324' ' ' ALA . . . . . . . . . . . . . . . -58.53 121.07 50.3 Favored Pre-proline 0 N--CA 1.43 -1.437 0 N-CA-C 115.362 1.616 . . . . 0.0 115.362 -178.176 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 325' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_endo -76.07 -20.07 15.14 Favored 'Trans proline' 0 CA--C 1.559 1.753 0 C-N-CA 121.606 1.537 . . . . 0.0 111.484 -177.577 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 326' ' ' LEU . . . . . 0.461 ' N ' HD12 ' B' ' 326' ' ' LEU 0.322 0.0 OUTLIER -147.45 161.31 41.32 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.849 0.86 . . . . 0.0 110.207 175.246 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild full ' B' B ' 327' ' ' SER . . . . . . . . . . . . . 50.0 m -82.65 148.15 28.12 Favored 'General case' 0 CA--C 1.498 -1.034 0 CA-C-O 121.612 0.72 . . . . 0.0 111.047 177.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 328' ' ' GLY . . . . . . . . . . . . . . . 156.65 -155.44 26.35 Favored Glycine 0 N--CA 1.432 -1.607 0 C-N-CA 119.252 -1.451 . . . . 0.0 111.059 178.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 329' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -117.01 134.89 54.17 Favored 'General case' 0 C--N 1.293 -1.858 0 CA-C-N 114.058 -1.071 . . . . 0.0 110.165 -177.049 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 330' ' ' ILE . . . . . . . . . . . . . 71.4 mt -74.37 141.51 15.98 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.614 0 C-N-CA 117.645 -1.622 . . . . 0.0 110.366 -179.184 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 331' ' ' VAL . . . . . . . . . . . . . 14.6 t -132.59 155.88 41.79 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.17 0 CA-C-N 114.511 -1.222 . . . . 0.0 108.728 -178.463 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 332' ' ' ASN . . . . . 0.504 ' HB3' ' OE2' ' B' ' 334' ' ' GLU . 13.5 m120 -71.5 138.45 48.95 Favored 'General case' 0 CA--C 1.497 -1.084 0 CA-C-O 121.405 0.621 . . . . 0.0 111.055 178.804 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 333' ' ' ILE . . . . . 0.476 ' CD1' ' CG1' ' B' ' 439' ' ' VAL . 8.2 tt -67.84 -23.68 29.64 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.884 0 C-N-CA 118.642 -1.223 . . . . 0.0 108.768 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 334' ' ' GLU . . . . . 0.504 ' OE2' ' HB3' ' B' ' 332' ' ' ASN . 0.8 OUTLIER -73.9 -14.13 61.01 Favored 'General case' 0 C--N 1.292 -1.915 0 C-N-CA 118.742 -1.183 . . . . 0.0 110.555 180.0 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 335' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -94.99 12.52 28.12 Favored 'General case' 0 C--N 1.307 -1.275 0 N-CA-C 113.776 1.028 . . . . 0.0 113.776 -179.796 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 336' ' ' VAL . . . . . . . . . . . . . 3.0 t -86.52 130.95 47.31 Favored Pre-proline 0 C--N 1.288 -2.09 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 179.204 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 337' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_exo -70.5 48.16 0.74 Allowed 'Trans proline' 0 C--N 1.313 -1.317 0 C-N-CA 122.688 2.259 . . . . 0.0 111.702 -173.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 338' ' ' ASP . . . . . . . . . . . . . 65.3 t0 -150.74 115.81 5.32 Favored 'General case' 0 C--N 1.29 -1.987 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 179.796 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 339' ' ' VAL . . . . . . . . . . . . . 19.8 m -60.32 -37.96 75.89 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.256 0 C-N-CA 119.04 -1.064 . . . . 0.0 111.669 -178.482 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 340' ' ' VAL . . . . . 0.82 ' HA ' HD12 ' B' ' 345' ' ' ILE 0.406 17.6 m -62.36 -34.81 66.28 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 C-N-CA 116.983 -1.887 . . . . 0.0 112.136 -179.851 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 341' ' ' PHE . . . . . . . . . . . . . 69.5 m-85 -84.26 -44.38 13.92 Favored 'General case' 0 C--N 1.261 -3.248 0 O-C-N 120.185 -1.572 . . . . 0.0 109.777 179.625 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 342' ' ' ALA . . . . . . . . . . . . . . . -60.35 -37.9 82.14 Favored 'General case' 0 CA--C 1.487 -1.454 0 N-CA-C 108.793 -0.818 . . . . 0.0 108.793 -177.513 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 343' ' ' GLU . . . . . 0.435 ' O ' ' HG2' ' B' ' 344' ' ' LYS . 60.2 mt-10 -86.12 5.44 33.79 Favored 'General case' 0 C--O 1.209 -1.027 0 CA-C-O 123.061 1.41 . . . . 0.0 111.005 178.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 344' ' ' LYS . . . . . 0.562 ' HB2' ' O ' ' B' ' 347' ' ' GLY . 0.0 OUTLIER 51.1 40.06 24.85 Favored 'General case' 0 CA--C 1.502 -0.874 0 O-C-N 120.414 -1.429 . . . . 0.0 113.94 179.215 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 345' ' ' ILE . . . . . 0.921 HG22 ' HB1' ' A' ' 71' ' ' ALA . 25.8 mt -67.25 -30.4 49.1 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.956 0 CA-C-O 123.58 1.657 . . . . 0.0 110.63 178.556 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 346' ' ' VAL . . . . . 0.439 HG12 ' H ' ' B' ' 346' ' ' VAL 0.29 11.1 p -89.49 -7.77 10.82 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.953 0 CA-C-N 112.422 -2.172 . . . . 0.0 111.842 -175.495 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 347' ' ' GLY . . . . . 0.562 ' O ' ' HB2' ' B' ' 344' ' ' LYS . . . 133.44 -175.56 20.13 Favored Glycine 0 C--O 1.207 -1.576 0 N-CA-C 108.775 -1.73 . . . . 0.0 108.775 176.541 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 348' ' ' ASP . . . . . 0.602 ' OD2' ' SD ' ' B' ' 443' ' ' MET . 70.4 m-20 -119.48 155.38 32.19 Favored 'General case' 0 C--N 1.31 -1.15 0 C-N-CA 118.021 -1.471 . . . . 0.0 112.847 179.667 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 349' ' ' GLY . . . . . . . . . . . . . . . 172.17 -137.63 4.37 Favored Glycine 0 CA--C 1.536 1.405 0 C-N-CA 117.787 -2.149 . . . . 0.0 111.33 177.329 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 350' ' ' ILE . . . . . 0.454 ' C ' HD12 ' B' ' 350' ' ' ILE . 2.8 pp -135.2 175.13 11.64 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.665 0 O-C-N 121.561 -0.964 . . . . 0.0 108.629 178.624 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 351' ' ' ALA . . . . . . . . . . . . . . . -121.52 158.49 28.36 Favored 'General case' 0 C--N 1.306 -1.305 0 C-N-CA 124.701 1.2 . . . . 0.0 108.421 175.549 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 352' ' ' ILE . . . . . . . . . . . . . 58.5 mt -133.39 128.92 55.81 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.843 0 O-C-N 121.595 -0.69 . . . . 0.0 110.965 178.032 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 353' ' ' LYS . . . . . . . . . . . . . 5.1 tmtt? -86.23 108.85 19.09 Favored Pre-proline 0 C--N 1.307 -1.275 0 N-CA-C 101.447 -3.538 . . . . 0.0 101.447 174.767 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 354' ' ' PRO . . . . . 0.454 ' HB3' HD22 ' B' ' 326' ' ' LEU . 2.0 Cg_endo -71.38 150.13 57.84 Favored 'Trans proline' 0 C--N 1.309 -1.534 0 C-N-CA 123.601 2.868 . . . . 0.0 113.08 -170.894 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 355' ' ' THR . . . . . . . . . . . . . 73.5 p -138.57 1.65 2.16 Favored 'General case' 0 C--N 1.315 -0.914 0 O-C-N 121.856 -0.527 . . . . 0.0 110.19 177.654 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 356' ' ' GLY . . . . . . . . . . . . . . . -108.76 -144.62 10.94 Favored Glycine 0 CA--C 1.533 1.196 0 O-C-N 121.444 -0.785 . . . . 0.0 114.592 -177.705 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 357' ' ' ASN . . . . . . . . . . . . . 22.1 p30 -142.85 14.32 1.91 Allowed 'General case' 0 CA--C 1.493 -1.237 0 O-C-N 122.317 -0.519 . . . . 0.0 112.11 -179.308 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 358' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -157.23 155.12 30.3 Favored 'General case' 0 N--CA 1.415 -2.219 0 C-N-CA 115.488 -2.485 . . . . 0.0 113.382 178.567 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 359' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -114.86 121.47 43.35 Favored 'General case' 0 N--CA 1.438 -1.051 0 CA-C-N 114.931 -1.031 . . . . 0.0 109.097 178.864 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 360' ' ' VAL . . . . . . . . . . . . . 3.1 m -114.36 174.55 2.75 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.797 0 CA-C-O 122.739 1.257 . . . . 0.0 110.921 -178.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 361' ' ' ALA . . . . . . . . . . . . . . . -68.03 126.76 93.03 Favored Pre-proline 0 C--N 1.289 -2.025 0 CA-C-N 113.797 -1.547 . . . . 0.0 109.762 179.199 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 362' ' ' PRO . . . . . 0.404 ' HG2' HD13 ' B' ' 387' ' ' LEU . 18.0 Cg_endo -86.05 -1.4 8.66 Favored 'Trans proline' 0 C--N 1.323 -0.81 0 CA-C-N 120.083 1.065 . . . . 0.0 110.344 -179.543 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 363' ' ' VAL . . . . . 0.434 ' HA ' HG22 ' B' ' 415' ' ' VAL . 17.1 m -158.52 165.03 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 CA-C-O 121.477 0.656 . . . . 0.0 111.202 -178.167 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 364' ' ' ASP . . . . . 0.823 ' OD1' HG23 ' B' ' 415' ' ' VAL . 48.1 m-20 -81.58 127.27 32.68 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 103.484 -2.784 . . . . 0.0 103.484 174.683 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 365' ' ' GLY . . . . . 0.484 ' HA3' ' O ' ' B' ' 380' ' ' GLU . . . 173.99 -157.96 26.42 Favored Glycine 0 C--N 1.302 -1.346 0 N-CA-C 110.738 -0.945 . . . . 0.0 110.738 -175.487 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 366' ' ' THR . . . . . 0.599 HG22 ' HG3' ' B' ' 412' ' ' ARG . 33.3 p -123.72 134.84 53.63 Favored 'General case' 0 C--N 1.314 -0.976 0 C-N-CA 119.805 -0.758 . . . . 0.0 111.448 -177.384 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 367' ' ' ILE . . . . . 0.799 HG21 ' O ' ' B' ' 408' ' ' GLU . 1.6 tp -68.69 140.45 18.93 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.01 0 C-N-CA 117.629 -1.628 . . . . 0.0 107.357 178.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 368' ' ' GLY . . . . . . . . . . . . . . . -101.89 -64.09 0.75 Allowed Glycine 0 C--N 1.282 -2.447 0 CA-C-O 122.064 0.813 . . . . 0.0 114.278 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 369' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -141.5 136.38 31.15 Favored 'General case' 0 C--N 1.281 -2.407 0 CA-C-O 123.1 1.428 . . . . 0.0 111.833 -177.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 370' ' ' ILE . . . . . 0.64 HD12 ' OE1' ' B' ' 409' ' ' GLU . 97.5 mt -116.06 125.54 73.19 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.056 0 N-CA-C 105.583 -2.006 . . . . 0.0 105.583 179.629 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 371' ' ' PHE . . . . . 0.416 ' CE2' ' O3 ' ' B' ' 500' ' ' PO3 . 5.6 m-85 -62.69 145.36 54.89 Favored 'General case' 0 C--N 1.303 -1.413 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 -179.31 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 372' ' ' GLU . . . . . 0.443 ' HB2' ' CB ' ' A' ' 196' ' ' SER . 47.1 tp10 -61.71 -15.15 38.0 Favored 'General case' 0 C--N 1.296 -1.722 0 C-N-CA 123.717 0.807 . . . . 0.0 110.405 -178.338 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 373' ' ' THR . . . . . 0.667 ' OG1' ' CD2' ' B' ' 375' ' ' HIS . 41.6 p -97.63 5.2 49.73 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-O 123.591 1.663 . . . . 0.0 109.142 178.363 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 374' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 50.39 44.32 26.74 Favored 'General case' 0 C--N 1.263 -3.185 0 CA-C-N 113.207 -1.815 . . . . 0.0 112.66 175.416 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 375' ' ' HIS . . . . . 0.667 ' CD2' ' OG1' ' B' ' 373' ' ' THR . 0.3 OUTLIER -126.35 -1.54 6.93 Favored 'General case' 0 N--CA 1.429 -1.502 0 N-CA-C 113.557 0.947 . . . . 0.0 113.557 -177.499 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 376' ' ' ALA . . . . . . . . . . . . . . . -153.16 152.65 31.5 Favored 'General case' 0 N--CA 1.411 -2.406 0 O-C-N 120.616 -1.302 . . . . 0.0 111.108 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 377' ' ' PHE . . . . . . . . . . . . . 54.1 p90 -152.47 166.48 31.83 Favored 'General case' 0 C--N 1.308 -1.239 0 CA-C-O 123.021 1.391 . . . . 0.0 113.325 178.822 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 378' ' ' SER . . . . . 0.766 ' O ' HD12 ' B' ' 367' ' ' ILE 0.256 4.9 p -118.36 139.67 51.01 Favored 'General case' 0 N--CA 1.438 -1.065 0 CA-C-N 113.268 -1.787 . . . . 0.0 109.832 -178.776 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 379' ' ' ILE . . . . . . . . . . . . . 19.9 tt -143.32 150.08 17.83 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 175.735 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 380' ' ' GLU . . . . . 0.484 ' O ' ' HA3' ' B' ' 365' ' ' GLY . 0.7 OUTLIER -118.5 129.69 55.51 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 105.65 -1.982 . . . . 0.0 105.65 178.127 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 381' ' ' SER . . . . . . . . . . . . . 13.7 p -80.84 167.21 20.17 Favored 'General case' 0 C--N 1.297 -1.699 0 C-N-CA 118.433 -1.307 . . . . 0.0 108.183 -176.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 382' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -68.04 -31.03 70.41 Favored 'General case' 0 C--N 1.278 -2.505 0 C-N-CA 118.466 -1.294 . . . . 0.0 108.296 177.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 383' ' ' SER . . . . . . . . . . . . . 4.6 m -70.22 4.42 2.22 Favored 'General case' 0 C--N 1.315 -0.903 0 C-N-CA 125.326 1.45 . . . . 0.0 112.023 -179.69 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 384' ' ' GLY . . . . . . . . . . . . . . . 78.9 14.45 81.99 Favored Glycine 0 C--N 1.279 -2.613 0 N-CA-C 117.198 1.639 . . . . 0.0 117.198 -178.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 385' ' ' VAL . . . . . 0.817 HG21 ' CD1' ' B' ' 466' ' ' ILE . 64.8 t -92.34 132.97 35.22 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.374 0 CA-C-N 121.237 2.518 . . . . 0.0 110.9 177.797 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 386' ' ' GLU . . . . . 0.832 ' H ' ' ND2' ' B' ' 442' ' ' ASN . 97.1 mt-10 -96.82 121.97 39.26 Favored 'General case' 0 N--CA 1.476 0.846 0 O-C-N 121.617 -0.677 . . . . 0.0 110.264 176.812 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 387' ' ' LEU . . . . . 0.404 HD13 ' HG2' ' B' ' 362' ' ' PRO . 0.9 OUTLIER -116.42 158.85 22.87 Favored 'General case' 0 C--O 1.216 -0.675 0 CA-C-O 122.002 0.906 . . . . 0.0 110.778 -178.848 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 388' ' ' PHE . . . . . 0.542 ' CE2' ' HB2' ' B' ' 390' ' ' HIS . 80.5 t80 -144.48 108.97 4.86 Favored 'General case' 0 C--N 1.297 -1.703 0 CA-C-O 121.703 0.763 . . . . 0.0 110.692 177.476 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 389' ' ' VAL . . . . . . . . . . . . . 95.2 t -100.3 116.54 43.9 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.015 0 C-N-CA 124.404 1.081 . . . . 0.0 111.477 179.434 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 390' ' ' HIS . . . . . 0.542 ' HB2' ' CE2' ' B' ' 388' ' ' PHE . 3.2 t-80 -122.14 106.45 11.17 Favored 'General case' 0 C--O 1.202 -1.444 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.126 -179.277 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 391' ' ' PHE . . . . . . . . . . . . . 30.6 t80 -63.7 124.16 20.72 Favored 'General case' 0 CA--C 1.559 1.294 0 N-CA-C 116.573 2.064 . . . . 0.0 116.573 178.675 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 392' ' ' GLY . . . . . . . . . . . . . . . 69.38 -175.86 32.24 Favored Glycine 0 C--O 1.215 -1.082 0 CA-C-O 122.815 1.231 . . . . 0.0 114.467 175.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 393' ' ' ILE . . . . . 0.503 HD13 ' HB3' ' B' ' 433' ' ' SER . 0.2 OUTLIER -118.15 132.64 67.39 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.155 0 CA-C-O 123.109 1.433 . . . . 0.0 109.224 179.4 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 394' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 54.63 25.93 6.88 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-N 114.064 -1.425 . . . . 0.0 111.29 -177.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 395' ' ' THR . . . . . . . . . . . . . 48.8 p -64.44 -20.0 65.89 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 115.38 1.622 . . . . 0.0 115.38 -179.617 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 396' ' ' VAL . . . . . 0.525 HG23 HG21 ' B' ' 373' ' ' THR . 15.0 p -57.04 -32.85 41.1 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.86 0 O-C-N 120.016 -1.678 . . . . 0.0 109.324 177.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 397' ' ' GLU . . . . . 0.757 ' OE1' ' CG ' ' A' ' 122' ' ' TYR . 98.5 mt-10 -58.47 -20.09 42.41 Favored 'General case' 0 CA--C 1.566 1.567 0 C-N-CA 119.806 -0.758 . . . . 0.0 112.216 -179.329 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 398' ' ' LEU . . . . . 0.467 HD12 ' N ' ' B' ' 398' ' ' LEU . 10.8 mp -78.26 -3.22 41.75 Favored 'General case' 0 CA--C 1.564 1.511 0 O-C-N 119.536 -1.978 . . . . 0.0 113.861 178.046 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 399' ' ' LYS . . . . . 0.524 ' HZ1' ' HD3' ' A' ' 186' ' ' ARG . 63.7 mttp 49.04 46.05 22.65 Favored 'General case' 0 C--N 1.279 -2.466 0 N-CA-C 116.081 1.882 . . . . 0.0 116.081 -179.264 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 400' ' ' GLY . . . . . . . . . . . . . . . 90.84 -13.42 65.99 Favored Glycine 0 CA--C 1.541 1.671 0 N-CA-C 115.465 0.946 . . . . 0.0 115.465 176.229 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 401' ' ' GLU . . . . . . . . . . . . . 92.9 mt-10 -61.87 121.19 12.31 Favored 'General case' 0 C--N 1.284 -2.252 0 O-C-N 121.28 -1.129 . . . . 0.0 112.053 -179.576 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 402' ' ' GLY . . . . . 0.532 ' O ' ' NZ ' ' B' ' 404' ' ' LYS . . . 97.77 -7.11 62.92 Favored Glycine 0 C--O 1.202 -1.9 0 N-CA-C 114.903 0.721 . . . . 0.0 114.903 178.292 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 403' ' ' PHE . . . . . . . . . . . . . 73.9 m-85 -115.78 152.37 33.42 Favored 'General case' 0 C--N 1.283 -2.302 0 C-N-CA 124.023 0.929 . . . . 0.0 110.945 177.724 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 404' ' ' LYS . . . . . 0.532 ' NZ ' ' O ' ' B' ' 402' ' ' GLY . 0.0 OUTLIER -141.97 113.45 7.73 Favored 'General case' 0 C--N 1.317 -0.83 0 C-N-CA 124.726 1.21 . . . . 0.0 109.214 176.865 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 405' ' ' ARG . . . . . 0.712 ' NH1' ' OE2' ' B' ' 409' ' ' GLU . 4.9 ttm180 -67.28 123.45 20.37 Favored 'General case' 0 CA--C 1.463 -2.371 0 C-N-CA 120.401 -0.52 . . . . 0.0 109.956 178.845 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 406' ' ' ILE . . . . . 0.407 HG13 ' HG3' ' B' ' 421' ' ' GLU . 23.8 mm -106.15 -35.17 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.314 0 C-N-CA 115.008 -2.677 . . . . 0.0 108.169 -179.323 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 407' ' ' ALA . . . . . . . . . . . . . . . -95.06 178.27 5.61 Favored 'General case' 0 N--CA 1.435 -1.21 0 C-N-CA 118.763 -1.175 . . . . 0.0 112.165 -179.263 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 408' ' ' GLU . . . . . 0.799 ' O ' HG21 ' B' ' 367' ' ' ILE . 39.4 mt-10 -118.37 151.37 37.87 Favored 'General case' 0 C--O 1.212 -0.886 0 N-CA-C 112.547 0.573 . . . . 0.0 112.547 179.017 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 409' ' ' GLU . . . . . 0.712 ' OE2' ' NH1' ' B' ' 405' ' ' ARG . 0.0 OUTLIER -60.74 137.06 58.23 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 118.595 -1.242 . . . . 0.0 108.022 175.345 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 410' ' ' GLY . . . . . 0.655 ' N ' HG23 ' B' ' 367' ' ' ILE . . . 89.36 -5.02 84.33 Favored Glycine 0 N--CA 1.475 1.239 0 O-C-N 121.709 -0.619 . . . . 0.0 111.617 -179.548 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 411' ' ' GLN . . . . . 0.581 ' H ' ' CG2' ' B' ' 367' ' ' ILE . 30.0 tt0 -66.05 138.09 57.53 Favored 'General case' 0 C--N 1.287 -2.132 0 CA-C-O 123.032 1.396 . . . . 0.0 112.818 179.521 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 412' ' ' ARG . . . . . 0.599 ' HG3' HG22 ' B' ' 366' ' ' THR . 0.0 OUTLIER -86.19 132.76 33.94 Favored 'General case' 0 N--CA 1.42 -1.937 0 CA-C-N 114.066 -1.425 . . . . 0.0 107.247 175.71 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 413' ' ' VAL . . . . . . . . . . . . . 34.5 m -140.14 160.29 25.96 Favored 'Isoleucine or valine' 0 CA--C 1.472 -2.056 0 C-N-CA 117.367 -1.733 . . . . 0.0 112.97 -176.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 414' ' ' LYS . . . . . 0.481 ' HE3' ' OD2' ' B' ' 417' ' ' ASP . 0.5 OUTLIER -110.79 156.7 20.71 Favored 'General case' 0 C--N 1.286 -2.179 0 CA-C-N 111.739 -2.482 . . . . 0.0 108.371 174.784 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 415' ' ' VAL . . . . . 0.823 HG23 ' OD1' ' B' ' 364' ' ' ASP . 44.1 t -45.71 135.73 2.11 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.085 0 CA-C-O 121.653 0.74 . . . . 0.0 111.673 176.474 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 416' ' ' GLY . . . . . . . . . . . . . . . 89.14 -13.01 64.5 Favored Glycine 0 C--O 1.212 -1.235 0 O-C-N 121.552 -0.718 . . . . 0.0 114.552 178.066 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 417' ' ' ASP . . . . . 0.481 ' OD2' ' HE3' ' B' ' 414' ' ' LYS . 91.9 m-20 -63.04 136.32 57.75 Favored 'General case' 0 C--N 1.294 -1.817 0 O-C-N 120.813 -1.404 . . . . 0.0 109.861 179.144 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 418' ' ' THR . . . . . . . . . . . . . 23.3 m -76.7 132.39 39.31 Favored 'General case' 0 CA--C 1.497 -1.061 0 CA-C-O 123.008 1.385 . . . . 0.0 111.068 -177.744 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 419' ' ' VAL . . . . . 0.472 ' O ' HG13 ' B' ' 420' ' ' ILE . 44.8 t -105.88 -48.57 8.92 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.551 0 CA-C-N 113.427 -1.715 . . . . 0.0 109.164 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 420' ' ' ILE . . . . . 0.472 HG13 ' O ' ' B' ' 419' ' ' VAL . 11.0 mt -148.35 143.47 19.05 Favored 'Isoleucine or valine' 0 CA--C 1.48 -1.741 0 N-CA-C 114.037 1.125 . . . . 0.0 114.037 -177.198 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 421' ' ' GLU . . . . . 0.49 ' O ' ' HD2' ' B' ' 404' ' ' LYS . 48.7 mt-10 -112.16 147.4 36.22 Favored 'General case' 0 CA--C 1.482 -1.647 0 C-N-CA 116.701 -2.0 . . . . 0.0 107.399 175.847 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 422' ' ' PHE . . . . . 0.525 ' HA ' ' O ' ' B' ' 402' ' ' GLY . 36.0 p90 -132.81 163.69 28.51 Favored 'General case' 0 C--N 1.298 -1.667 0 CA-C-O 122.096 0.951 . . . . 0.0 111.53 -179.239 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 423' ' ' ASP . . . . . 0.436 ' OD1' ' HD2' ' B' ' 425' ' ' PRO . 10.3 t0 -100.7 98.04 8.63 Favored 'General case' 0 C--O 1.214 -0.775 0 CA-C-N 114.505 -1.225 . . . . 0.0 109.695 176.88 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 424' ' ' LEU . . . . . 0.614 ' HB3' ' HD3' ' B' ' 425' ' ' PRO . 3.1 tp -59.47 -54.71 53.3 Favored Pre-proline 0 C--N 1.292 -1.932 0 N-CA-C 115.97 1.841 . . . . 0.0 115.97 -176.035 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 425' ' ' PRO . . . . . 0.614 ' HD3' ' HB3' ' B' ' 424' ' ' LEU . 20.6 Cg_exo -56.73 -44.93 40.45 Favored 'Trans proline' 1 C--N 1.246 -4.853 0 C-N-CA 121.641 1.56 . . . . 0.0 109.665 -175.722 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 426' ' ' LEU . . . . . 0.7 ' O ' HD12 ' B' ' 426' ' ' LEU . 0.5 OUTLIER -57.03 -51.06 70.76 Favored 'General case' 0 C--N 1.314 -0.965 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 177.863 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 427' ' ' LEU . . . . . . . . . . . . . 49.5 mt -68.41 -31.46 70.81 Favored 'General case' 0 C--N 1.281 -2.371 0 O-C-N 121.088 -1.008 . . . . 0.0 111.955 -178.441 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 428' ' ' GLU . . . . . . . . . . . . . 20.6 mt-10 -65.04 -37.67 88.35 Favored 'General case' 0 C--N 1.278 -2.534 0 N-CA-C 106.768 -1.567 . . . . 0.0 106.768 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 429' ' ' GLU . . . . . . . . . . . . . 10.1 tt0 -75.28 -42.45 54.81 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-N 115.04 -0.982 . . . . 0.0 113.197 177.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 430' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -94.67 -29.3 14.9 Favored 'General case' 0 C--N 1.307 -1.262 0 N-CA-C 116.34 1.978 . . . . 0.0 116.34 -175.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 431' ' ' ALA . . . . . . . . . . . . . . . -78.61 142.93 36.87 Favored 'General case' 0 C--N 1.263 -3.162 0 N-CA-C 115.421 1.637 . . . . 0.0 115.421 -176.63 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 432' ' ' LYS . . . . . . . . . . . . . 66.8 mmtt -55.73 -37.75 68.87 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 179.136 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 433' ' ' SER . . . . . 0.503 ' HB3' HD13 ' B' ' 393' ' ' ILE . 3.8 t -163.82 143.93 8.38 Favored 'General case' 0 C--N 1.296 -1.733 0 C-N-CA 125.078 1.351 . . . . 0.0 110.601 178.352 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 434' ' ' THR . . . . . . . . . . . . . 75.9 p -96.05 -0.64 50.17 Favored 'General case' 0 C--O 1.222 -0.349 0 CA-C-N 114.773 -1.103 . . . . 0.0 110.535 179.409 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 435' ' ' LEU . . . . . 0.495 ' HA ' HD23 ' B' ' 435' ' ' LEU . 17.0 mt -56.16 130.56 44.74 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 177.086 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 436' ' ' THR . . . . . . . . . . . . . 92.9 m -119.01 97.01 50.62 Favored Pre-proline 0 N--CA 1.431 -1.381 0 N-CA-C 118.058 2.614 . . . . 0.0 118.058 -173.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 437' ' ' PRO . . . . . 0.451 ' HD2' ' O ' ' B' ' 390' ' ' HIS . 8.3 Cg_exo -67.11 142.98 63.39 Favored 'Trans proline' 0 N--CA 1.446 -1.27 0 C-N-CA 117.107 -1.462 . . . . 0.0 114.421 -179.208 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 438' ' ' VAL . . . . . . . . . . . . 0.314 1.6 m -125.82 104.62 13.44 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 N-CA-C 105.142 -2.169 . . . . 0.0 105.142 173.48 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 439' ' ' VAL . . . . . 0.476 ' CG1' ' CD1' ' B' ' 333' ' ' ILE . 34.5 m -123.44 158.74 28.62 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.583 0 N-CA-C 116.338 1.977 . . . . 0.0 116.338 -176.692 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 440' ' ' ILE . . . . . 0.832 HD13 HD11 ' B' ' 449' ' ' LEU . 3.3 mp -97.45 125.31 50.6 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.225 0 N-CA-C 104.618 -2.364 . . . . 0.0 104.618 178.815 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 441' ' ' SER . . . . . . . . . . . . . 69.6 m -98.23 -4.45 35.29 Favored 'General case' 0 C--N 1.295 -1.78 0 CA-C-O 123.209 1.481 . . . . 0.0 112.946 -175.64 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 442' ' ' ASN . . . . . 0.832 ' ND2' ' H ' ' B' ' 386' ' ' GLU 0.482 9.2 m-20 -97.76 15.19 24.42 Favored 'General case' 0 C--N 1.259 -3.368 0 C-N-CA 130.041 3.337 . . . . 0.0 114.592 -179.794 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 443' ' ' MET . . . . . 0.602 ' SD ' ' OD2' ' B' ' 348' ' ' ASP . 65.3 ttp -33.88 -44.05 0.15 Allowed 'General case' 0 C--N 1.284 -2.274 0 N-CA-C 115.586 1.698 . . . . 0.0 115.586 -174.135 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 444' ' ' ASP . . . . . . . . . . . . . 72.2 m-20 -65.67 -11.37 44.33 Favored 'General case' 0 C--N 1.282 -2.35 0 CA-C-O 115.88 -2.009 . . . . 0.0 110.995 -179.543 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 445' ' ' GLU . . . . . . . . . . . . . 74.9 mm-40 -105.59 12.72 30.9 Favored 'General case' 0 C--N 1.296 -1.731 0 CA-C-N 123.049 2.659 . . . . 0.0 111.539 -179.716 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 446' ' ' ILE . . . . . 0.554 HD12 HG21 ' B' ' 440' ' ' ILE . 96.7 mt -120.44 140.92 43.0 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.053 0 C-N-CA 115.898 -2.321 . . . . 0.0 113.898 -177.12 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 447' ' ' LYS . . . . . . . . . . . . 0.255 98.7 mttt -74.51 -54.61 7.19 Favored 'General case' 0 C--O 1.222 -0.377 0 CA-C-N 114.376 -1.283 . . . . 0.0 109.751 -179.802 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 448' ' ' GLU . . . . . 0.461 ' O ' ' HA ' ' B' ' 466' ' ' ILE . 0.0 OUTLIER -147.4 145.48 29.26 Favored 'General case' 0 C--N 1.288 -2.071 0 CA-C-O 123.831 1.777 . . . . 0.0 113.879 177.19 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 449' ' ' LEU . . . . . 0.832 HD11 HD13 ' B' ' 440' ' ' ILE . 0.5 OUTLIER -115.58 112.22 21.86 Favored 'General case' 0 N--CA 1.414 -2.228 0 CA-C-N 110.961 -2.836 . . . . 0.0 109.958 177.284 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 450' ' ' ILE . . . . . . . . . . . . . 62.1 mt -109.0 112.33 40.02 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.231 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 177.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 451' ' ' LYS . . . . . . . . . . . . . 34.7 mttt -85.07 129.77 34.74 Favored 'General case' 0 C--N 1.305 -1.343 0 C-N-CA 124.635 1.174 . . . . 0.0 113.2 -178.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 452' ' ' LEU . . . . . . . . . . . . 0.301 31.5 mt -94.29 175.63 6.62 Favored 'General case' 0 N--CA 1.415 -2.194 0 CA-C-O 122.67 1.224 . . . . 0.0 112.314 -179.341 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 453' ' ' SER . . . . . . . . . . . . 0.277 0.5 OUTLIER -131.05 160.38 34.8 Favored 'General case' 0 C--N 1.296 -1.749 0 CA-C-N 113.455 -1.702 . . . . 0.0 114.729 -174.371 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 454' ' ' GLY . . . . . . . . . . . . . . . 100.31 -158.87 19.4 Favored Glycine 0 CA--C 1.529 0.944 0 N-CA-C 118.743 2.257 . . . . 0.0 118.743 174.327 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 455' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -94.75 142.34 27.57 Favored 'General case' 0 C--O 1.215 -0.739 0 CA-C-N 111.987 -2.107 . . . . 0.0 109.939 -178.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 456' ' ' VAL . . . . . 0.537 HG11 HG12 ' B' ' 463' ' ' VAL . 16.5 m -132.02 159.65 42.97 Favored 'Isoleucine or valine' 0 CA--C 1.46 -2.515 0 CA-C-O 122.795 1.283 . . . . 0.0 110.042 -177.549 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 457' ' ' THR . . . . . . . . . . . . . 20.5 m -122.73 123.64 41.55 Favored 'General case' 0 C--N 1.272 -2.773 0 CA-C-N 112.693 -2.049 . . . . 0.0 108.319 -179.63 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 458' ' ' VAL . . . . . . . . . . . . . 11.9 p -37.22 123.71 0.16 Allowed 'Isoleucine or valine' 0 C--O 1.217 -0.638 0 CA-C-O 123.808 1.765 . . . . 0.0 113.974 179.24 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 459' ' ' GLY . . . . . . . . . . . . . . . 61.1 25.97 65.15 Favored Glycine 0 CA--C 1.487 -1.683 0 CA-C-N 112.792 -2.003 . . . . 0.0 114.155 175.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 460' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -136.5 -53.24 0.72 Allowed 'General case' 0 C--N 1.287 -2.117 0 CA-C-O 121.979 0.895 . . . . 0.0 111.9 178.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 461' ' ' THR . . . . . 0.453 ' CG2' HG12 ' B' ' 456' ' ' VAL . 8.9 m -85.41 122.99 73.51 Favored Pre-proline 0 C--N 1.284 -2.27 0 N-CA-C 114.097 1.147 . . . . 0.0 114.097 -175.691 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 462' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -62.48 141.42 86.53 Favored 'Trans proline' 0 CA--C 1.54 0.792 0 C-N-CA 123.104 2.536 . . . . 0.0 109.723 177.642 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 463' ' ' VAL . . . . . 0.537 HG12 HG11 ' B' ' 456' ' ' VAL . 29.3 m -116.68 -27.97 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 O-C-N 121.692 -0.63 . . . . 0.0 112.173 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 464' ' ' ILE . . . . . . . . . . . . . 30.5 mt -141.08 151.09 19.94 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.063 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 179.343 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 465' ' ' ARG . . . . . . . . . . . . . 5.9 mtt180 -125.89 130.72 51.89 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 105.78 -1.933 . . . . 0.0 105.78 176.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 466' ' ' ILE . . . . . 0.823 ' CG1' ' HB ' ' B' ' 320' ' ' ILE . 40.1 pt -128.38 155.61 40.19 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.632 0 C-N-CA 118.971 -1.091 . . . . 0.0 109.825 -178.064 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 467' ' ' LYS . . . . . 0.429 ' O ' HG23 ' B' ' 446' ' ' ILE . 1.0 OUTLIER . . . . . 0 C--N 1.295 -1.787 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 176.64 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 500' ' ' PO3 . . . . . 0.416 ' O3 ' ' CE2' ' B' ' 371' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 stop_ save_